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This work reports the synthesis and use of novel glycopolymeric structures 
synthesised via polymer and supramolecular chemistry for lectin-binding studies.  
A novel β-cyclodextrin initiator was developed for the polymerisation of sequence-
controlled star-shaped polymers. Three distinct methods were explored, using well known 
‘click’ or ‘click-like’ reactions after which it was found that radical thiol-ene offers the best 
initiator. Subsequently, this β-cyclodextrin based initiator was used for the sequence-
controlled polymerisation of three different acrylates via single-electron transfer – living 
radical polymerisation (SET-LRP). 
In a second project, the influence of arm number and arm length of star-shaped 
glycopolymers was investigated towards a series of lectins found on dendritic and 
Langerhans cells. Novel star shaped initiators were synthesised and characterised and 
subsequently used for the polymerisation of glycomonomers via SET-LRP. Lectin-binding 
affinity for the synthesised glycopolymers was finally investigated via surface plasmon 
resonance (SPR) 
The third project describes the synthesis of novel glycopolymeric structures starting 
from commercially available polyethylenimine (PEI) via a supramolecular approach. Firstly, 
commercially available PEI was modified to contain appending adamantane units. Secondly 
a β-cyclodextrin was modified to contain seven appending mannose sugars, and also a β-
cyclodextrin based mannose star-shaped glycopolymer was synthesised. Subsequently 
mannosylated PEI’s (glycoPEI) were achieved by host-guest complexation between the 
adamantyl residues and the β-cyclodextrin based mannose compounds. Finally the 
glycoPEIs were used as a self-amplifying RNA (saRNA) delivery platform both in vitro and 
ex vivo. 
Finally, the synthesis and characterisation of single-chain glycopolymeric 
nanoparticles achieved via a supramolecular approach were described. Mannose and ethyl 
hexyl acrylate containing amphiphilic glycopolymers with appending chiral benzene-1,3,5-
tricarboxamide (BTA) units were synthesised via SET-LRP. After dissolution, heating and 
sonication, these polymeric compounds formed single-chain polymeric nanoparticles 
(SCPNs). These SCPNs were subsequently physically characterised via DLS, CD and SAXS 
and furthermore tested for their lectin binding efficiency via SPR towards a series of lectins 
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Introduction to glycopolymer 
synthesis 
 
Glycopolymers are synthetic carbohydrate containing materials capable of 
interacting and binding to specific targeting lectins, which are crucially important in 
many biological processes. Over the last decade, advances in synthetic chemistry 
and polymerisation techniques have enabled the development of sequence and 
architecturally controlled glycopolymers for different types of bioapplications such as 
drug delivery and release purposes, gene therapy, lectin-based biosensors and 
much more. These precision glycopolymers are able to mimic structural and 
functional features of the naturally existing glycocalyx. This introductory chapter will 
focus on synthesis methods, recent advances in precision synthesis and 
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I Introduction to glycopolymer 
synthesis 
I.1 Controlled Radical Polymerisation Techniques 
One of the most important mile stones in polymer synthesis is undoubtedly the 
development of the living polymerisations by Michael Szwarc in 1956.1,2 Szwarc firstly 
demonstrated the principle with an anionic polymerisation of styrene in an alkali metal / 
naphthalene system in THF. He found that the viscosity of the system would increase 
gradually after the initial addition of the monomer to the initiator system which is perfectly 
in line with polymer chain growth. However, after addition of ‘new’ monomer to the 
system he found another increase in viscosity which indicated that the polymer chains 
had yet again grown and concluded the polymerisation had never been terminated. The 
term living polymerisation was then denoted as a chain growth polymerisation for which 
termination and/or transfer reactions were absent. 
The first living polymerisations were based on anionic and cationic polymerisation 
techniques. Due to the fact that equal charges do not react with one another, termination 
and transfer reactions can be excluded, resulting in the preservation of the active chain 
ends. The main drawbacks though, are the incompatibility of such techniques to certain 
functional groups, the low number of compatible monomers and the need for stringent 
reagent preparation and reaction conditions. 
Free radical polymerisations (FRP) on the other hand enabled the synthesis of 
high molecular weight polymers owing to their mild reaction conditions and high tolerance 
toward solvents, impurities and several functional groups.3 Unlike living polymerisations, 
FRP still suffers from a lack of control over most important polymer features such as 
molecular weight, end-group functionality and dispersity. All essential elements for well-
defined organic polymeric materials. 
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I.1.1 Introduction to Controlled Radical Polymerisation methods 
In order to resolve the above mentioned problems with FRP, controlled radical 
polymerisation techniques (CRP) were developed over the past 20 years.4 These 
methods offer an exceptional control over the polymerisation process, which allows the 
development of well-defined polymers with a good control over molecular weight, 
composition, dispersity, overall architecture and end-group functionality.  
The observed limited control during the FRP process is mainly caused by the high 
concentration of radicals [𝑃•] in the reaction mixture. The biradical termination reaction 
during radical polymerisations displays a second rate order (quadratic relation with the 
concentration of radicals in the reaction medium, 𝑅𝑡 = 𝑘𝑡[𝑃
•]2), while propagation is a 
first order rate process.5 In general all controlled radical polymerisation techniques rely 
on a dynamic equilibrium between the active propagating radicals and various dormant 
species. Hence, resulting in a dramatic decrease in concentration of active propagating 
radicals. At concentrations in the range of ppm to ppb, termination reactions are 
negligible. The fast equilibrium between active and dormant species results in all polymer 
chains propagating at the same rate enabling the synthesis of homogeneous products. 
Another way to achieve a controlled radical polymerisation consists of a degenerative 





𝑅𝑝 = Propagation rate  𝑘𝑡 = Termination rate coefficient 
𝑅𝑡 = Termination rate   [𝑃𝑛
•] = Radical concentration 
𝑘𝑝 = Propagation rate coefficient [𝑀] = Monomer concentration 
  
Several CRP methods have been developed based on these general 
mechanisms, and the most widely used ones can be listed as nitroxide mediated 





Scheme I.1.1 Controlled radical polymerisation mechanism: a) Deactivation/activation process; 
b) Degenerative exchange process. 
In general, nitroxide mediated polymerisation (NMP) relies on the dissociation of 
an initiator into two radicals 𝑅•. Subsequently these radicals can react in an irreversible 
way with vinyl monomers, thereby starting the polymerisation process. Generation of the 
dormant species is in this case achieved by the reaction of a radical chain end with a 
stable persistent nitroxide radical in the reaction medium. Typically tetramethyl 
piperidinyloxy (TEMPO) or N-tert-butyl-1-diethylphosphono-2 2-dimethylpropyl nitroxide 
(SG1) are used (Figure I.1.1). Although a high control over polymer properties is 
achieved, the required (high) reaction temperature and low monomer compatibility limit 
the applicability, since mostly styrenic or acrylic derivatives are used.10 
 
Figure I.1.1 a) Nitroxide stabile radicals applied in NMP: TEMPO (left) and SG1 (middle); b) 
Thiocarbonylthio compounds used in RAFT polymerisations (right). 
I.1.1.1 Reversible chain transfer polymerisation 
Reversible chain transfer polymerisation encompasses several polymerisation 
techniques, including iodine transfer polymerisation (ITP), which is more thoroughly 
explained in a review on iodo compounds in radical polymerisations, and reversible 
addition-fragmentation chain-transfer polymerisation (RAFT).11 RAFT was first reported 
in 1998 by Rizzardo et al. and the group of Charmot. The wide range of functional 
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monomers which are polymerisable via RAFT and the possibility to introduce different 
end-group functionalities at the α-terminus via the chain transfer agent (CTA) enables 
the synthesis of well-defined complex macromolecules. 
 
Scheme I.1.2 Reversible chain transfer in RAFT polymerisations 
RAFT relies on a degenerative exchange process whereby a thiocarbonylthio 
compound is used as a chain transfer agent (CTA), creating a free living radical 
polymerisation system. A wide variety of thiocompounds have been reported as CTA’s 
including dithioesters, dithiocarbamates, trithiocarbonates and xanthates. 
Mechanistically, the RAFT process involves a series of addition-fragmentation steps. At 
first, the addition of a propagating radical 𝑃𝑛
• to the CTA results in the formation of a 
polymeric thiocarbonylthio compound and a new radical 𝑅•.This newly formed radical 
readily reacts with surrounding monomers forming a new propagating radical 𝑃𝑚
• . The 
fast equilibrium between the active propagating radicals and the dormant polymeric 
thiocarbonylthio compounds provides polymers with a low dispersity Đ. A more detailed 
explanation of these methods can be found in a number of reviews. 6,7,10,11 
I.1.2 Cu-Mediated Polymerisation 
In the following section, copper catalysed controlled radical polymerisation 
techniques will be more thoroughly examined. At first, Atom Transfer Radical 
Polymerisation, aka ATRP, will be discussed, subsequently the more novel Cu0-
mediated polymerisation will be addressed.  
I.1.2.1 Atom Transfer Radical Polymerisation 
Atom Transfer Radical Polymerisation (ATRP) is one of the most commonly 
controlled radical polymerisation techniques used in modern day research. ATRP was 
developed in 1995 by two separate groups independently, namely the groups of 
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Sawamoto12 and Matyjaszewski13. The name Atom Transfer Radical Polymerisation 
refers to the key step reaction which ensures a good control and uniform chain growth, 
the atom transfer step.  
The general mechanism of ATRP relies on a reversible redox process which 
creates radicals in the system. A transition metal complex (𝑀𝑡
𝑛/𝐿) in its lower oxidation 
state catalyses the formation of active radicals abstracting a halogen atom X 
homolytically of an ATRP initiator (𝑅 − 𝑋).14 The reaction generates an alkyl radical 𝑅•, 
while the metal complex is transformed into its higher oxidation state (𝑋 − 𝑀𝑡
𝑛+1/𝐿). The 
newly active radical species can then propagate with vinyl monomer species, be 
reversibly transformed into a dormant species (𝑃𝑛 − 𝑋) through the addition of a halogen 
atom or undergo a termination reaction (radical-radical coupling or disproportionation). 
The low levels of active species however make that the termination reactions are 
negligible.15 
 
Scheme I.1.3 Main ATRP equilibrium, shifted to the sleeping state. Propagation only occurs when 
activated. 
Several transition metal complexes can be employed (e.g. molybdenum, iron, 
rhodium, palladium and copper). The metal complex needs to fulfil a few requirements: 
- The complex needs to have a free coordination space, which is necessary for 
addition of the halogen atom to the complex. 
- The metal’s lower oxidation state should be more stable as compared to its 
higher oxidation state, this in order to achieve a lower radical concentration. 
- The reversible redox process should occur fast. 
- The complex should show high affinity towards halogen atoms and a low 
affinity towards other species in the system. 
The most commonly used transition metal is copper, whereas certain iron and 
ruthenium complexes have also been reported. The wide use of copper is due to its high 
applicability with several monomers and the relatively low cost. A myriad of ligands have 
been extensively studied and used in Cu-mediated ATRP, the most important ligands 
include aromatic pyridine derivatives and aliphatic amines such as tris(2-
pyridylmethyl)amine (TMPA) and N,N,N’,N’,N”-pentamethyldiethylenetriamine 
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(PMDETA).16 This type of CRP has been successfully used with a whole range of 
monomer types, such as styrenes, (meth)acrylates, (meth)acrylamides and acrylonitriles 
leading to polymers with predetermined molecular weights, narrow dispersities and good 
control over the functionalities. ATRP of nitrogen containing monomers however, proves 
to be troublesome as monomer and polymer complexation with the catalyst can lower its 
activity. 
Although well-defined polymers are readily obtained via ATRP, the major 
disadvantage of this system is the need for high amounts of transition metal catalyst. 
Despite several purification methods have been developed to address this problem, 
there was still a need for lower transition metal concentrations, as these purification 
methods were generally time-consuming and prohibitively expensive.  
The development of three new concepts by Matyjaszewski et al. allowed for a 
reduction of catalyst while still maintaining a controlled polymerisation. The first concept 
‘Activators ReGenerated by Electron Transfer’ (ARGET) ATRP makes use of an excess 
of reducing agent in the system (e.g. derivatives of hydrazine, ascorbic acid, sugars,…) 
that regenerates the active catalyst from the deactivating species that accumulate via 
unavoidable termination reactions. In the second concept which is called ‘Initiators for 
Continuous Activator Regeneration’ (ICAR) ATRP, the use of reducing agent (in ARGET) 
is replaced by radical initiators which continually reduce and regenerate Cu(I) species. 
Furthermore, the use of an externally applied electrochemical potential over the system, 
allows for a reversible activation of the copper catalyst for ATRP by a one-electron 
reduction of an initially added air-stable cupric species Cu(II)/L, and thus the eATRP 
concept.9,17 These methods allow for a vast reduction in catalyst amount to only a few 
ppm leading to near colourless products. Moreover, the reactions are less sensitive to 




Scheme I.1.4 Main ICAR, ARGET and eATRP equilibria. Compared to classic ATRP, a reductant 
is added in order to reduce the increasing amount of oxidised metal species due to termination 
reaction. 
I.1.2.2 Cu0-Mediated Living Radical Polymerisation 
In 2006 Percec et al. reported a new concept solving the need for high catalyst 
amounts in ATRP.18–20 This then relatively new technique, further referred to as Single 
Electron Transfer – Living Radical Polymerisation (SET-LRP), makes use of the initiators 
commonly used in ATRP, in combination with elemental copper as the active species, 
which makes it resemble ATRP mechanistically. By altering the reaction conditions 
favouring electron transfer and disproportionation of in situ produced Cu(I) and the 
change of active catalyst to Cu(0), a different polymerisation mechanism is acquired.  
The proposed mechanism can be divided into four main steps: 
- Activation of the initiator and dormant chains by Cu(0) via a heterogeneous 
single electron transfer (SET). 
- Disproportionation of in situ produced Cu(I) into Cu(0) and Cu(II). 
- Propagation of the growing polymer chains. 
- Deactivation of the propagating polymer radicals by Cu(II) forming Cu(I), 




Scheme I.1.5 Proposed mechanism for the Cu0-mediated polymerisation 
Essential to the Cu(0)-mediated system is the disproportionation step, which 
delivers both the activating and the deactivating species. In absence of this step, the 
polymerisation would not be sufficiently controlled due to the lack of deactivating Cu(II). 
In contrast to aqueous media, this disproportionation of Cu(I) does not happen 
necessarily. Rapid disproportionation can be attained by using suitable N-ligands, and 
can often be confirmed in a visual manner by the formation of a blue or green colour in 
the reaction mixture due to the presence of Cu(II).21 
The solubility of the copper and halide ions in the reaction mixture are also strongly 
determined by the solvent composition. Generally, strongly polar or protic solvents give 
rise to dissociated Cu(I)X and Cu(II)X2 salts and highly solvated ions. The addition of 
multidentate N-ligands such as Me6TREN, TREN or PMDETA further enhances this 
dissociation, as the copper ions are stabilised as complexes. 
I.1.2.3  Critical comparison of SARA ATRP and SET-LRP 
Besides the mechanism proposed by Percec stated above, another concept 
developed by Matyjaszewski et al. called ‘Supplemental Activator and Reducing Agent 
ATRP’ (SARA ATRP) debates this principle. The main difference between these two 
concepts lies in the role of the different copper species during the polymerisation. 
Although the exact same components are used in both mechanisms, the difference lies 




In SARA ATRP Cu(I) is regarded as the major activator of alkyl halides. On the 
other hand, Cu(0) functions as a supplemental activator and a reducing agent of Cu(II) 
via comproportionation. In contrast to SET-LRP where the activation of the alkyl halides 
occurs by outer sphere electron transfer (OSET), the electron transfer in the activation 
step in SARA ATRP occurs via an inner sphere electron transfer (ISET).19,22 
 
Scheme I.1.6 Proposed mechanisms for SARA ATRP and SET-LRP, showing the most 
contributing reactions in bold.22 
In recent literature both research groups (Matyjaszewski and Percec) have made 
compelling arguments for either proposed mechanism, which are nicely summarised in 
the recent review by Haddleton et al.19 However, a universally applicable mechanism 
should be identified in order to end this controversy, because this labelling of reactions, 
as Matyjaszewski stated, is comparable to differentiating between SN1 and SN2 reactions 
in traditional organic chemistry. Furthermore, for our research objectives, the resulting 
polymer features are way more important than the occurring reaction mechanism. For 
this reason, experimental methods in this thesis, are employed as they have been found 
in SET-LRP literature. The advantages of SET-LRP are first of all the simple removal of 
the copper catalyst from the polymer, as it is heterogeneous to the polymerisation 
system. Secondly the polymerisation rates are a lot quicker as compared to conventional 
ATRP, while using a lot less copper catalyst. However, the main advantage of using 
SET-LRP remains the high chain-end fidelity (even at 99% conversion), which makes 





I.2  Click Reactions in Polymer Chemistry 
At present, in material science, organic chemistry and pharmacological areas, 
there’s an increasing demand for the preparation of structurally complex molecules 
through a rational design. From an industrial point of view, practical applications can only 
exist if the required synthetic route is both synthetically and economically viable. A 
synthetic route’s success is mainly dependent on the success of the individual reactions. 
For this reason, a change in strategy was needed in order to provide reliable synthetic 
pathways.  
This change in strategy had arrived in 2001 when the term ‘click’ chemistry was 
introduced by Sharpless et al..23 ‘Click’ chemistry encompasses a number of coupling 
procedures that comply with a set of stringent criteria: “The reaction must be modular, 
wide in scope, give very high yields, generate only inoffensive byproducts that can be 
removed by non-chromatographic methods, and be stereospecific (but not necessarily 
enantioselective). The required process characteristics include simple reaction 
conditions (ideally, the process should be insensitive to oxygen and water), readily 
available starting materials and reagents, the use of no solvent or a solvent that is benign 
(such as water) or easily removed and simple product isolation. Purification –if required- 
must be by non-chromatographic methods, such as crystallization or distillation and the 
products must be stable under physiological conditions.” Chemically, this means a ‘click’ 
reaction should be orthogonal (highly specific and regioselective). A high thermodynamic 
driving force (usually above 20 kJ/mol) achieves these required characteristics. Such 
processes usually proceed rapidly to completion and tend to be highly selective. Most 
common examples of click chemistry include: 
- Cycloadditions to unsaturated species, notably 1,3-dipolar cycloaddition 
reactions, but also Diels-Alder type of cycloaddition reactions. 
- Nucleophilic substitution reactions, especially ring-opening reactions of 
strained heterocyclic electrophiles such as epoxides, aziridines, etc. 
- Carbonyl reactions (excluding aldol reactions): e.g. urea formation, amide 
formation, etc. 
- Additions to carbon-carbon double bonds: oxidative reactions such as 
epoxidations, dihydroxylation, aziridination but also Michael addition 
reactions especially the thiol-ene reaction. 
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However, the term ‘click’ reaction has become such a powerful, relevant and 
commonly used term that articles and reviews use the term ‘click’ to describe reactions 
that often do not proceed to high conversions or require tedious purification methods. 
For this reason several polymer chemists have teamed up to defend the core ideas of 
‘click’ chemistry and pointed out a set of requirements that should be fulfilled in order for 
a reaction to be labelled as ‘click’ in the context of macromolecular chemistry.24 The 
additional polymer specific criteria include equimolarity and easy large-scale purification. 
I.2.1 Copper(I) Catalysed Azide-Alkyne Cycloaddition 
The most important and most frequently employed click reaction is undoubtedly 
the Huisgen 1,3-dipolar azide-alkyne cycloaddition. The popularity of this reaction can 
mainly be attributed to the fact that alkyne and azide components can easily be 
incorporated into a wide range of substituents. Additionally, this type of click reaction is 
very unique as the azide moiety is absent in almost all natural compounds and lacks 
reactivity towards other functional groups. However, the major drawbacks of the original, 
uncatalysed azide-alkyne (Huisgen) cycloaddition were that it proceeded rather slowly, 
requiring high temperatures or pressures and yielding a mixture of different (1,4- and 1,5-
)triazoles, which was not in line with the simple reactions conditions and stereospecificity. 
These rather important drawbacks were successfully overcome by the introduction of the 
copper catalysed 1,3-dipolar cycloaddition reaction of azides and alkynes, independently 
reported by Meldal et al. and Sharpless et al..25,26 Using a Cu(I) catalyst, exclusively 
yields the 1,4-substituted 1,2,3-triazole and excessively accelerates the reaction, 




Scheme I.2.1 Proposed mechanism for the Cu(I)-catalysed azide-alkyne cycloaddition. 
Unlike the thermal dipolar azide-alkyne cycloaddition which occurs through a 
concerted mechanism, the Cu(I) catalysed azide-alkyne click reaction is thought to 
proceed via a stepwise mechanism. It is mainly accepted that the stepwise catalytic cycle 
starts with the formation of a Cu(I) acetylide species via the π-complex. In addition to 
Cu(I), also other metal catalysts such as Ni(II), Pt(II) and Pd(II) have been investigated 
however, their catalytic activity seems much lower as compared to Cu(I). Ru(II) on the 
other hand is of particular interest as this metal allows the coupling of azides to internal 
alkynes whereas Cu(I) only catalyses the reaction on terminal alkynes. Moreover, the 
different catalytic mechanism of the Ru(II) catalyst results in only pure 1,5-substituted 
1,2,3-triazoles when the azide is clicked with a terminal alkyne.  
I.2.2 Metal-free Click Chemistry 
Although, very efficient, disadvantages such as the need for metal catalyst and 
safety issues related to the use of azides have made this reaction quite unsuitable for 
biological and/or industrial applications. These drawbacks have inspired scientists to 




I.2.2.1  Strain-Promoted Azide-Alkyne Cycloadditions 
The strain-promoted azide-alkyne cycloaddition (SPAAC) was first noted in 1961 
by Wittig and Krebs who noticed that the reaction between cyclooctyne and phenylazide 
proceeded explosively fast (explosionsartig).27 In 2004 Bertozzi et al. proposed to use 
this SPAAC reaction in chemical biology, however, the first generation of these 
unactivated cyclooctynes gave rather slow kinetics as compared to the CuAAC 
reaction.28,29 This limitation was dramatically improved through the introduction of 
electron-withdrawing groups (such as fluoride) on the α-position of the triple bond. The 
high reactivity can be explained by the geometrical deformation of the alkyne bond due 
to the ring strain, along with the electron deficiency of the triple bond. However, 
considering the absence of regioselectivity (1,4- and 1,5-substituted triazoles) and the 
fact that the synthesis of these substituted cyclooctynes is rather demanding, it seems 
improbable that these reactions will fully replace the CuAAC reaction.   
 
Scheme I.2.2 Strain-promoted azide-alkyne cycloaddition reaction of an azide with a cyclooctyne. 
I.2.2.2  ‘Click’-Inspired Thiol-X Reactions 
Thiols are inherently extremely reactive due to the high polarizability and available 
d-orbitals on the sulphur atom. This high reactivity has led to thiols being used for a 
variety of very efficient thiol-based reactions with a myriad of readily available and useful 
substrates. Thiolate anions, for example, can mainly be employed in nucleophilic 
reactions such as Michael additions to electron poor alkenes, but also reactions with 
isocyanates, epoxides and halogens. On the other hand, thiyl radicals find their 
substrates in an array of electron rich alkynes and alkenes. However, this high reactivity 
of thiols implies a restriction. Despite often being classified as a ‘click’ reaction, thiol-X 
reactions are not chemoselective or orthogonal towards solvents, reagents and 
functional groups other than the desired thiol-X reaction which is not in line with the 
original definition by Sharpless vide supra. The following two sections will discuss the 
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most important of thiol-X reactions, namely the radical thiol-ene reaction and the 
nucleophilic (Michael addition) thiol-ene reaction. For further information on other thiol 
related ‘click’ reactions, the reader is referred to the excellent review by Hoyle et al.30  
 
Scheme I.2.3 A variety of efficient thiol-X reactions. EWG=electron withdrawing group. X=Br, I 
and R1=aliphatic or aromatic groups.30 
Radical thiol-ene reaction. The thiol-ene reaction has first been mentioned as 
early as in 1905. Basically, the radical thiol-ene reaction consists of three parts: initiation, 
propagation and finally termination. Research conducted by Yağcı et al., pointed out that 
initiation is preferred to happen photochemically using type I photo initiators such as 
DMPA.31 Following the formation of radicals, the thiol is converted into the corresponding 
thiyl radical through hydrogen abstraction. Subsequently the propagation follows two 
main steps. At first, the thiyl radical inserts itself into the carbon-carbon double bond 
resulting in a carbon centred radical. Secondly, the newly formed carbon radical 
abstracts a hydrogen from a thiol in close proximity, resulting in the formation of the anti-
Markovnikov thiol-ene product and a new thiyl radical. Termination finally ensues by 





Scheme I.2.4 Mechanism for the radical Thiol-Ene reaction. 
Radical thiol-yne reaction. Although similar to the radical thiol-ene reaction, the 
radical thiol-yne reaction offers a unique way of synthesizing dithiols with 1,2-
regioselectivity. Analogous to the radical thiol-ene reaction, a thiyl radical is formed 
photochemically or thermally. This newly formed thiyl radical further undergoes 
immediate addition to the triple bond resulting in an intermediate thioether vinyl radical. 
Ensuing this first thiol-ene reaction, a second thiol is added radically in a rate three times 
faster as compared to the initial thiol-yne reaction.  
 
Scheme I.2.5 Proposed mechanism for the radical Thiol-Yne reaction. 
Nucleophilic thiol-ene reaction. Apart from the radical mechanism vide supra, 
thiol-ene reactions can also occur via a 1,4-Michael addition to activated alkenes. This 
thiol-Michael addition reaction can easily be catalysed using catalytic amounts of either 
a nucleophile or a base. The base catalysed reaction occurs via three distinct steps. 
First, a thiolate anion is created by deprotonation of the thiol by the base. Secondly, the 
thiolate anion adds to the electron deficient alkene yielding an enolate anion. Lastly, 
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deprotonation of a protonated base or thiol results in the formation of the thioether end 
product. The yield and reaction kinetics of this base-catalysed system mainly depend on 
the concentration and strength of the base catalyst, the thiol 𝑝𝐾𝑎, but also steric 
accessibility and nature of the electron withdrawing group. 
 
Scheme I.2.6 The base and nucleophile catalysed Michael addition reaction mechanisms. 
In contrast to the base-catalysed reaction the nucleophile in the nucleophilic 
pathway does not really catalyse the reaction. It rather reacts with the electron-deficient 
alkene generating a strong base. The amount of active thiolate that is generated is 
strongly influenced by the nucleophilicity of the catalyst. For this purpose phosphines 
tend to be better catalysts as compared to several amines. Further information on thiol-
ene reactions, regarding substrate reactivity for example can be found in a review by 




I.3 Supramolecular Interactions 
As the title of this PhD suggests, supramolecular interactions will form an important 
tool in the synthesis of our desired compounds and thus understanding the dynamic 
nature of these physicochemical interactions is essential. J.-M. Lehn defined the field as 
following: Supramolecular chemistry, the chemistry beyond the molecule, is the designed 
chemistry of the intermolecular bond, just as molecular chemistry is that of the covalent 
bond.33 The field of supramolecular chemistry originates from back in the 1960s when 
new discoveries such as crown ethers (by Pedersen), cryptands (by Lehn) and 
spherands (by Cram) led scientists to realise that small, complementary molecules could 
be made to recognise each other via noncovalent interactions.34–36 Noncovalent 
interactions include ionic interactions (ion-ion, ion-dipole, dipole-dipole), metal 
coordination, hydrogen bonding, Van der Waals forces, solvophobic interactions, etc. 
The relevant interactions important for this thesis will briefly be discussed, for further 
information and better understanding of the underlying principles in supramolecular 
chemistry, the reader is referred to an excellent review by Hans-Jörg Schneider.37 
I.3.1 Host-guest interactions: Cyclodextrins 
 
Figure I.3.1 Chemical structure of cyclodextrins (left): n=1 α-cyclodextrin, n=2 β-cyclodextrin and 
n=3 γ-cyclodextrin and chemical structure of adamantane (right) 
Cyclodextrins are cyclic oligosaccharides which consist of six, seven, eight or 
even more glucopyranose units respectively called α-cyclodextrin, β-cyclodextrin and γ-
cyclodextrin. X-ray structures revealed that in cyclodextrins, the secondary hydroxyl 
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groups (C2 and C3) are found on the wider edge of the ring while the primary hydroxyl 
groups (C6) are on the other edge.38 The apolar C3 and C5 hydrogens and ether-like 
oxygens are furthermore found at the inside of these torus-like molecules. These 
structural features result in a molecule displaying a hydrophilic exterior, dissolvable in 
water and an apolar cavity which acts as a hydrophobic matrix described as a ‘micro 
heterogeneous environment.39 The synthetically (enzymatically) most accessible of 
cyclodextrins is β-cyclodextrin and as a consequence the lowest-priced and generally 
the most useful. The most important properties of cyclodextrins can be found in Table 
I.3-1. 
Table I.3-1 Cyclodextrin properties39 
Property α-cyclodextrin β-cyclodextrin γ-cyclodextrin 
Number of glucopyranose units 6 7 8 
Molecular weight (g/mol) 972 1135 1297 
Solubility in water at 25˚C (%,  w/v) 14.5 1.85 23.2 
Outer diameter (Å) 14.6 15.4 17.5 
Cavity diameter (Å) 4.7–5.3 6.0–6.5 7.5–8.3 
Height of  torus (Å) 7.9 7.9 7.9 
Cavity volume (Å3) 174 262 427 
 
The most remarkable feature of cyclodextrins is their inherent capability to form 
host-guest complexes with a wide variety of solid, liquid and gaseous compounds. Guest 
molecules are held within the cavity of the respective cyclodextrin forming an 
intermolecular complex. The hydrophobic cavity of the cyclodextrin molecule displays a 
microenvironment which can accommodate appropriately sized apolar molecules. 
During the formation of the inclusion complex, no covalent bonds are broken or formed, 
however the main driving force of complex formation stems from the release of energy-
rich water molecules from the cavity resulting in an increase of entropy. The hydrophobic 
guest molecules displace the water molecules resulting in an apolar-apolar association 
which furthermore decreases the cyclodextrin’s ring strain, finally resulting in a more 
stable lower energy state. As all supramolecular interactions, host-guest complexation 
is not fixed but displays a rather dynamic equilibrium. This dynamic equilibrium highly 
depends on how well the host and guest ‘fit’ together and secondly on the 
thermodynamic interactions between the different components of the system 
(cyclodextrin, guest and solvent). A net energetic driving force is crucial to achieve 
complex formation.  
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Generally, four main interactions can be identified which help shift the equilibrium 
towards the inclusion complex. These comprise: 
 The displacement of high energy water molecules from the cavity. 
 An increase in hydrogen bonds as displaced water returns to the aqueous 
environment. 
 A reduction in repulsive interactions between the (hydrophobic) guest and 
the aqueous environment. 
 An increase in hydrophobic interactions between the guest and the apolar 
cavity. 
Perhaps the most famous of all guest molecules is the hydrocarbon adamantane. 
Adamantane derivatives are capable of forming unusually strong complexes with β-
cyclodextrin owing to the fact that the adamantyl residue perfectly fits inside the cavity 
and the water molecules thus not have any space inside the cavity. The adamantane 
residues have an approximate spherical shape with an estimated radius of 3.6 Å which 
is slightly larger than the free space radii (Rp and Rs) close to the H3 and H5 atoms (Figure 
I.3.2).40 For this reason, two separate complexes can be formed with the adamantane 
guest located either at the primary rim region (complex cp) or at the secondary rim region 
(complex cs). Association constants of adamantane derivatives with β-cyclodextrin 
generally range around 3.52 × 104 for rimantadine (amino derivative of adamantane) and 
1.42 × 105 for adamantyl methanol. 
 
Figure I.3.2 Equilibrium between expected inclusion complexes formed by β-CD and adamantane 
derivatives, data in Å.40 
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I.3.2 Directional supramolecular motifs: Benzene-1,3,5- tricarboxamides 
Besides β-cyclodextrin, another supramolecular system will be exploited further 
down in this thesis. The benzene-1,3,5-tricarboxamide moiety, further simply referred to 
as BTA, and its derivatives have been extensively studied over the past 20 years (Figure 
I.3.3).41,42 BTAs have the inherent ability to self-assemble into helical supramolecular 
polymers which are stabilised by threefold hydrogen bonding.  
 
Figure I.3.3 General chemical structures of N- and C=O-centred benzene1,3,5-tricarboxamide 
(BTA) molecules. 
 The three amide moieties are able to form hydrogen bonds and (under selected 
conditions) they are capable of growing into one-dimensional supramolecular polymers 
(Figure. I.3.4). When a chiral centre is introduced into the alkyl side chains, helicity of 
the one-dimensional aggregates is achieved. This can be proved using circular dichroism 
(CD) spectroscopy in dilute apolar solutions, which shows a strong Cotton effect around 
225 nm. 
 
Figure I.3.4 Schematic representation of benzene-1,3,5-tricarboxamide into helical one-
dimensional stacks. 
 Apart from self-assembly in apolar solvents, solubility and additionally self-
assembly of the BTA moieties in water was also achieved via two distinct design 
strategies. The first and most straightforward strategy employs the replacement of the 
aliphatic chains of the BTA derivative by chiral poly(ethylene glycol) side chains, resulting 
in C3 symmetrical bipyridine discotics which self-assemble in water using strong 
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directional π-π and strong hydrophobic interactions.43 The second strategy, is based on 
the principle of hydrophobic shielding. 44 A BTA derivative containing an L-phenylalanine 
and aminobenzoate based spacer, provides a hydrophobic pocket in which the BTA core 
can still self-assemble using triple H-bonding. Water solubility, in this case, is furthermore 
achieved by a highly charged peripheral metal chelate complex.  
 
Figure I.3.5 Chemical structure of water soluble BTAs using tetra-ethyleneglycol and α-D-
glucopyranoside. 
More recently the same principle of a combination of hydrophobic shielding and 
the use of a water soluble group was employed in two distinct ways (Figure I.3.5). 
Hydrophobic shielding is achieved by using long chiral dodecyl alkyl spacers between 
the BTA and the water soluble group in both cases. Solubility in water was then achieved 
using water soluble tetra-ethylene glycol units, the second method (and most recent one) 
employs simple monosaccharides to achieve this water solubility.45,46 Using shorter alkyl 
spacers reflects the need of hydrophobic shielding as the compounds with shorter alkyl 
spacers self-assemble into shorter one-dimensional aggregates or not even at all and 




I.4 Glycopolymers and Lectin Recognition 
Multivalent protein-carbohydrate interactions play a pivotal role in a wide range 
of complex biological processes, such as intercellular recognition, signal transduction 
and host-pathogen recognition.47–51 Carbohydrates exhibit a great interaction capacity to 
specific lectins thanks to their monomeric units and their inherent highly branched 
nature.52–54 This specific interaction is greatly enhanced by a multivalency effect of 
densely packed carbohydrate molecules with unique functionalities, which is known as 
the “glycocluster effect”.55,56 The interactions between carbohydrates and lectins are 
created by hydrogen bonding, van der Waals' interactions and hydrophobic stacking at 
the molecular level.57,58 In contrast to other types of proteins, lectins are not products of 
the immune system and they display a great diversity in terms of their structure and 
size.59–61 Glycopolymers, which are essentially synthetic carbohydrate containing 
macromolecules, are able to mimic structural and functional features of oligosaccharides 
thanks to variations in anomeric status, linkage positions, branching, and introduction of 
site specific substitutions.62–66 A wide range of oligosaccharides have the capability of 
covering functionally important areas of lectins, of modulating the interactions with other 
biomolecules, and of affecting the rate of biological processes which in turn involves 
conformational changes thanks to their very sensitive sugar coding.67,68 This special 
sugar coding system allows them to have crucial biological roles with unusual 
oligosaccharide sequences, unusual presentations of common terminal sequences and 
even modifications of the sugars themselves.69,70 Hence, even though at present there 
has been great progress on the synthesis of well-defined glycopolymers and 
glyconanoparticles, there is still a demand for higher precision control on monomer 
sequences, compositions, and architectures in order to understand the nature of the 
carbohydrate-lectin interaction in more detail. 
During the last decade, there has been a great deal of interest in the integration 
of carbohydrates in nanotechnology.71–74 Advances in glyconanotechnology have 
allowed for the creation of  different bioactive glyconanostructures for various health 
related applications such as drug delivery, gene therapy, pathogen detection, toxin 
inhibition and the development of lectin-based biosensors.75–78 Nanoparticles 
functionalised with carbohydrates present a highly multivalent way for lectin interactions 
and allow for high local concentrations of ligands on a relatively small surface.79,80 
Glyconanoparticles as carbohydrate-based systems, provide a controlled platform for 
glycobiological studies because of their ability to mimic the behaviour of the naturally 
existing glycocalyx.80 Therefore, the design and engineering of highly innovative 
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glyconanoparticles with unique physicochemical properties will help further 
enhancement of specific recognition properties on multivalent scaffolds in glycoscience.  
  In the last couple of years, “single chain technology” has been explored for a 
deeper understanding of the multivalent functions and the precise folding mechanism of 
naturally occurring single-chain architectures of macromolecules in biological systems, 
such as secondary and tertiary structures of proteins and enzymes.81–83 In nature, many 
biomolecules exhibit reversible self-folding processes that are necessary for interfacial 
molecular recognition.84,85 Therefore, the introduction of precise synthetic single polymer 
chain folding is an important step forward towards the creation of more complex 
macromolecules with specific functionalities and properties in order to imitate complex 
biological systems. Not only polymer chemists are interested in developments in single-
chain collapse, but also researchers from various other areas, especially those in 
biology. Biologists are drawn to this field due to the inherent opportunities controlled 
folding would enable, in order to achieve synthetic polymers with specific biological 
functions.86–88 In light of these developments, single-chain folding of glycopolymers was 
discussed as a the newest step forward.       
I.4.1 Glycopolymers 
The increasing interest in glycopolymer synthesis resulted in a myriad of synthetic 
polysaccharides used as carbohydrate-vaccines, drug delivery systems and even found 
applications in tissue engineering exhibiting molecular-recognition abilities, 
biocompatibility and biodegradability. As stated before, the use of sugars as small 
molecule inhibitors offers great potential in pharmacological applications. On the other 
hand most carbohydrate ligands bind to their protein receptor rather weakly (usually 
association constants are way below 106 M-1). In order to achieve higher association 
constants, biology aggregated most saccharides into higher-order oligomeric structures 
of very high valency. The tight binding limitation was thus circumvented through 
multivalency. This phenomenon of enhancement in affinity by multivalency, noted by Lee 
et al. in 1995, is referred to as the ‘cluster glycoside effect’.89 
Generally, strategies in glycopolymer synthesis are carried out either by post-
glycosylation of preformed polymers or by direct polymerisation of glycomonomers. 
Several reviews have been published over the last decade by Stenzel, Haddleton, 
Cameron and recently Seto et al., reporting different glycopolymer architectures ranging 
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from linear to dendritic glycopolymers with different molecular weights, functional groups 
and carbohydrate densities.90–93 
I.4.1.1 Direct polymerisation of glycomonomers 
Glycopolymer synthesis via the direct polymerisation of saccharide containing 
monomers can be carried out by a range of polymerisation techniques. These include 
the ring-opening polymerisation (ROP), living anionic polymerisation, ring-opening 
metathesis polymerisation (ROMP), free-radical polymerisation (FRP), and furthermore 
controlled free-radical polymerisation techniques (CRP). This section will only 
encompass controlled radical polymerisation techniques, further information regarding 
other polymerisation techniques can be found in reviews by Stenzel, Haddleton, Becer 
and Albertin et al..90–92,94 
 
Nitroxide-Mediated Polymerisation (NMP). The first ever developed controlled 
radical polymerisation technique NMP has only been applied few times in glycopolymer 
synthesis. The main disadvantages the technique suffers from are the high temperatures 
needed to achieve homolytic cleavage of the alkoxyamine needed to initiate the 
polymerisation. Synthesis of glycopolymers via NMP was first described in 1998 by 
Fukuda et al. employing a styrenic monomer.95 Big differences were observed when 
using either protected or unprotected galactoses. Polymerisation of the unprotected 
monomer yielded only low conversions and low molecular weight polymers, whereas the 
polymerisation of the protected monomer afforded uniform polymers while going to high 
conversions under the same conditions.  
 
Atom transfer radical polymerisation (ATRP).  Fukuda et al. further employed 
ATRP as a facile way of synthesizing glycopolymers.96 The main advantage of ATRP 
over NMP is the lower polymerisation temperature. It is widely known that glycopolymers 
and their glycomonomers are unstable at temperatures higher than 120 °C. The main 
disadvantage of ATRP however, is the need for copper catalyst leaving toxic Cu ions 
which could potentially be harmful in biomedical applications. Glycopolymers thus have 
to be thoroughly purified before use. Haddleton and co-workers furthermore used ATRP 
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in combination with click chemistry to prepare glycopolymers. The group clicked different 
ratios of mannose and galactose based azides resulting in a change of epitope density 
which influenced the binding affinity of these glycopolymers to rat mannose-binding lectin 
(MBL).97  
 
Reversible addition-fragmentation transfer (RAFT) polymerisation. RAFT 
has been a valuable tool for the preparation of glycomonomers which is reflected by the 
number of publications using this polymerisation technique to date. A typical RAFT 
polymerisation process employs temperatures in the range of 60 to 70 °C. Moreover, this 
method is highly applicable in biomedical engineering as the polymerisation can be 
performed in water and no toxic catalyst is needed. The use of a RAFT based 
glycomonomers furthermore pointed out that glycomonomer functionality is also 
important. The absence of bioactivity was shown when a glycopolymer containing 
mannose moieties did not show any significant binding affinity to ConA, not even after 
8h.98 This was attributed to the fact that the used methacryloyl functionality was 
introduced at the C6 position. For this reason glycopolymers are frequently conjugated 
to the polymer backbone via their anomeric C1 position. A recent article by Schubert et 
al. reported the synthesis of a new methacrylic fructose glycomonomer polymerised via 
RAFT which yielded glycopolymers showing an enhanced cellular uptake in to breast 
cancer cells as compared to other glycopolymers. These were shown using a 
Rhodamine B label utilising the thiol-functionality derived from the RAFT end group.99 
 
 
Single Electron Transfer-Living Radical Polymerisation (SET-LRP). SET-
LRP has recently become a valuable tool for the synthesis of well-defined glycopolymers 
because of its excellent control over polymer dispersity and its high chain end group 
fidelity. The importance of the SET-LRP technique, which unfortunately still needs the 
use of copper catalyst, can be shown by the high impact journals in which the articles 
are published. In 2013 Haddleton et al. published an article describing the synthesis of 
well-defined glycopolymers prepared via SET-LRP employing monomers synthesised by 
the copper catalysed azide-alkyne click reaction (CuAAC).100 Both sequence-controlled 
co-polymers of mannose and glucose based monomers were synthesised, as sequence 
controlled glycopolymers of a mannose based monomer and di(ethylene glycol) ethyl 
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ether acrylate (DEGEEA). Furthermore, this report showed that glycopolymer backbone 
plays an important role in binding behaviour to lectins as two mannose based 
homopolymers showed different binding affinity. A homopolymer with an acrylic 
backbone displayed higher binding affinity than a homopolymer with a methacrylic 
backbone. In 2014 an article was published by Becer et al. describing the synthesis of 
cyclodextrin based glycoconjugates prepared via SET-LRP.101 The synthesised star 
glycopolymers showed an unprecedented high binding affinity towards the lectin DC-
SIGN. This exceptionally high binding affinity was attributed to the high valency of 
mannose moieties on the star polymer. Furthermore, the star glycopolymers showed 
high loading capacity of hydrophobic anti-cancer and anti-HIV drugs which renders them 
promising for HIV therapeutics and in smart drug delivery systems. 
I.4.1.2 Post polymerisation glycosylation of synthetic polymers 
Even though carbohydrate-containing monomers have been successfully 
polymerised, post-glycosylation of preformed polymers offers an excellent alternative for 
glycopolymer synthesis. Glycopolymer libraries of different architectures can easily be 
attained by attaching carbohydrate moieties to preformed polymer backbones. Crucial in 
this approach is the presence of a functional handle along the polymer scaffold through 
which the sugar moieties can be attached. Several of these post-functionalization 
approaches have nicely been reviewed and summarised by Klok et al..102 
The main focus of most preformed polymer modifications was put on 
aminosaccharides which yielded amide linkages between the carbohydrate and the 
polymer backbone. This focus can be justified because of the good nucleophilicity of 
amines as compared to other functional groups such as alcohols which are omnipresent 
in saccharides. Polymer scaffolds bearing active carbonyl moieties such as N-
hydroxysuccinimide (NHS) esters, carboxylic acids and anhydrides have frequently been 





Figure I.4.1 Synthesis of glycopolymers using amide linkages. R= Sugar moiety 
A different route of preparing glycopolymers consists of post-glycosylation using 
‘click’ reactions. This approach has been nicely summarised in a review by Becer et al..92 
The copper catalysed azide-alkyne cycloaddition reaction has been shown to be a very 
effective and versatile strategy for the preparation of glycomonomers. As mentioned 
before, the removal of copper catalyst still remains a challenge for biological applications. 
Regardless of this drawback, the reaction has been employed for the preparation of 
glycopolymers with different topologies and carbohydrate content.  
Apart from the CuAAC reaction, also thiol-based ‘click’ reactions have extensively 
been employed. For this, thiol functional sugars were reacted with alkene, alkyne, chloro 
and epoxide groups yielding glycopolymers. The most interesting of these reactions 
perhaps, is the use of the thiol-para-fluoro ‘click’ reaction. This strategy has been utilised 
by Schubert et al. in combination with NMP yielding well defined homopolymers in a 




Scheme I.4.1 Synthesis of glycopolymers using thiol-para-fluoro ‘click’ reaction 
I.4.2 Lectins 
Lectins, a name derived from the past participle of the Latin verb legere which 
means to select or to choose, are defined as sugar-binding proteins which bind reversibly 
but with high specificity to carbohydrates.90,104 Lectins have been demonstrated to be 
critical in a variety of life processes and essential for several viral infections and 
pathogeneses in numerous organisms. A wide range of different lectins have been 
identified to date, these lectins find their sources not only in plants but also in animals 
and even microorganisms. Although all these lectins have at least one thing in common, 
the ability to bind carbohydrates, they are still quite diverse in terms of structure and size. 
For this reason, lectins are often categorised in large families depending on their function 
or functional parameters. In what follows, the most important lectins will briefly be 
described.90,104 
I.4.2.1 Plant lectins 
The function of plant lectins is still uncertain although it is suggested that they 
play a role in plant germination and perhaps in the seed’s survival itself. 
Legumes. The largest family of lectins is the legume family which consists of 
over 70 lectins that have been isolated to date. Legumes usually have molecular weights 
that are below 40 kDa and often require the presence of divalent cations such as Ca2+ 
and Mn2+. Legumes often consist of 2 or 4 subunits with at least 1 binding site each. The 
most important plant lectin, in a glycopolymer chemist point of view perhaps, is the lectin 
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Concanavalin A (ConA). ConA is a lectin which is extracted from jack beans, it is also 
the first ever lectin to be discovered and characterised, and the first ever lectin to be 
commercially available. More important perhaps, is the fact that ConA binds with strong 
affinity to mannose, but also glucose. Another important plant lectin is the lectin Peanut 
agglutinin (PNA). PNA has specific binding affinity towards galactose and preferably to 
galactosyl (β-1,3) N-acetylgalactosamine. PNA does not need divalent cations to bind 
galactose but binding is augmented in the presence of Ca2+.  
Cereal lectins. Cereal lectins are composed of two subunits which both have 2 
binding sites (usually). Cereal lectins do not require the presence of divalent cations to 
have binding affinity and are known to be rich in disulphide bonds. The most important 
cereal lectin is Wheat Germ Agglutinin (WGA) which exists in three different isoforms, 
WGA1, WGA2 and WGA3. Each consists of two identical subunits and all of them are 
rich in cysteine (disulphide bonds). Moreover, WGA has a strong specificity for N-
acetylglycosamine and N-acetylneuraminic acid (sialic acid). 
Other lectins. Perhaps the most famous lectin, due to its appearance on the 
television show ‘Breaking bad’, is the lectin Ricin. Ricin and its closely related Ricinus 
communis agglutinin (RCA120) are two lectins produced by the beans of the castor tree 
and are perhaps one of the most toxic lectins. Both lectins have a strong affinity to β-
galactose. 
I.4.2.2 Animal lectins 
At present, animal lectins are categorised into many families based on their 
conserved structure of sequence motifs for sugar binding and carbohydrate specificities 
(Table I.4.1).105 Animal lectins play an important role in a variety of functions. Some of 
the most important functions include: self- and non-self-recognition, acting as recognition 
molecules within the immune system, mediation of cellular growth, mediation of 










































I-Type lectin Sialic acid, Variable Ig-like domains Cell membrane No 




F-Type lectin L-Fucose F-type sequence motif Extracellular No 

























C-Type lectins. C-type lectins are lectins that are dependent on the presence of 
Ca2+ in order to interact with carbohydrates. Usually they consist of complex structures 
with carbohydrate recognition domains (CRD) of about 120 amino acids. In contrast to 
plant lectins previously discussed, C-type lectins can have a variable number of subunits 
with 1-8 binding sites each. C-type lectins are further divided into subfamilies. An 
example of such a C-type lectin is the hepatic asiologlycoprotein (hepatic lectin) which 
is specific for galactose/ N-acetylgalactosamine.  
Another very important example is the animal lectin DC-SIGN which is the 
dendritic cell-specific intercellular adhesion molecule-3-grabbing non integrin that is 
expressed on dendritic cells, cells which take part of the immune system. DC-SIGN is an 
interesting target with high affinity for mannose and plays a role in the main pathway the 
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HIV virus uses to enter the dendritic cell during infection. The HIV virus uses its 
glycoprotein gp120, which is heavily glycosylated with mannose residues, to adhere to 
DC-SIGN, subsequently another helical glycoprotein called gp41 unfolds enabling the 
HIV virus to enter the dendritic cell. Another C-type lectin found on macrophages is the 
mannose receptor. The mannose receptor can also be found on hepatic and lymphatic 
endothelia, on tracheal smooth muscle cells, on mesangial cells in the kidneys and on 
retinal pigment epithelium. As the name suggests, there is a strong preference in binding 
to mannose, but also fucose and N-acetyl glucosamine have some binding affinity. 
Selectins are a family of cell adhesion molecules (CAMs). Selectins are related 
to C-type lectins due to their related amino terminus and a calcium-dependent manner 
of binding. Selectins have a strong tendency to interact with sialyl-CD15 (a 
tetrasaccharide), which consists of sialic acid, galactose, fucose, and N-
acetylgalactosamine. There are 3 subtypes of selectins which include: E-selectins (in 
endothelial cells), P-Selectins (in platelets and endothelial cells) and lastly L-selectins (in 
leukocytes). 
Galectins (S-Type). Formerly called S-type lectins, galectins are suggested to 
play a role in cancer proliferation and roles in other functions such as inflammation. Most 
galectins have a high affinity for β-galactosides, with a strong preference to lactose and 
N-acetyl lactosamine. Galectins are divided into three subgroups. The first group 
comprises galectins in the dimeric form that consists of only carbohydrate recognition 
domains. The second group encompasses galectins where the CRD is attached at the 
N-terminus and which has a high sequence repetitive domain. The last group are 
galectins that consist of two tandemly connected CRDs. 
I.4.3 Maximizing lectin recognition  
For glycopolymers to achieve effective lectin binding and affect signal 
transduction, they must bind to at least one but usually multiple copies of their protein 
receptor. Glycopolymers thus have to be tailored to inhibit glycan interactions with a cell 
surface receptor or to cluster receptors for signalling. To achieve this, there are some 
glycopolymer features influencing activity, which need to be considered.107 
Glycopolymer length, functional affinity and receptor clustering. The 
development of living polymerisations (with almost no termination) have enabled the 
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synthesis of polymers of defined length. A minimum length of glycopolymer is often 
required as lectins often consist of multiple subunits. Optimal binding usually needs at 
least two binding sites bridged by the glycopolymer. Furthermore, it should also be noted 
that when all accessible binding sites are occupied, an increase in polymer length will 
not further yield enhancements in functional affinity (avidity). Glycopolymer length not 
only influences functional affinity, but it also influences the ability to cluster multiple 
receptors and the amount clustered. It is sometimes found that clustering multiple 
receptors leads to more effectively transmitted signals and thus shows that glycopolymer 
length influences signal strength.   
Density of the saccharide ligands. Altering the epitope density on the polymer 
backbone also has a strong influence on the glycopolymer functional affinity. There are 
two ways in which carbohydrate ligand density can be manipulated: copolymerisation of 
a sugar bearing monomer with a biologically inactive monomer, or post-polymerisation 
functionalization of a polymer with a biologically inert ligand and a sugar bearing ligand. 
Both methods allow for a variation in level of carbohydrate substitution. Although it is 
often the case that the highest saccharide substitution level gives the best binding 
affinity, this cannot be generalised. It is found that the spacing between two sugar units 
has the most important influence. The spacing between two carbohydrates should match 
that of the binding epitopes on the lectin. 
Polymer backbone flexibility. The flexibility (or rigidity) of the polymer backbone 
has a strong impact on the glycopolymer’s ability to bind receptors. Although rigid 
polymers would avoid an entropic penalty when binding, it is found that they are less 
capable of adapting to protein interfaces, lowering the binding affinity. However, 
polymers which are too flexible pay a big conformational penalty leading to a low binding 
affinity as well. Not only backbone flexibility plays a role, but also flexibility of the linker 
(which connects the saccharide to the backbone). It seems thus likely that the most 
active glycopolymers will be the ones that maintain a balance between rigidity and 




I.5 Sequence-controlled glycopolymers 
 
Until recently, glycopolymer synthesis was mainly limited to the synthesis of 
homomultivalent sugar containing polymers. In the last couple of years however, in 
polymer chemistry, there has been a shift towards absolute control over monomer 
sequence. Unlike for peptide synthesis, polymer synthesis had not yet been established 
in a sequence controlled manner up until now. New methods have been developed 
enabling good control over primary and secondary structures in polymer design. This 
was not different in glycopolymer design, where it is believed that a better control over 
glycopolymer architecture will not only lead to a better lectin binding affinity, but will also 
introduce a much desired selectivity towards specific lectins. That an improved control 
over architecture has significant influence on glycopolymer binding, has already been 
shown by the development of star glycopolymers, which showed to bind better to specific 
lectins compared to their linear counterparts.101,108 Various research groups have 
contributed to this emerging field of precision glycopolymer synthesis in diverse 
approaches.  
In 2013 Barner-Kowollik et al. described several approaches to acquire sequence 
controlled polymers.109  Three different approaches were suggested, providing a degree 
of sequence control. The first approach consisted of the classical step-by-step synthesis 
yielding sequence-defined polymers, which are often prepared on solid-phase. The 
second approach relies on classical reversible-deactivation-based synthesis of block 
copolymers, this consists of the sequential polymerisation (with isolation of intermediate 
polymers) of sequentially added monomers. Thirdly Barner-Kowollik suggested the 
sequence-controlled polymerisation of different monomers in a one-pot process, without 
isolation steps via time-regulated chain extensions. For the synthesis of periodic 
polymers containing a sequence defined periodic repetition of monomers, two other 
approaches can be added. The fourth approach would be the polymerisation of a defined 
oligomer into a polymer with repeated sequence, these are often observed in Nature 
(e.g. glycosaminoglycans, collagen, etc.). The fifth approach would consist of the 
combination of one or multiple orthogonal reactions, either for the polymerisation or post-





Figure I.5.1 a) Classical step-by-step synthesis of sequence-defined polymers. b) Sequential 
polymerisation (with isolation of intermediate polymers) of sequentially added monomers. c) 
Sequence-controlled polymerisation via time regulated chain extensions, without the need for 
isolation steps. d) Polymerisation of a sequence-defined oligomer into a periodic polymer. e) Post-
polymerisation modification via orthogonal reactions resulting in a periodic polymer.110 
I.5.1 Sequence-defined glycooligomers 
This first approach was first introduced in glycopolymer synthesis by the group of 
Hartmann, who elegantly borrowed standard peptide synthesis coupling procedures 
combined with click reactions. In order to achieve these solid phase bound oligomers, 
different building blocks had to be prepared (Scheme I.5.1). The group designed various 
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blocks using a doubly protected diethylenetriamine key intermediate as an asymmetrical 
precursor capable of being functionalised at the secondary amine.111–113  
 
Scheme I.5.1 Building block synthesis: The Triple bond functionalized building block (TDS) with 
a Succinyl rest synthesized starting from Diethylenetriamine and an Ethylenedioxy building 
block (EDS).111 
At first, homomultivalent glycooligomers presenting mannose were synthesised 
via an on-resin 1,3-dipolar cycloaddition to a scaffold composed of these building blocks 
(Scheme I.5.2). These mannose containing oligomers could show that binding affinity 
towards the lectin Con A was not only dependent on the number of presented sugars on 
the scaffold, but also on chemical composition of the scaffold and the spacing in between 
the ligands. The same technique has more recently been applied using fucose as the 
carbohydrate of interest.114 
 
Scheme I.5.2 Solid-phase synthesis of glycopolymer segments.111 
37 
 
After the successful synthesis of these homomultivalent glycooligomers, more 
diverse heteromultivalent glycooligomers were prepared presenting different 
combinations of Man, Gal and Glc with a controlled number and position of ligands. 
These glycooligomers were further subject to evaluation for their binding behaviour 
towards the lectin ConA.115 More interestingly maybe, was the combination of these 
building blocks with a new photoswitchable building block containing an azobenzene 
moiety.116 Use of this building block provided a controlled reduction in binding affinity 
upon E  Z photoisomerization towards the galactophilic lectin (PA-IL), a tetrameric, 
calcium dependent lectin which specifically binds to α-galactosides. This E  Z 
photoisomerization provides to reversibly isomerise between an extended and planar 
form (E-isomer) and a more compact and twisted state (Z-isomer). 
The same principle of building blocks combined with click reactions, was further 
explored using an in-flow conjugation of thioglycosides to a double-bond presenting 
diethylenetriamine precursor via thiol-ene chemistry.113 The main difference here is that 
the building blocks were functionalised with glycosides prior to the solid phase synthesis. 
After glycosylation, these protected carbohydrate containing building blocks were 
coupled to the solid-phase resulting in monodisperse sequence-defined glycooligomers 




Figure I.5.2 Schematic presentation of the solid phase synthesis of end-functionalised 
macromonomers using tailor-made building blocks (left) and their step-growth polymerisation via 
thiol-ene coupling (right). 117 
The same group has now achieved to bring this approach one-step forward using 
a combination of solid phase synthesis and step-growth polymerisation by photoinduced 
thiol-ene coupling.117,118 Firstly, two sets of macromonomers were prepared via solid 
phase assembly of functional building blocks introducing either a hydrophilic spacer 
block with thiol end groups or sugar-presenting blocks with varying number of sugar units 
in the side chain and alkene end groups. Subsequently, as seen in Figure I.5.2, 
photoinduced thiol-ene coupling step-growth polymerisation were undertaken to obtain 
specifically sequence-controlled glycopolymers with high molecular weight. Obviously, 
this advanced approach will lead to synthesise precision glycopolymers with higher 
molecular weight multiblock copolymers for polymer chemists in this field. The technique 
was recently optimised by introducing norbornene as an improved “ene”, yielding much 




I.5.2 Sequence-control via time regulated additions 
Although solid-phase polymer synthesis allows for an absolute control over 
glycopolymer sequence and allows for the synthesis of monodisperse polymers, the fact 
that synthesis occurs on a solid-phase limits the application of this method on a larger 
scale. In 2007 Lutz et al. published a report in which they described a kinetic strategy 
allowing control over microstructure in radical chain-growth polymerisations.120,121 The 
method relies on the time-regulated sequential addition of N-substituted maleimides 
during the chain growth polymerisation of styrenes. The great difference in monomer 
reactivity renders it possible to incorporate the maleimides at specific places along the 
polymer chain. In 2013 the group further used this technique for the synthesis of single 
chain sugar arrays (Figure I.5.3). They polymerised three different triple bond containing 
maleimides, each containing protecting groups of different lability, allowing for the 
selective deprotection of each set of monomers.122 After each deprotection step different 
azide-functionalised hexoses were clicked to the polymer backbone. The method 
demonstrated that sugars could be placed at certain locations along a bioinert 
polystyrene backbone. Although this proposed technique does not deliver monodisperse 
sequence-defined glycopolymers, it does provide controlled polymers on a larger scale. 
 
Figure I.5.3 General strategy for the synthesis of single-chain sugar arrays.122 
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I.5.3 Sequence-control via time regulated chain extensions 
This first use of controlled radical polymerisations showed great potential in the 
development of sequence-controlled glycopolymers and was thus further exploited. 
Controlled radical polymerisations offered not only better polydispersities during chain 
growth, but copper mediated radical polymerisations also introduced a much better chain 
end fidelity. This increased chain end fidelity inspired Haddleton et al. for the synthesis 
of sequence controlled glycopolymers via copper(0) mediated living radical 
polymerisation (Cu(0)-LRP) as developed by Percec et al. in 2002/2006.18,100,123  The 
group made use of the retention of the chain end to perform chain extensions after 
monomer consumption (Scheme I.5.3). Sequential addition of new monomer after 
consumption of each block provided sequence controlled block copolymers of well-
defined length and with low dispersities.  
This route was employed for the preparation of a whole range of different 
glycopolymers based on acrylate monomers containing sugar units synthesised via the 
1,3-dipolar cycloaddition. These glycopolymers, containing mannose, glucose and 
fucose moieties, were examined for their binding behaviour towards DC-SIGN, a lectin 
highly present on dendritic cells. Higher-affinity binding was observed for polymers with 
a higher mannose content, although no effect of sequence on binding was detected. 
 
Scheme I.5.3 Schematic representation of the synthesis of multiblock glycopolymers by 
sequential addition of glycomonomers at defined periods of time via Cu(0)-LRP. 124 
The use of Cu(0)-LRP for the preparation of sequence-controlled glycopolymers 
was further adopted in combination with other ‘click’-like reactions. In this case, 
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Haddleton et al. synthesised a sequence-controlled prepolymer that could selectively be 
glycosylated at different places.124 The prepolymer was synthesised using an epoxide 
containing glycidyl acrylate and TMS protected propargyl acrylate. A post-polymerisation 
modification was carried out via thiol-X reactions using 1-thio-β-D-glucose tetraacetate. 
After this the TMS group was deprotected and subsequently the free triple bonds were 
used for conjugation of azide-functionalised mannose. 
Qian et al. made use of sequential ATRP for the synthesis of triblock copolymer-
grafted silica microparticles.125 First, the authors immobilised ATRP initiators on the 
surface of the silica particles and afterwards the glycopolymers were grown on that 
surface (Figure I.5.4). Unlike with the previous approach (using Cu(0)-LRP) the silica 
particles were isolated and washed in between the polymerisation of each block. The 
glycopolymer grafted silica particles were then further used for efficient and selective 
enrichment of glycopeptides. 
 
Figure I.5.4 Schematic overview of the preparation of triblock copolymer-grafted silica 




I.5.4 Sequence-control via orthogonal reactions 
Lastly, the fourth approach was applied by Chen et al.126 The group first prepared 
poly(methacrylic acid) via the RAFT polymerisation process. Subsequently the free 
pending acid groups were used in an Ugi reaction with gluco- or mannosamine, 
incorporating a first sugar into the chain, and propargyl isocyanoacetamide which 
tactfully introduced a terminal alkyne. These terminal alkynes were then finally employed 
to click gluco- or mannosyl azide onto the polymer chain (Scheme I.5.4).  
 
Scheme I.5.4 Modular synthesis of glycopolymers via Ugi reaction and click chemistry. 
Although the last couple of years, the main focus of polymer chemistry has been 
the precise control over monomer sequence, this cannot really be interpolated towards 
glycopolymers for which the field is still in its infancy. Few research groups have currently 
attempted to tackle this problem, and each technique comes with its advantages and 
drawbacks. Perfect monodisperse sequence-defined polymers could readily be achieved 
via solid-phase glycopolymer synthesis, however multiple steps are required to achieve 
only small amounts of product. Keeping that in mind, chain growth polymerisation could 
be favoured. Lutz et al. demonstrated that sequence-controlled glycopolymers can be 
achieved based on a difference in monomer reactivity. However, also in this case several 
deprotection steps are required for the post-polymerisation glycosylations. Chain 
extensions via copper mediated polymerisations seem very promising as these 
techniques can easily be scaled up and occur in a one pot manner. Although there is a 
good control over sequence of the block copolymer, each block still has a distribution 
and in this aspect it is still inferior to the solid-phase synthesis approach regarding 
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‘control’. However, the dispersities of the blocks are relatively low, allowing for a well-




I.6 Self-assembly of glycopolymers 
 
Recently it has become more and more clear that presentation of the saccharide 
units is of great importance in achieving enhanced lectin-glycopolymer binding. 
Glyconanoparticles with different morphologies can readily be obtained depending on 
the hydrophilicity/hydrophobicity and the length of the different blocks in the block-
copolymer which have an effect on the packing parameter.127–129 Over the past decade 
a whole range of different self-assembling glycopolymers have been synthesised and 
their composition and presenting morphologies have been greatly summed up in a 
review by Chen et al.130 In this section different methods will be summarised for the 
preparation of these assemblies, along with most important and recent publications. 
I.6.1 Self-assembly based on amphiphilicity  
The synthesis of glycopolymeric amphiphiles was first reported in 1999, by Li et 
al.131 The authors prepared a set of block-copolymers based on polystyrene-b-poly[2-β-
D-glycopyranosyloxy)ethyl acrylate]. By varying the composition, the solvent and the 
concentration, they were able to prepare different morphologies ranging from spherical 
micelles to cylindrical micelles and vesicles called polymersomes. Now more than 20 
years later, many articles have been published on the synthesis of different amphiphilic 
glycopolymers, each one differing either in choice of the hydrophobic block, choice of 
the sugar and/or of course the polymerisation procedure.130,132–136 
In the last few years, one of the most active groups working on glycopolymer self-
assemblies and their use in biomedical applications is undoubtedly the group of Stenzel. 
The group prepared several glycopolymers via different methods. In 2014 the group 
published a collaborative report with the group of Du Prez, where they elegantly used 
the thiolactone strategy developed by Espeel et al. (Scheme I.6.1).137 The authors firstly 
prepared a statistical copolymer of N-isopropyl acrylamide and N-homocysteine 
thiolactone acrylamide. The glycopolymers were prepared by using a one-pot procedure 
in which the thiolactone ring is opened by an aliphatic amine which releases a thiol that 
was subsequently reacted with a bromine functionalised saccharide already present in 
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the reaction mixture. The size of the obtained particles after dialysis could be tuned by 
varying the length of the amine side chains. 
 
Scheme I.6.1 One-pot reaction pathway to glycopolymer-based nanoparticles, employing a 
double modification (aminolysis and nucleophilic substitution) of thiolactone-containing 
polyacrylamides. 137 
Another strategy in which the group managed to tune glycopolymer morphology 
was using two sets of block-copolymers and simply changing the mixing ratio (Figure 
I.6.1).138 Two sets of block-copolymers were prepared, the first based on mannose 
acrylate and n-butyl acrylate. For the second, mannose acrylate was replaced by 
oligo(ethylene)glycol methyl ether acrylate (OEGMEA, Mn = 480 g mol-1). It was observed 
that glycopolymer morphologies with higher mannose content had better cellular uptake 
which suggests that mannose concentration is more important than shape and size 
effects.  The same group furthermore prepared biodegradable glycopolymer micelles as 
drug delivery platforms via RAFT.139 In order to achieve biodegradability in the 
glycopolymer block, a 5,6-benzo-2-methylene-1,3-dioxepane (BMDO) monomer was 




Figure I.6.1 Synthetic pathway for the preparation of glyco-nanoparticles with different 
morphologies. 138 
Zentel et al. employed active esters for the preparation of polymersomes forming 
block-glycopolymers.140 The hydrophobic block of the copolymer consists of a statistical 
copolymer of lauryl methacrylate and 2-(2,2-dimethyl-1,3-dioxolane-4-yl)ethyl 
methacrylate. The incorporation of the last monomer provides a controlled pH responsive 
disintegration of the polymersomes, which can be used for controlled cargo release.  
The group of Lecommandoux published several papers on the synthesis and self-
assembly of amphiphilic glycopolypeptides.141 Their approach was first introduced using 
two oligosaccharides, dextran or hyaluronan as the hydrophilic block combined with 
poly(γ-benzyl-L-glutamate) as the hydrophobic block (Scheme I.6.2).142 Tree-like 
structures were prepared via the Huisgen cycloaddition reaction of an azide 
functionalised oligosaccharide and alkyne functionalised small propargyl glycine block. 
Another strategy they employed was again the use of a block-copolymer consisting of 
poly(γ-benzyl-L-glutamate) and polypropargylglycine.143 Here the alkynes were clicked 
to azide functionalised iminosugars. The obtained glycopolypeptides were capable of 
self-assembling but the polymers did generate the tree-like structure. In a last publication 





Scheme I.6.2 Oligosaccharides coupling onto poly(γ-benzyl-L-glutamate)-block-poly(propargyl 
glycine) by Huisgen cycloaddition. 142 
Apart from varying different block lengths, Satoh et al. prepared a range of 
miktoarm block-copolymers to obtain different glycopolymer morphologies.145 A series of 
different miktoarm polymers was prepared in which the amount of arms per block was 
changed, this altered the packing parameter, resulting in a change in micelle size. The 
miktoarm polymers were prepared by clicking alkyne functionalised maltoheptaose using 
the copper catalysed azide-alkyne cycloaddition to azide functionalised poly-ε-
caprolactones.  
An interesting approach was used for the synthesis of gradient glycopolymers by 
Wei et al.146 The group made use of the in situ enzymatic monomer transformation using 
Novozym 435. Gradient glycolymers were prepared via the RAFT polymerisation of 
2,2,2-trifluoroethyl methacrylate (TFEMA) (Scheme I.6.3). The presence of Novozym 
435 and 1,2:3,4-di-O-isopropylidene-α-D-galactopyranose resulted in the gradual 
conversion of TFEMA into 1,2:3,4-di-O-isopropylidene-6-O-methacryloyl-α-D-
galactopyranose (DIMAG) in the reaction medium delivering a gradient glycopolymer as 
a final product. Comparison of the binding affinity of these galactose containing block-, 
gradient and statistical glycopolymers showed that binding affinity towards the lectin 
RCA120 was optimal for the glycopolymer with the block structure. The use of concurrent 
RAFT polymerisation and enzymatic monomer transformation was further used by the 




Scheme I.6.3 One-pot synthesis of the gradient glycopolymer via concurrent enzymatic monomer 
transformation and RAFT polymerisation. 146 
Self-assembly was also observed by Böker et al., for double-hydrophilic 
glycopolymers consisting of poly(hydroxyethyl acrylate) (PHEMA) and an N-acetyl 
glucosamine monomer (Scheme I.6.4).148 The authors state that although their PHEMA 
block should have a cloud point of at least 32 °C and thus be water soluble, they still 
obtained formation of spherical nanoparticles.  
 
Scheme I.6.4 General scheme for the synthesis of PHEMA-b-PGlcNAcEMA. 148 
 Self-assembled block-copolymers containing sugars are often used for drug 
delivery systems. However often little attention is drawn to the actual location of the drug 
inside the self-assembly or the effect of the drug on the polymer properties. Recently, 
Stenzel et al., have shown that their drug of choice (curcumin) was unexpectedly located 
in the shell of the micelle and furthermore showed that an accumulation of their drug in 




I.6.2 Temperature-triggered self-assemblies  
Instead of using hydrophobic blocks in the design of the block-copolymer, several 
research groups have opted to use double hydrophilic blocks in which the non-
saccharide block is a hydrophilic thermoresponsive block. Upon heating of the dissolved 
polymers in water, often based on poly(diethylene glycol methacrylate) (PDEGMA) and 
poly(N-isopropylacrylamide) (PNIPAM), the particles aggregate due to the LCST 
behaviour of the aforementioned polymers. The LCST or lower critical solution 
temperature is the critical temperature below which the components of a mixture are 
miscible for all compositions. LCST behaviour is entropy driven as hydrating water gets 
released into the bulk water and depends on the hydrophilic-hydrophobic balance of the 
polymer, the end groups, the polymer chain length, presence of salts and pH of the water. 
In 2008 Alexander et al. prepared block-copolymers of PDEGMA and poly(2-
glucosyloxyethyl methacrylate) via several controlled radical polymerisation techniques 
(Scheme I.6.5).150 By changing the temperature above or below the LCST of the 
PDEGMA, the authors were capable of controlling the size of the obtained vesicles. 
PDEGMA was further used by Stenzel and collaborators for the synthesis of 
thermoresponsive micelles first in combination with thiol-ene ‘click’-like chemistry and 
further in combination with copper catalysed azide-alkyne ‘click’ chemistry.151,152 
 
Scheme I.6.5 Synthetic strategies for the preparation of glucose functionalised (co)polymers. (B1) 
HEMA, AIBN, DMAc, 70 °C; (B2) AIBN, toluene, 80 °C; (B3) 4-pentenoic anhydride, DMAP, 
pyridine, DMF; (B4) UV, glucothiose, DMPA, DMF. 150 
Haddleton et al. further employed the novel aqueous SET-LRP for the synthesis 
of their double hydrophilic block-copolymers.153 Rapid disproportionation of CuBr allows 
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for a fast polymerisation with high conversions. Diethylene glycol ethyl ether acrylate 
(DEGEEA) was polymerised in combination with mannose acrylate, yielding well defined 
polymeric nanoparticles above the LCST.  
  The other commonly used polymer with LCST behaviour, PNIPAM, was also 
employed for the synthesis of thermoresponsive glycopolymers. Zhu et al. prepared 
triblock glycopolymers consisting of two blocks of PNIPAM and a glucose containing 
block via RAFT.154 Besides these polymers were further capable of self-assembling. The 
use of PNIPAM was further employed in combination with an adamantane containing 
block by Becer et al. (Scheme I.6.6).155 The adamantane blocks were subsequently 
made more hydrophilic using the supramolecular interaction of adamantane and β-
cyclodextrins decorated with mannose units in water.  
 
Scheme I.6.6 The triblock copolymer synthesised by sequential RAFT polymerisation and its 
host–guest interaction with self-assembly behaviour. 155 
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I.6.3 pH-responsive self-assemblies 
A potentially interesting feature, especially in regards to drug release, would be 
the integration of pH-responsive blocks controlling the self- and disassembly of block-
glycopolymers. Armes et al. firstly reported the synthesis of these pH-responsive 
glycopolymers in 2003.156 The group synthesised different triblock-glycopolymers via 
ATRP based on poly(ethylene glycol) (PEG) and 2 different sugar monomers 2-
gluconamidoethyl methacrylate (GAMA) and 2-lacto-bionamidoethyl methacrylate 
(LAMA). The pH-sensitive blocks were composed of 2-(diethylamino)ethyl methacrylate 
(DEA) or 2-(diisopropylaminoethyl methacrylate (DPA). Self-assembly of glycopolymers 
could be triggered by changing the acidity below or above pH 7. The same GAMA 
monomer was further employed by Dong et al. for the fabrication of star-shaped 
polypeptide/glycopolymer biohybrids composed of poly(γ-benzyl-L-glutamate).157 By 
using G0-PAMAM as a core and by varying the pH, the size of the produced micelles 
could be tuned. Another group used dendronised lysine for this purpose.158 
Wang et al. on the other hand produced pH-sensitive block glycopolymers of 
poly(2-(diethylamino)ethyl methacrylate) (PDEAEMA) and poly(3-O-methacryloyl-a,b-D-
glucopyranose) (PMAGlc) via RAFT.159 Spherical micelles were formed with PDEAEMA 
as the hydrophobic cores and PMAGlc as the hydrophilic shells in alkaline aqueous 
solution (Fig. I.6.2). 
 
Figure I.6.2 Illustration of the micellization of PDEAEMA-b-PMAGlc block copolymer in water and 
recognition with protein Con A. 159 
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Not only dis- or self-assembly can be triggered but also changes in various self-
assembling morphologies can be achieved using pH-sensitive blocks. Change of 
morphology was obtained by Stenzel et al. based on a single triblock-copolymer of 
poly(2-acryloylethyl-α-D-mannopyranoside)-b-poly(n-butylacrylate)-b-poly(4-
vinylpyridine) (PAcManA70-b-PBA369-b-PVP370).160 The obtained morphologies were 
quite interesting ranging from flower-like micelles, cylindrical micelles, raspberry-like 
morphologies to nanocaterpillars, all depending on the processing conditions (pH of the 
aqueous environment during dialysis) (Scheme I.6.7).  
 
Scheme I.6.7 Synthesis of triblock copolymer and its self-assembly in methanol followed by 
dialysis against aqueous solutions of different pH values. 160 
3.4. Self-assembly based on electrostatic interactions 
Ionic interactions are the strongest noncovalent interactions and can thus form a 
strong basis for the self-assembly or loading of glycopolymeric nanoparticles. Narain et 
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al. achieved nanoparticles by using the electrostatic interaction of negatively charged 
plasmid DNA and a cationic block-glycopolymer consisting of 3-gluconamidopropyl 
methacrylamide and 3-aminopropyl methacrylamide.161 Wang et al. furthermore used a 
diblock glycopolymer consisting of 2-(methacrylamido) glucopyranose and methacrylic 
acid monomers synthesised via RAFT in combination with a quaternary ammonium 
chitosan as a cross-linker (Figure I.6.3).162 Optimisation of the synthesis conditions 
resulted in the formation of glyconanogels with a compact ionic cross-linked core and a 
glucose corona as was confirmed by TEM. 
 
Figure I.6.3 Schematic illustration of the preparation of bioactive poly-electrolyte nanogels from 
natural and synthetic sugar polymers. 162 
The group of Chen, firstly synthesised a copolymer with dopamine and amino 
groups that were cable of self-assembling with zinc phthalocyanine into stable 
nanoparticles (Scheme I.6.8).163 These positively charged nanoparticles were then 
further complexed with the same block-glycopolymer used by Wang et al. yielding 
glycopolymer decorated nano-phthalocyanine nanoparticles. 
Although many different self-assembling glycopolymer structures have been 
achieved over the past two decades, the number of architectures is still limited, ranging 
from micelles to polymersomes for diblock based glycopolymers. More interesting 
structures could be achieved by using triblock copolymers as evidenced vide supra, 
however glycopolymer-lectin binding affinity showed to be more influenced by the density 
of the sugar ligands than the overall glycopolymeric architecture. Looking back to nature, 
these types of self-assembled architectures can be found on the scale of cells and 
organelles. Selectivity and specificity however, occur on the scale of proteins and 
receptors embedded in these nanostructures. It has become clear that in order to 
achieve the selectivity and specificity often observed in Nature, control should be 
performed on the smallest scale possible. As illustrated in the first section, control over 
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primary structure is possible, but what differs in comparison to natural glycosylated 
proteins is the absence of controlled single-chain folding. 
 
 




I.7 Single-chain folding of glycopolymers 
 
Single-chain polymeric nanoparticles (SCPNs), single polymeric chains capable 
of folding into a nanoparticle, have gained much interest over the past decade. 
Surprisingly, the new advances in this relatively young field have not yet extensively been 
applied in combination with glycopolymers. Taken in mind that glycopolymers are mainly 
soluble in water and primarily synthesised for biomedical applications, ranging from 
imaging probes to synthetic vaccines and drug-delivery carriers, it should be clear that 
single-chain folding must be able to occur in water. Interactions that can be used include 
covalent linkages, metal coordination, hydrogen bonds, ionic interactions and 
hydrophobic interactions as is common in Nature’s protein folding.  
Preparation of SCPNs can primarily be divided into two fundamentally distinct 
synthetic strategies, as introduced by Barner-Kowollik et al..164,165 These two approaches 
are on the one hand ‘selective point folding’ and on the other hand ‘repeat unit folding’ 
(Figure I.7.1). Selective point folding of macromolecules makes use of complementary 
recognition units at predefined positions along the polymer chain to achieve extremely 
well-defined nanoparticles. On the other hand repeat unit folding offers a less-defined 
and chaotic collapse, although it should be noted that this approach is synthetically more 
accessible. In order to achieve folding as found in nature, selective point folding is 
preferred, especially for glycopolymer systems where individual distances in between 
saccharide units can have a great influence on lectin-binding.  
 
Figure I.7.1 Single-chain folding of well-defined synthetic polymers via repeat unit folding and 
selective point folding.165 
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I.7.1 Selective point folding 
As previously stated, selective point folding is the preferred approach for the 
preparation of well-defined glycopolymeric structures. The field however is still young 
and most contributions have been conducted in non-competing solvents based on 
hydrogen bonding arrays. An interesting example of this selective point folding 
methodology was introduced by Barner-Kowollik using a combination of two orthogonal 
H-donors and acceptor units.166 Via this approach based on the interaction of thymine 
and diaminopyridine and the self-association of cyanuric acid and the Hamilton wedge, 
the authors achieved an 8-shaped macromolecule. Although very elegant, this approach 
was conducted in a non-competing solvent which eliminates its use in water. 
Approaches that can be combined with glycopolymers in aqueous environments 
are those based on metal-ligand interactions, host-guest interactions and covalent 
linkages. An important example of these host-guest interactions, is the well-known 
association between adamantane and β-cyclodextrin. Barner-Kowollik and coworkers 
successfully employed this interaction for the preparation of cyclic α-ω-functionalised 
poly(N,N-dimethylacrylamide).86 Single-chain folding and dissociation were able to be 
monitored by dynamic light scattering (DLS) and nuclear Overhauser enhancement 
spectroscopy (NOESY). In NOESY, the nuclear Overhauser cross relaxation in the 
mixing period between nuclear spins is utilized to determine the correlations. A 
correlation is thus found between atoms which are closer than 5 Å in proximity. The same 
group further introduced metal-ligand complexation to achieve selective point folding.167 
Triphenylphosphine ligands were employed to afford single-chain metal complexes in 
the presence of Pd(II) ions at high dilution. Although the experiments were performed in 
chloroform and dichloromethane, it still proves the relevance of metal-coordination as a 
synthetic platform.  
I.7.2 Repeat unit folding 
In contrast to the ‘selective point folding’ approach, ‘repeat unit folding’ has 
received significant interest with numerous contributions and Pomposo et al. as one of 
the main contributors.164,165,168 As mentioned before, single-chain folding of 
glycopolymers demands self-assembly in water in order to have significant applications. 
Many covalent links have been utilised to date for the formation of SCPNs via covalent 
bonds, these include thiol-ene and thiol-yne coupling,169,170 Michael addition,171–173 amide 
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formation,174 tetrazine-norbornene reaction,175 alkyne homocoupling,176 tetrazole-ene 
ligation,177 and disulphide linkages.178 It is evident that the scope of covalent linkages is 
broad and that many other contributions are expected in the following years.  
Furthermore the dynamic nature of supramolecular interactions can be useful for 
reversible and responsive glycopolymer synthesis. The most fascinating contributions in 
this field are undoubtedly from the group of Meijer and Palmans. The use of self-
recognising motifs such as the benzene-1,3,5-tricarboxamides (BTA) proved to be very 
beneficial for SCNP formation even in water, as is evidenced by many contributions 
(Scheme I.7.2).179–184  Upon reduction of temperature, BTA moieties self-assemble into 
helical aggregates inducing a collapse into an SCPN. Evidently, every major 
supramolecular interaction which has a high association constant in water could be used. 
Many options are still to be explored.  
 
Figure I.7.2 Collapse of an L-Proline containing water soluble polymer, based on the self-
assembly of BTA moieties.184 
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I.7.3 Single-chain folding glycopolymers 
Although little applied in glycopolymer science, single-chain folding technology 
based on both covalent and non-covalent interactions has received a significant increase 
of interest as evidenced by myriad publications in recent years. In order to achieve 
specificity in lectin-glycopolymer binding it is clear that ‘selective point folding’ is 
preferred over ‘repeat unit folding’ in glycopolymer design and all of this in an aqueous 
environment. Only the precise synthesis of not only the correct sugar moieties along the 
polymer chain, but also the precise collapse into a nanoparticle will provide efficient 
control. Self-assembly into single-chain nanoparticles is found in nature on the scale of 
proteins and other biomacromolecules. It should thus be clear that further effort into the 
synthesis of these glyconanoparticles will most probably result in a gain in molecular 
understanding of lectin recognition events and be beneficial for future syntheses of 
glycopolymeric ligands. 
The first scientific report describing the synthesis of single-chain folding 
glycopolymers stems from a collaboration of the groups of Stenzel and Barner-
Kowollik.185 The groups collaborated by synthesising fluorescent single-chain folding 
glycopolymers and reported their subsequent functionalisation onto nanodiamonds 
(Scheme I.7.1). Collapse of the synthesised glycopolymers was achieved by a post-
polymerisation functionalisation step, which introduced profluorescent photoactive 
tretrazole groups and furan-protected maleimide moieties. By subsequently irradiating 
highly diluted aqueous solutions of the polymers, they managed to trigger intramolecular 




Figure I.7.3 Synthetic Approach for the Preparation of SCNP-Decorated Nanodiamonds. 185 
 The second report of single-chain nanotechnology in glycopolymer science, was 
by Yilmaz et al.186 In this report the group synthesised tri-block copolymers via RAFT 
containing adamantane and cyclodextrin at the rear ends of the polymer. The reversible 
single-chain folding of the glycopolymers was subsequently achieved by dissolving the 
polymers under high dilution in water and the self-assembly itself was then investigated 
using 2D NOESY. They were able to demonstrate an increase in lectin binding affinity 
as compared to unfolded linear structures (Figure I.7.4). 
 




Finally, the last report (to the best of my knowledge) describes the synthesis of 
glucose containing single-chain folding glycopolymers, again by the group of Stenzel 
(Figure I.7.5).187 As in their first report, here again the repeat unit folding method was 
used. Firstly, glycopolymers were synthesised containing protected thiols along the 
glycopolymer chain. Single-chain folding was then achieved by deprotection of the thiols 
using hydrazine and subsequently adding PEG diacrylate.  
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Development of a novel 
cyclodextrin based initiator 




In this chapter, I discuss the synthesis and use of a novel β-cyclodextrin based SET-
LRP initiator. Three different approaches towards the synthesis of this initiator, based 
on three ‘click’ like reactions (copper(I)-catalysed azide-alkyne cycloaddition, 
nucleophilic thiol-ene reaction and radical thiol-ene reaction), have been explored 
and discussed. Synthesis via radical thiol-ene proved to be most successful in 
achieving this. The β-cyclodextrin based initiator was subsequently used for the 
polymerisation of several acrylates in a controlled fashion yielding 7-arm multiblock-
copolymers. The achieved sequence-controlled polymers exhibit low dispersities (≤ 
1.12) and were completed under 6.5 h at high monomer conversion (≥95 %) for each 
block. 
 
Section II.2.2 was performed by Dr. G. Yilmaz 
 
Parts of this chapter have been published: 
Abdouni, Y., Yilmaz, G. & Becer, C. R. Sequence Controlled Polymers from a 
Novel β-Cyclodextrin Core. Macromol. Rapid Commun. 38, 1700501 (2017).
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II Development of a novel 




  Over the last decade, there has been an increased interest in the development 
of more structurally complex macromolecules both in terms of monomer sequence as in 
overall architecture.1–3 Function in Nature’s macromolecules is not only determined by 
its primary structure but also by its overall molecular architecture, displaying 
sophisticated properties such as molecular recognition and catalysis. For this reason, 
many different nonlinear molecular architectures have been established ranging from 
cyclic polymers to dendritic, graft, brush, hyperbranched and star-shaped (co)polymers.4 
These, together with advances in controlled polymerisation methods at the end of the 
last century, have paved the way for the recent explosion of novel precision 
macromolecules, specifically tailored to exhibit distinct features.5,6 
  Star polymers, in particular, can be prepared either via three distinct approaches 
namely via the arm-first approach, via the coupling-onto method or via the core-first 
approach. In light of architectural precision, a core-first approach offers an enhanced 
control over the number of arms, as the arm-first approach usually gives a broad 
distribution of number of arms per molecule.7 The coupling-onto method, on the other 
hand, requires a high coupling efficiency often acquired via ‘click’ reactions after full 
conversion of the active chain end groups.   
  In 2001 Haddleton and co-workers introduced β-cyclodextrin (a homochiral cyclic 
oligosaccharide containing 7 glucopyranose units and thus 21 free hydroxyl groups), as 
a multifunctional core initiator for the preparation of well-defined star-shaped polymers 
via copper mediated controlled radical polymerisations.8 However, more recent 
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publications have shown that full substitution of the 21 hydroxyl groups is not achieved 
and that a mixture of star initiators is obtained.9 More recently, the group of Li employed 
a less substituted version of this β-cyclodextrin core initiator with only 4 initiating sites on 
average.10–12  
  Stenzel and coworkers introduced the use of a β-cyclodextrin derived star RAFT 
agent for the synthesis of spherical glycopolymer architectures (Figure II.1.1).13,14 The 
interesting feature about this multifunctional β-cyclodextrin derived RAFT agent is that 
only the top face of the β-cyclodextrin is converted to RAFT agents, whereas the bottom 
face is not. This leaves the possibility for small molecules to access the hydrophobic core 
for potential host-guest complexations. Although RAFT has proven to be a very useful 
technique in the preparation of extremely well-defined multiblock-co-polymers by the 
group of Perrier, it was found not suitable for the synthesis of core-first star shaped 
polymers as it is prone to many termination reactions.15–18. 
 
Figure II.1.1 β-Cyclodextrin-derived star RAFT agent.13 
  As mentioned vide supra, copper mediated controlled radical polymerisations 
offer an elegant way of achieving interesting architectures. The group of Haddleton has 
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used these techniques for the synthesis of sequence controlled polymers both in DMSO 
and in aqueous systems.19–21 Encouraged by these results, our group was recently able 
to prepare star-shaped polymers via SET-LRP in DMSO and pentablock star shaped 
polymers in less than 90 minutes via aqueous SET-LRP starting from a water soluble 
glycerol core.22,23  
  Inspired by these findings and the interesting features a β-cyclodextrin core could 
provide, we have developed a novel β-cyclodextrin derived SET-LRP star initiator (β-CD 
initiator). This chapter describes the synthesis route towards this novel star initiator via 





II.2 Results and discussion 
II.2.1 Synthesis of a β-cyclodextrin initiator 
For the preparation of the β-cyclodextrin based initiator three different synthesis 
routes were explored of which the former two have proven not to be successful (Scheme 
II.2.1).  
 
Scheme II.2.1 Schematic overview of the different approaches towards a monofacially 
functionalized cyclodextrin initiator. 
The first synthesis route explored (Scheme II.2.1A), was based on the copper(I)-
catalysed azide-alkyne cycloaddition (CuAAC), well-known as the ‘click’ reaction.26 For 
this, the secondary hydroxyl groups on primary rim region of the β-cyclodextrin were 
selectively brominated using triphenylphosphine and N-bromosuccinimide and 
subsequently converted into azides via a simple azide nucleophilic substitution in 
dimethylformamide (DMF). A terminal alkyne containing SET-LRP initiator was 
synthesised by simple substitution reaction between propargyl alcohol and 
bromoisobutyryl bromide. This SET-LRP initiator was then ‘clicked’ to the per-(6-deoxy-
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6-azido)-β-cyclodextrin, however gel permeation chromatography (GPC) and MALDI-
TOF analysis showed the synthesis was prone to side reactions. Figure II.2.1A shows 
the MALDI-TOF mass spectrum or CD7-CuAAC which shows a lot of side products with 
a higher molecular weight which have not been identified. These findings were confirmed 
in the GPC chromatogram, showing products at shorter retention times, thus confirming 
the higher molecular weight of the side products (Figure II.2.1B). 
 
Figure II.2.1 A) MALDI-TOF mass spectrum of compound CD7-CuAAC with the isotopic 
distribution of the peak of interest (red) and the theoretical isotopic distribution (black) A; B) GPC 
chromatogram of compound CD7-CuAAC including the chemical structure of the desired 
compound CD7-CuAAC. 
For the second approach (B), the brominated cyclodextrin was thiolated using 
thiourea and subsequent hydrolysis and acidification yielded per-6-thio-β-cyclodextrin 
(β-CD-(SH)7). Taking into account the oxidative instability of the thiols, this compound 
should be used as quickly as possible and be stored under argon. Subsequently the 
Michael addition was performed in DMF to 2-(2-bromoisobutyryloxy) ethyl acrylate as the 
Michael acceptor in the presence of triethylamine as a base catalyst and dimethyl phenyl 
phosphine as nucleophilic catalyst and doubling as a reductant for possible disulphide 
bridges.27 Also for compound CD7-Michael, a combination of MALDI-TOF analysis and 
GPC revealed that although the desired compound was achieved, many side products 
were observed which could be ascribed to a competitive nucleophilic thio-bromo 
reaction, illustrating why reactions involving thiols cannot be named ‘click’ reactions as 






Figure II.2.2 A) MALDI-TOF mass spectrum of compound CD7-Michael with the isotopic 
distribution of the peak of interest (black) and the theoretical isotopic distribution (red); B) GPC 
chromatogram of compound CD7-Michael including the chemical structure of the desired 
compound CD7-Michael. 
The third approach proved to be the most successful (C), for this the thiolated β-
cyclodextrin was reacted with a large excess of allyl 2-bromo-2-methylpropionate via the 
radical thiol-ene reaction in DMF.28,29 To account for possible disulphide bridges, present 
in the starting product, two equivalents of dithiothreitol were added as a reductant 60 
hours prior to the radical thiol-ene reaction. Also here, MALDI-TOF analysis and GPC 
were performed. The desired product was achieved, however the GPC chromatogram 
showed minor dimer formation (Figure II.2.3). As this product gave the best results, it 
was further used for the synthesis of sequence-controlled star polymers. 
 
Figure II.2.3 A) MALDI-TOF mass spectrum of compound CD7-Radical (I7) with the isotopic 
distribution of the peak of interest (black) and the theoretical isotopic distribution (red); B) GPC 
chromatogram of compound CD7-Radical (I7) including the chemical structure of the desired 




Figure II.2.4 A) 1H-NMR spectrum (in DMSO-d6) of per-6-deoxy-6-(thiopropyl-2-bromo-2-
methylpropanoate)-β-cyclodextrin (CD7-Radical (I7)). 
II.2.2 Sequence-controlled polymerisation of acrylates 
The novel β-cyclodextrin based initiator CD7-Radical (I7) was subsequently used 
for the SET-LRP polymerisation of three different acrylates in DMSO (Figure II.2.5).30 A 
variety of star multiblock copolymers based on methyl acrylate, ethyl acrylate and n-butyl 
acrylate were synthesised in various compositions demonstrating the versatility of the 
approach. 
 
The multi-block copolymerisation was initiated with 60 repeating units of methyl 
acrylate (MA) per arm using the ratio of [MA] : [I] : [CuBr2] : [Me6TREN] = 60 : 1 : 0.04 : 
0.19. A higher amount of monomers per arm was chosen for the first block, as it was 
found that using a smaller amount would result in elevated levels of terminating radical 
radical coupling. Typically a Schlenk tube was charged with same ratio of first block 
monomer methyl acrylate (MA), pre-activated Cu(0) wire (5 cm), CuBr2  and Me6TREN 
in DMSO (1 ml)  and then the mixture was degassed by gentle bubbling of argon gas for 
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30 min. Pre-degassed β-CD initiator in 1 ml was then added via gas tight syringe 
sequentially. The Schlenk tube was sealed and the reaction mixture was allowed to 
polymerise at 25oC. After a polymerisation time of 1.5 h, NMR evidenced that the 
polymerisation reaction was terminated. The second block solution of 10 repeating units 
of ethyl acrylate (EA) per arm was then degassed with argon for 20 min and subsequently 
transferred via cannula to the Schlenk tube under argon protection and allowed to 
polymerise which was finished after 1.5 h. Finally, a third block of 10 repeating units of 
n-butyl acrylate (BA) per arm was added, for which the polymerisation was finished after 
2.5 h.  
  
Figure II.2.5 A) Representative scheme for the obtained triblock β-CD initiated copolymer 
M42E7B7; B) SEC traces of M42E7B7; C) 1H NMR spectra displaying full conversion for each 
block. 
The obtained polymers were very well defined, demonstrating low 
polydispersities and radical-radical coupling and no tailing was observed (see section 
II.4.3). As previously described, four different multi-block copolymers were synthesised 
(Table II.2.1), demonstrating the versatility of the approach. We were able to keep the 
dispersity (Đ) of the multi-block copolymers below 1.12 with each block finished under 
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2.5 hours at monomer conversions over 95% and a total polymerisation time under 6.5 
h. Number average molar masses (Mn) and dispersities were determined via THF GPC 
relative to PMMA standards. As often found for star polymers, measured molar masses 
were lower than theoretical molar masses. 
 
Table II.2.1 Summary of monomer (MA = methyl acrylate, EA = ethyl acrylate, BA = n-butyl 
acrylate) conversions, number average molar masses (Mn) and molar mass distributions (Đ) of 
the synthesised triblock copolymers. 
a) Conversion (ρ) obtained from 1H NMR; b) Mn,NMR = ([M]o/[CD-initiator]o x conversion x Mmon) + MCD-init; c) Determined by 















99 - -  38800 35600 1.06 1.5 
- 98 -  45800 43500 1.07 1.5 





99 - -  38800 35300 1.06 1.5 
- - 97  47800 45700 1.09 2 





- 99 -  44700 41900 1.07 1.5 
98 - -  50750 48400 1.08 2 





- 99 -  44700 41700 1.08 1.5 
- - 96  53600 51100 1.10 2.5 




In conclusion, we have investigated several synthesis routes towards 
monofacially functionalized β-cyclodextrin based SET-LRP star initiators using ‘click’ and 
‘click’ like reactions. It was found that the radical thiol-ene reaction proved to be most 
successful in achieving this. The other two synthesis routes not only gave too many side 
reactions, but the first synthesis route also produces copper residues that can further 
interfere in the copper mediated polymerisation processes. Furthermore we have 
demonstrated that this novel β-cyclodextrin based initiator can be used for the synthesis 
of core-first 7-arm multi-block star shaped polymers based on different acrylates. All 
synthesised multiblock-copolymers have excellent dispersities (≤ 1.12), even at high 
monomer conversions and were completed under 6.5 h. As the hydrophobic cavity of the 
β-cyclodextrin core should still be accessible, we hope to have drawn a basis for novel 




II.4 Experimental section 
II.4.1 Materials 
Methyl acrylate (MA) (99%, contains ≤100 ppm MEHQ as inhibitor), ethyl acrylate 
(EA) (99%, contains ≤100 ppm MEHQ as inhibitor) and butyl acrylate (BA) (99%, 
contains ≤100 ppm MEHQ as inhibitor were purchased from Sigma Aldrich Chemical 
Company (Dorset, UK). Tris(2-(dimethylamino)ethyl)amine (Me6TREN) was previously 
synthesised within the group. All other reagents and solvents were obtained at the 
highest purity available from Sigma Aldrich Chemical Company. MA, EA and BA were 
passed through a basic alumina column to remove inhibitors prior to polymerisation.  
II.4.2 Instruments and analysis 
Proton (1H-NMR) nuclear magnetic resonance spectroscopy (Bruker DPX-
400/600) was used to determine the chemical structure of the synthesised initiators and 
polymers. Samples were dissolved at 10 mg/mL concentration in CDCl3 or DMSO-d6 as 
solvent.  
Gel Permeation Chromatography (GPC) measurements were conducted on an 
Agilent 1260 infinity system operating in THF containing 2% triethylamine (TEA) and 
equipped with refractive index detector (RID) and variable wavelength detector (VWD), 
2 PLgel 5 µm mixed-C columns (300×7.5mm), a PLgel 5 mm guard column (50x7.5mm) 
and an autosampler. The instrument was calibrated with linear poly(methyl methacrylate) 
(PMMA) standards.  
Matrix assisted laser desorption/ionisation – time of flight mass spectroscopy 
(MALDI-TOF MS) was performed using a Bruker Daltonics Autoflex MALDI-ToF mass 
spectrometer, equipped with a nitrogen laser at 337 nm with positive ion ToF detection. 
Polymer samples were measured as follows; solutions in acetonitrile of trans-2-[3-(4-tert-
Butylphenyl)-2-methyl-2-propenylidene]malononitrile (DCTB, ≥98%) as matrix (30 
mg·mL−1), potassium trifluoroacetate (KTFA) as cationisation agent (10 mg·mL−1) and 
sample (10 mg·mL−1) were spotted separately on the MALDI plate (0.7 μL each) and 
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mixed on the plate. Spectra were recorded in reflectron mode and the mass spectrometer 
was calibrated with a peptide mixture up to 6000 Da. 
II.4.3 Experimental procedures 
II.4.3.1 Synthesis of per-(6-deoxy-6-bromine)-β-cyclodextrin (β-CD-(Br)7) 
 
Scheme II.4.1 Schematic representation of the synthetic approach to β-CD-(Br)7. 
Triphenylphosphine (Ph3P, 40.39 g, 154.0 mmol) was dissolved in anhydrous 
DMF (150 mL) under stirring and cooled down to 0 °C. N-bromosuccinimide (NBS, 27.41 
g, 154.0 mmol) was dissolved in anhydrous DMF (40 mL) and the solution was added 
dropwise to the Ph3P solution under Ar atmosphere and then stirred at ambient 
temperature for 30 min. β-Cyclodextrin (β-CD, 11.35 g, 10.00 mmol) (previously 
recrystallized three times from water and dried in a vacuum oven at 50 °C for two days) 
was dissolved in anhydrous DMF (150 mL). The obtained Ph3P/NBS solution was then 
added dropwise to the β-cyclodextrin solution at ambient temperature after which the 
solution temperature was increased to 80 °C. The mixed brown solution was stirred 
under Ar atmosphere overnight at 80 °C. Afterwards MeOH (40 mL) was added at 
ambient temperature and stirring was continued for 30 min. The reaction mixture was 
then cooled to 0 °C and the pH was adjusted to 9 by adding sodium methoxide, while 
further stirring for 1 h. The reaction mixture was then poured into stirred ice-water (4 L) 
resulting in a fine precipitate which was filtered and washed with MeOH. Heptakis (6-
deoxy-6-bromo)-β-cyclodextrin was obtained as beige solids and dried under vacuum for 
1 day. Yield: 11.32 g, 70%). 
1H NMR (400 MHz, DMSO-d6, 298 K, ppm): δ =6.02 (d, 7 H, 6.7 Hz), 5.89 (d, 7 H, 1.9 
Hz), 4.98 (d, 7 H, 3.4 Hz), 4.00 (d, 7 H, 9.8 Hz), 3.82 (t, 7 H, 9.3 Hz), 3.65 (m, 14 H), 3.38 
(m, 14 H, overlap with H2O) 
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MALDI-TOF MS m/z: calculated for C42H63Br7O28K+: 1614.73; found, 1614.74 
II.4.3.2 Synthesis of per-(6-deoxy-6-azido)-β-cyclodextrin (β-CD-(N3)7) 
 
Scheme II.4.2 Schematic representation of the synthetic approach to β-CD-(N3)7. 
Heptakis (6-deoxy-6-bromo)-β-cyclodextrin (10.0 g, 6.34 mmol) was dissolved in 
anhydrous DMF (80 mL) and NaN3 (5.78 g, 88.8 mmol). The resulting suspension was 
stirred at 70 °C under Ar for 36 h. The suspension was then allowed to cool down and 
precipitated in 2 L of stirred ice-water. The precipitate was filtered, washed with water 
and redissolved in DMF (20 mL) and precipitated in 1L of stirred ice-water. The 
precipitate was filtered and washed with water and with little acetone. The resulting 
product was a white solid (yield: 7.2 g, 86.5 %) and was dried under vacuum overnight. 
 
1H NMR (400 MHz, DMSO-d6, 298 K, ppm): δ =5.90 (d, 7 H, 6.8 Hz), 5.75 (d, 7 H, 2 Hz), 
4.91(d, 7 H, 3,4 Hz), 3.74 (m, 14 H), 3.59 (m, 14 H), 3.36 (m, 14 H, overlap with H2O). 
MALDI-TOF MS m/z: calculated for C42H63N21O28K+: 1348.37; found, 1348.27 
II.4.3.3 Synthesis of propargyl-2-bromoisobutyrate 
 




Propargyl alcohol (7.50 mL, 7.22 g, 129 mmol) and triethylamine (28.7 mL, 20.8 
g, 206 mmol) were dissolved in dichloromethane (DCM) (150 mL) and cooled down to 0 
°C in an ice-water bath. A solution of α-bromoisobutyryl bromide (BIBB) (20.7 mL, 38.5 
g, 167 mmol) in 20 mL DCM was added dropwise over a period of 20 min. The mixture 
was allowed to stir for 1 h at 0 °C after which it was allowed to reach room temperature 
and stirring was continued overnight. The solution was washed 3 x 50 mL 10% HCl 
solution, 3 x 50 mL saturated NaHCO3 solution, 3 x 50 mL water and subsequently dried 
over MgSO4. After evaporating the solvent via rotary evaporation, the product was 
purified by column chromatography on silica gel using DCM: hexane (1:3) affording a 
colourless oil. (yield: 75%, 20 g). 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ = 4.78 (d, 2 H, 2.4 Hz), 2.52 (t, 1 H, 2.4 Hz), 
1.96 (s, 6 H) 
II.4.3.4 Synthesis of per-6-deoxy-6-((1,2,3-triazol-4-yl)methyl 2-bromoisobutyrate)-
β-cyclodextrin (CD7-CuAAC)  
 
Scheme II.4.4 Schematic representation of the synthetic approach to per-6-deoxy-6-((1,2,3-
triazol-4-yl)methyl 2-bromoisobutyrate)-β-cyclodextrin. 
A solution of β-CD-(N3)7 (500 mg, 0.381 mmol, propargyl 2-bromoisobutyrate 
(626 mg, 3.00 mmol), bipy (953 mg, 6.00 mmol) in DMSO (5 ml) was deoxygenated by 
three freeze-pump-thaw cycles. The solution was then transferred via cannula under 
nitrogen into a Schlenk tube, previously evacuated and filled with nitrogen, containing 
CuBr (438 mg, 3.00 mmol). The resulting solution was stirred at 50 °C for 24 h. When 
the reaction was completed, the reaction mixture was purged with air for 1 h. The solution 
was precipitated in 40 mL of methyl tert-butyl ether (MTBE) and centrifuged at 8000 rpm 
for 5 min. The solvent was decanted and fresh MTBE was added, mixed and centrifuged 
again. This procedure was repeated 4 times in order to remove DMSO, excess propargyl 
initiator and Cu/bipy) residues. The final product could be recovered as beige powder 
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(355 mg, yield: 65%). As can be seen in the MALDI-TOF spectrum many side reactions 
occurred.  
II.4.3.5 Synthesis of per-6-thio-β-cyclodextrin (β-CD-(SH)7) 
 
Scheme II.4.5 Schematic representation of the synthetic approach to β-CD-(SH)7 
β-CD-(Br)7 (5.00 g, 3.17 mmol) and thiourea (2.50 g, 33.3 mmol) were dissolved 
in DMF (50 mL) and the mixture was heated to 70 °C under argon atmosphere. After 24 
h, DMF was removed under reduced pressure and the obtained brown oil was dissolved 
in water (200 mL). Sodium hydroxide (2.22 g, 55.5 mmol) was then added and the 
reaction mixture was heated to a gentle reflux under nitrogen atmosphere. After 1 h, the 
resulting suspension was acidified with aqueous KHSO4 forming a white precipitate which 
was then filtered and washed thoroughly with water and dried under vacuum. Compound 
β-CD-SH7 was recovered as white powder (yield: 3.20 g, 81%).  
 
1H NMR (400 MHz, DMSO-d6, 298 K, ppm): δ =5.91 (d, 7 H, 6.8 Hz), 5.81 (d, 7 H, 2 Hz), 
4.93(d, 7 H, 3.3 Hz), 3.68 (t, 7 H, 8.5 Hz), 3.61 (t, 7 H, 9.2 Hz), 3.29-3.40 (m, 14 H, 
overlap with H2O), 3.19 (m, 7H), 2.75 (m, 7 H), 2.13 (t, 7 H, 8.3 Hz) 
II.4.3.6 Synthesis of 2-(2-Bromoisobutyryloxy) ethyl acrylate 
 




Hydroxyethyl acrylate (10.0 mL, 10.1 g, 871 mmol) and triethylamine (17.0 mL, 
12.3 g, 122 mmol) were dissolved in dichloromethane (DCM) (150 mL) and cooled down 
to 0 °C in an ice-water bath. A solution of α-bromoisobutyryl bromide (BIBB) (12.9 mL, 
24.0 g, 104 mmol) in 20 mL DCM was added dropwise over a period of 20 min. The 
mixture was allowed to stir for 1 h at 0 °C after which it was allowed to reach room 
temperature and stirring was continued overnight. The solution was washed 3 x 50 mL 
10% HCl solution, 3 x 50 mL saturated NaHCO3 solution, 3 x 50 mL water and 
subsequently dried over MgSO4. After evaporating the solvent via rotary evaporation, the 
product was purified by column chromatography on silica gel using petroleum ether: ethyl 
acetate (5:1) affording a colourless oil. (yield: 81% , 18.7 g). 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ = 6.43 (dd, 1 H, 1.4 Hz, 17.4 Hz), 6.13 (dd, 1 
H, 10.5 Hz, 17.4 Hz), 5.86 (dd, 1 H, 1.4Hz, 10.5 Hz), 4.41 (s, 4 H), 1.92 (s, 6 H) 
II.4.3.7 Synthesis of per-6-deoxy-6-(thio-propanoyl-oxy-ethyl 2-bromoisobutyrate)-
β-cyclodextrin (CD7-Michael) 
 
Scheme II.4.7 Schematic representation of the synthetic approach to per-6-deoxy-6-(thio-
propanoyl-oxy-ethyl 2-bromo-2-methylpropanoate)-β-cyclodextrin 
Per-6-thio-β-cyclodextrin (500 mg, 0.401 mmol), 2-(2-Bromoisobutyryloxy) ethyl 
acrylate (1.49 g, 5.62 mmol), dimethylphenylphosphine (20 µL, 19.3 mg, 0.140 mmol), 
triethylamine (0.100 mL, 72.6 mg, 7.18 mmol) were dissolved in 15 mL of 
dimethylformamide (DMF). A drop of water was added to the reaction mixture and the 
mixture was allowed to stir at room temperature for 5 h. The solution was precipitated in 
100 mL of methyl tert-butyl ether (MTBE) and centrifuged at 8000 rpm for 5 min. The 
solvent was decanted and fresh MTBE was added, mixed and centrifuged again. This 
procedure was repeated 4 times in order to remove DMF and excess 2-(2-
bromoisobutyryloxy) ethyl acrylate. Subsequently the product was dried under vacuum 
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yielding a fine beige (769 mg, yield: 62%). As can be seen in the MALDI-TOF spectrum 
many side reactions occurred. 
II.4.3.8 Synthesis of allyl 2-bromoisobutyrate 
 
Scheme II.4.8 Schematic representation of the synthetic approach to allyl 2-bromoisobutyrate 
Allyl alcohol (16.2 mL, 16.4 g, 282 mmol) and triethylamine (47.2 mL, 34.2 g, 339 
mmol) were dissolved in diethyl ether (150 mL) and cooled down to 0 °C in an ice-water 
bath. A solution of α-bromoisobutyryl bromide (BIBB) (29.0 mL, 54.0 g, 234 mmol) in 20 
mL diethyl ether was added dropwise over a period of 20 min. The mixture was allowed 
to stir for 1 h at 0 °C after which it was allowed to reach room temperature and stirring 
was continued overnight. The solution was washed 3 x 50 mL 10% HCl solution, 3 x 50 
mL 5% NaOH solution, 3 x 50 mL water and subsequently dried over MgSO4. After 
evaporating the solvent via rotary evaporation, the product was purified by column 
chromatography using chloroform as the eluent affording a colourless oil. (yield: 76% , 
23 g). 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ = 5.9 (ddt, 1 H, 5.5 Hz, 10.6 Hz, 17.2 Hz), 
5.35 (dq, 1 H, 1.5 Hz, 17.2 Hz), 5.24 (dq, 1 H, 1.3 Hz, 10.6 Hz), 4.63 (dt, 2 H, 1.4 Hz, 5.6 
Hz), 1.91 (s, 6 H) 
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II.4.3.9 Synthesis of per-6-deoxy-6-(thiopropyl-2-bromo-2-methylpropanoate)-β-
cyclodextrin (CD7-Radical = I7) 
 
Scheme II.4.9 Schematic representation of the synthetic approach to per-6-deoxy-6-(thiopropyl-
2-bromo-2-methylpropanoate)-β-cyclodextrin (CD7-Radical = I7) 
Per-6-thio-β-cyclodextrin (2.50 g, 2.01 mmol), and dithiotreitol (DTT, 618 mg, 4 
mmol) were dissolved in 40 mL anhydrous DMF under Ar and heated to 60 °C. After 60 
h de reaction mixture was allowed to cool down to room temperature and allyl 2-
bromoisobutyrate (14.5 g, 70.2 mmol), 2,2-dimethoxy-2-phenylacetophenone (DMPA, 
179 mg, 7.02 mmol) were added to the reaction mixture and stirring was continued for 5 
h under UV irradiation (365 nm). The solution was precipitated in 500 mL of methyl tert-
butyl ether (MTBE) in ten 50 mL centrifuge tubes and centrifuged at 8000 rpm for 5 min. 
The solvent was decanted and all precipitated fractions collected in two 50 mL centrifuge 
tubes and fresh MTBE was added, mixed and centrifuged again. This procedure was 
repeated 4 times in order to remove DMF and allyl 2-bromoisobutyrate. Subsequently 
the product was dried under vacuum, yielding a fine beige solid. (3.7 g, yield: 68%).  
1H NMR (400 MHz, DMSO-d6, 298 K, ppm): δ = 5.90 (d, 7 H, 5.6 Hz), 5.8 (m, 7 H), 4.85 
(m, 7 H), 4.22 (t, 14 H, 5.2 Hz), 3.85 (m, 7 H), 3.57 (m, 7 H), 3.33 (m, 14 H), 3.09 (d, 7 
H, 10.6 Hz), 2.82 (m, 7 H), 2.69 (m, 14 H), 1.90 (s, 56 H) 
MALDI-TOF MS m/z: calculated for C91H147Br7O42S7K+:2733.12; found: 2733.36 
II.4.3.10 General procedure for SET-LRP 
A Schlenk tube was charged with same ratio of first block monomer (420 eq), 
pre-activated Cu(0) wire (5 cm), CuBr2  (0.33 mg, 0.28 eq) and Me6TREN (4.53 mg, 1.33 
eq) in DMSO (1 ml)  and then the mixture was degassed by gentle bubbling of argon gas 
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for 30 min. Pre-degassed CD-initiator in 1 ml (40 mg, 1 eq) was then added via gas tight 
syringe sequentially. The Schlenk tube was sealed and the reaction mixture was allowed 
to polymerise at 25˚C.  Sampling was carried out using a degassed syringe to check the 
conversion of MA.  After it reached to full conversion, the second block solution (70 eq 
in 0.5 mL DMSO) was then degassed with argon for 20 min and subsequently transferred 
via cannula to the Schlenk tube under argon protection to polymerise. A sample was 
taken for 1H NMR and GPC analysis to check full monomer conversion again. When the 
1H NMR result confirmed nearly full conversion, the last block (70 eq in 0.5 mL DMSO) 
was added into the polymerisation solution. Catalyst residues were removed by filtering 
through a column of neutral alumina prior to THF GPC analysis.  
 
Figure II.4.1 GPC traces of M42B7E7 (A); and 1H NMR spectra displaying full conversion for 





Figure II.4.2 GPC traces of E42M7B7 (A); and 1H NMR spectra displaying full conversion for 
each block (B). 
 
Figure II.4.3 GPC traces of E42B7M7 (A); and 1H NMR spectra displaying full conversion for 
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Influence of molecular 
architecture on glycopolymer 
lectin binding 
 
This chapter describes the synthesis and characterisation of radical initiators for 
SET-LRP and their use for the synthesis of mannose containing star glycopolymers 
with varying arm number and length. 2 sets of star glycopolymers were successfully 
synthesised and characterised via 1H-NMR and GPC. The first set encompasses 5 
star glycopolymers with a different amount of arms per molecule but with equal arm 
length. For the second set of 5, the amount of sugars per molecule was kept 
constant. The obtained star glycopolymers were subsequently evaluated for their 
lectin-binding affinity towards a series of a mix of both newly and previously studied 
C-type lectins present on dendritic and Langerhans cells via Surface Plasmon 
Resonance (SPR). In general, it is noticeable that binding activity and avidity 
increases with both the number of arms and the arm length of the glycopolymers. 
SPR measurements were performed by Dr. G. Yilmaz and Miss A. Monaco 
Parts of this chapter have been published: Oz, Y.; Abdouni, Y.; Yilmaz, G.; Becer, C. 
R.; Sanyal, A. Polym. Chem. 2019, 10 (24), 3351.  
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III Influence of molecular 
architecture on glycopolymer 
lectin binding 
III.1 Introduction 
Over the last two decades, a plethora of synthetic glycostructures have been 
synthesised and evaluated as possible biomimetics for the glycocalyx.1,2 Significance of 
the cellular glycocalyx is demonstrated by its role in major biological events such as 
protection against and recognition of pathogens, intercellular recognition and signal 
transduction.3,4 Glycoproteins and glycolipids which constitute the main building blocks 
of the glycocalyx are of significant importance from a biological point of view, however 
their synthetic complexity limits their use in biological studies. Their complexity originates 
from an inherent highly branched nature, this branched nature however, offers a great 
interaction ability towards lectins (or carbohydrate-binding proteins) with high 
specificity.5,6 Apart from this favourable specificity, lectin binding avidity can be notably 
enhanced by what is known as “the glycocluster effect”. The glycocluster effect is defined 
as the significant increase in binding affinity towards lectins, originating from multivalent 
protein-carbohydrate interactions working cooperatively.7,8 Over the last years, polymer 
chemists have greatly exploited this glycocluster effect, employing precision synthesis 
techniques in the hopes of finding new molecular architectures with improved binding 
avidity.9 Factors that influence this binding avidity include: saccharide density, backbone 
flexibility, glycopolymer length but also recently we’ve shown that linker flexibility has a 
not to be ignored effect.10,11 
 
The introduction of precision synthesis in polymer chemistry, enabled the 
production of different nonlinear molecular architectures ranging from dendritic, brush, 
graft, hyperbranched, star shaped and even cyclic polymers.12 In particular, star 
polymers can be achieved via three distinct synthetic routes. These synthetic routes 
encompass a core-first approach, a coupling-onto approach or lastly an arm-first 
95 
 
approach. Synthetically speaking, the coupling-onto method would require a high 
coupling efficiency. The arm-first approach on the other hand, generally gives a broad 
distribution of arms per molecule and for this reason, a core-first approach is often 
preferred as it offers an augmented control over the number of arms.13,14 Stenzel and 
coworkers, employed a core-first approach for the synthesis of 4-arm star glycopolymers. 
In their work it was confirmed that not only glycopolymer length and thus molecular 
weight, but also backbone rigidity has an important influence on binding affinity towards 
lectins.15,16 Mitchel et al. furthermore showed the possible use of star glycopolymers in 
immune response modulation by influencing cytokine expression.17  
 
As mentioned vide supra, lectins are proteins capable of binding carbohydrates 
with great specificity. Here newly synthesised glycopolymeric structures were tested 
towards one class of lectins, namely C-type lectins. C-type lectin receptors constitute a 
large family of both transmembrane and secreted proteins that contain one or more 
carbohydrate recognition domains known as C-type lectin-like domains (CTLD) which 
are calcium dependent in nature.18 A subdivision of these lectins has been classified as 
pattern recognition receptors as they induce immune response regulation by specific 
pathogen- or damage-associated molecule activation. CLRs that function in this way, 
employed in this study, comprise the dendritic cell-specific intracellular adhesion 
molecules (ICAM)-3 grabbing non-integrin (DC-SIGN or CD209), the liver/lymph node-
specific ICAM-3 grabbing non-integrin (L-SIGN, DC-SIGNR or CD209L), the C-type 
lectin-like receptor -1 (CLEC-1) and the dendritic cell-associated C-type lectin-2 (Dectin-
2).19–21 Other C-type lectins are involved in the detection and clearance of dead and dying 
cells, both crucial processes for the maintenance of organ and tissue homeostasis. 
These include soluble (secreted) C-type lectins such as the mannose-binding lectin 
(MBL) but also surfactant protein-D (SP-D), both members of the collectin family which 
facilitates dead cell clearance by recognition of mannose structures among other 
motifs.22 Furthermore membrane-bound CLRs such as the dendritic and epithelial cell 
receptor (DEC205) and the dendritic cell natural killer (NK) lectin group receptor 1 
(DNGR1) are among those able to detect cell-death.23–25 Lastly the Langerhans cell-
specific C-type lectin (Langerin or CD207) plays an important protective role, prompting 
uptake and degradation of viral particles such as the recognition of the HIV 
glycoproteins.26,27 
 
This chapter describes the synthesis and characterisation of two series of novel 
star glycopolymers starting from star initiators recently developed in the own group. 
Subsequently these mannose containing star glycopolymers have been tested towards 
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their ability to effectively bind the above mentioned newly and previously studied C-type 




III.2 Results and discussion 
III.2.1 Synthesis of a mannose glycomonomer 
The first step in making glycopolymers is the synthesis of a suitable 
glycomonomer. Here we synthesised a mannose glycomonomer as previously 
published.28  The mannose glycomonomer that we synthesised here is an acrylate that 
has shown to polymerise really well using SET-LRP in the past.28,29 To achieve this, D-
mannose was treated with propargyl alcohol in the presence of silica supported sulphuric 
acid. Subsequently 3-azidopropyl acrylate was prepared by reacting sodium azide with 
3-bromopropanol and the resulting 3-azidopropanol was then reacted with acryloyl 
chloride. Finally mannose acrylate was achieved by ‘clicking’ the propargyl-D-mannose 
to 3-azidopropyl acrylate using the well-known copper(I)-catalysed azide-alkyne 
cycloaddition (CuAAC) “click” reaction.  
 
Figure III.2.1 A) 1H-NMR spectrum of D-mannose acrylate in MeOD. 
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III.2.2 Synthesis of initiators 
 
Figure III.2.2 Chemical structures of the various SET-LRP initiators synthesised and used in 
this chapter. 
For the synthesis of the anticipated star glycopolymers, appropriate SET-LRP 
star initiators had to be synthesised. Initiator I1, which is the popularly used ethyl α-
bromoisobutyrate, was bought from Sigma-Aldrich and is the only non-newly synthesised 
initiator. Secondly initiator I3, which is a water-soluble three arm initiator based on 
commercially available glycerol ethoxylate (Mn ~ 1000 g/mol) and which has three 
initiating sites, was prepared by Dr. Resat Aksakal and used as received (after removing 
inhibitor on basic alumina).30 Initiator I7 was prepared as described in Chapter 2 and is 
the first initiator in this Chapter which is based on β-cyclodextrin containing 7 initiating 
sites. 
Initiator I8, is based on tripentaerythritol, a commercially available molecule 
containing 8 primary hydroxyls. Solubility of tripentaerythritol proved to be cumbersome 
in dry DMF and NMP. For this reason a mixture of dichloromethane (DCM) and pyridine 
was used, which resulted in a fine suspension of the product. The hydroxyl groups were 





Figure III.2.3 A) 1H-NMR spectrum of initiator I8, the tripentaerythritol initiator  
Lastly, initiator I15, the second β-cyclodextrin based initiator, was prepared 
according to literature as well.29 Here, β-cyclodextrin was dissolved in N-methyl-2-
pyrrolidone (NMP) and reacted with BIBB forming a mixture of products with different 
degrees of substitution. The primary hydroxyls were all converted, however conversion 
of the secondary hydroxyls at the secondary rim region of the β-cyclodextrin gave rise to 
sterical problems, limiting reactivity of adjacent secondary hydroxyls. MALDI-TOF 
analysis shed light on the amount of actual esterifications showing an average of 15 




Figure III.2.4 A) MALDI-TOF mass spectrum of initiator I15 depicting the different degrees of 
substitution. The minor peaks in between the major peaks are due to bromine loss. B) 1H-NMR 
spectrum of initiator I15.  
III.2.3 Synthesis of glycopolymers 
Two sets of star glycopolymers were subsequently prepared using SET-LRP in 
DMSO. The first set of glycopolymers (set S1) was generated with a different amount of 
arms per molecule but with equal arm length to obtain a similar size of star 
glycopolymers. The second set of glycopolymers (set S2) on the other hand also has a 
different amount of arms per molecule but an equal glycovalency per molecule. During 
the polymerisation, monomer concentration was deliberately kept low too avoid star-star 
coupling between polymers, as bimolecular radical termination is a very common side 
reaction. Additionally, detailed kinetic investigations were not the focus of this work but 





Figure III.2.5 A) GPC chromatograms of set S1. B) GPC chromatograms of set S2. C) Kinetic 
plots of set S1. D) Kinetic plots of set S2. 
Set S1 was polymerised using initiators I1-I15 corresponding to 1;3;7;8 and 15 
arm star glycopolymers respectively, details on the polymerisation procedures can be 
found in experimental section III.4. All polymerisations were stopped at max 90% 
conversion except polymer M7-210 which seemed to be more prone to termination 
reactions as can be deduced from the kinetic plots (Figure III.2.5 C). For this reason the 
polymerisation of M7-210 was stopped after 8h at approximately 85.6 % conversion. 
Overall all glycomonomer conversions were found to be within 85 % and 90% as 
determined by 1H-NMR. GPC chromatograms in DMF show an absence of star-star 
coupling however tailing can be observed for the polymers with a high amount of arms 
which can be attributed to a high local density of radicals around the star glycopolymer 
molecules (Figure III.2.5 A). Dispersities furthermore, were found to be rather high (1.36-
1.69) which is in correspondence with the tailing observed earlier for polymers M7-210 
to M15-450. As seen in Figure III.2.5 A, the GPC traces show a clear shift in molecular 
weight with increasing amount of arms per molecule. However number average 
molecular weights Mn compared to PMMA standards are found to be lower than 
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expected, as is often observed for star polymers due to the smaller hydrodynamic radius 
compared to a linear polymer of same molecular weight.31 
 
Table III.2.1 Summary of monomer conversions, number average molar masses (Mn), peak molar 
masses (Mp) and dispersities (Đ) of the synthesised star glycopolymers. 











M1-30 I1 Linear 30 89.3 10200 7500 10300 1.36 
M3-90 I3 Three arm 90 85.6 30200 24600 25300 1.39 
M7-210 I7 Seven arm 210 87.3 71150 18000 32800 1.69 
M8-240 I8 Eight arm 240 89.8 82100 20500 36400 1.51 
M15-450 I15 Fifteen arm 450 88.6 152400 44200 51900 1.59 
S2 
M1-150 I1 Linear 150 56.8 32050 30300 54700 2.26 
M3-150 I3 Three arm 150 54.5 32000 26300 43800 1.51 
M7-150 I7 Seven arm 150 54.3 33150 23900 36400 1.43 
M8-150 I8 Eight arm 150 54.3 32000 20400 31100 1.43 
M15-150 I15 Fifteen arm 150 50.2 31500 19450 30600 1.41 
Conversion (ρ) obtained from 1H NMR; b) Mn,NMR = ([M]o/[I]o x ρ x Mmon+ MI); 
c) Determined by DMF GPC (relative to PMMA 
stn.). 
Set S2 was polymerised with the same initiators I1-I15. A set of glycopolymers was 
polymerised using a monomer to initiating molecule ratio of 300/1, in order to determine 
the kinetics of the reactions for which then for each polymerisation the polymerisation 
time at 50 % conversion was determined via 1H-NMR. Using the kinetic data, the same 
reactions were repeated using the same polymerisation conditions and then stopped at 
50 % conversion. All polymerisations reached 50 % conversion within 3 h of 
polymerisation time except polymer M1-150 which took 29 h, as can be explained by the 
low concentration of propagating radicals compared to polymers M3-150 to M15-150. 
GPC chromatograms in DMF represent molecular weights that are quite close to each 
other (Figure III.2.5 B). Interestingly here, we can see a clear effect of hydrodynamic 
radius on measured molecular weight. Peak molecular weights (Mp) display a clear 
downward trend with increasing number of arms.31 Dispersities of polymers M3-150 to 
M15-150 are lower than those of polymers M3-150 to M15-150 which can be explained 
by the shorter amount of polymerisation time and thus termination reactions. Polymers 
M1-150 and M3-150 , however, have higher dispersities than polymers M1-30 and M3-
90 owing to a slower propagation rate and thus higher chance of competing side 
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reactions. After reaction, all polymers were dialysed against water to remove remaining 
glycomonomer and other impurities and measured by 1H-NMR in D2O (Figure III.2.6). 


















Figure III.2.6 1H-NMR in D2O of sets S1 and S2 showing the purity of the synthesised star 
glycopolymers, with clear visibility of the triazole peak at 8.0 ppm and disappearance of the vinyl 
protons between 6.5 and 5.5 ppm. 
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III.2.4 Surface Plasmon Resonance  
 
Figure III.2.7 Comparison of glycopolymer set S1 surface plasmon resonance (SPR) lectin 
binding results with DC-SIGN, DC-SIGNR, MBL and Langerin at a concentration of 4000 nM. 
Sets S1 and S2 were tested using SPR for their ability to bind a series of 9 
different lectins which can be found on dendritic and Langerhans cells, known from 
literature to bind mostly mannose or other carbohydrates. The SPR results for sets S1 
and S2, show that no significant binding interaction could be detected for the 
aforementioned glycopolymers with CLEC-1, a lectin that acts as an inhibitory receptor 
in dendritic cells, which is able to dampen T-cell responses and for which specific 
carbohydrate binding affinity is not known yet.32 Also DNGR-1, which is known to bind F-
actin exposed by dying cells and which furthermore facilitates cross-presentation of 
antigens associated with dead cells by dendritic cells, showed no binding towards the 
mannose containing glycopolymers.33 Hence, we can safely state that no binding pockets 
are present for mannose binding on these lectins. DEC-205, which role in antigen uptake, 
processing and presentation has been well characterised, showed only poor binding 
capability limited to polymers M8-240 and M15-450.34 However, binding for these 




Figure III.2.8 Comparison of glycopolymer set S2 surface plasmon resonance (SPR) lectin 
binding results with DC-SIGN, DC-SIGNR, MBL and Langerin at a concentration of 4000 nM. 
As expected, the SPR results reveal that the mannose containing glycopolymers 
display a relatively high and strong binding affinity with the other lectins. Figure III.2.9A, 
which shows results for set S1 comprising of polymers with a different amount of arms 
per molecule but of equal arm length, indicates that the association constants (Ka) 
increase with the number of arms per glycopolymer reaching the highest Ka values for 
M15-450. This tends to be true for Langerin, SP-D and Dectin-2 although M8-240 (with 
8 arms) seems to have an optimal amount of arms for the lectins DC-SIGN and MBL, 
both known to bind mannose really well. As seen in Table III.4.1 and  Table III.4.3 for 
DC-SIGN  and MBL the Ka values of M8-240 is one order of magnitude higher than the 
Ka value of M15-450 and two orders of magnitude higher than linear M1-30. DC-SIGNR 
(or L-SIGN) is the only lectin in this sample collection with a preference for M7-210 
however it must be noted that all Ka values for DC-SIGNR are around 107 M-1. 
Dissociation rate constants kd are in generally very low for entire set S1, indicating that 
the interacted mannose units on the arms tend to remain bound or that rebinding of 
released mannose units occurs rather than the dissociation of the complex when the 






Figure III.2.9 Graphical representation of association constants (Ka) for glycopolymer set S1 and 
S2 with various lectins, as determined by SPR. 
Star glycopolymer set S2 on the other hand, shows a nice decreasing trend in 
lectin binding affinity with increasing amount of arms and thus decreasing arm length 
(Figure III.2.9B). Surprisingly, even though the glycopolymers in set S2 exhibit very 
similar binding trends according to their Rmax values, linear M1-150 demonstrates the 
highest Ka value and thus highest binding affinity for almost all lectins except MBL and 
Langerin. Langerin, which functions as an innate anti-viral defence mechanism and an 
antigen receptor that’s involved in adaptive immune responses, shows a preferential 
binding to polymer M7-150.35 However also here it must be noted that the difference with 
M1-150 is rather small. Furthermore, particularly lower dissociation rate constants (kd) 
were observed for M1-150 with all lectins, which means that M1-150  binds more strongly 
than other glycopolymers in set S2. We can attribute this decrease in set S2 to a 







In summary, two sets of novel star shaped mannose containing glycopolymers 
were synthesised via SET-LRP starting from a series of star polymer initiators previously 
developed in the research group. Both sets of initiators and corresponding glycopolymers 
were fully characterised via 1H-NMR, GPC and MALDI-TOF mass spectrometry. Lectin 
binding studies were performed via surface plasmon resonance (SPR), towards a series 
of newly and previously studied lectins. SPR measurements showed that molecular 
architecture (number and length of the star glycopolymer arms) has a significant effect 
on the association constants between the glycopolymer and the lectin. Overall, we can 
conclude that binding strength increases with both the number of arms and the arm 
length of the glycopolymers. In addition to the confirmation that increased glycovalency 
increases overall binding ability and avidity, the SPR results also revealed that different 






III.4 Experimental section 
III.4.1 Materials 
Tris(2-(dimethylamino)ethyl)amine (Me6TREN) was previously synthesised 
within the group. D-Mannose glycomonomer was synthesised as previously 
reported.36,37All other reagents and solvents were obtained at the highest purity available 
from Sigma Aldrich Chemical Company unless stated otherwise.  
III.4.2 Instruments and analysis 
Proton (1H-NMR) nuclear magnetic resonance spectroscopy (Bruker DPX-
400/600) was used to determine the chemical structure of the synthesised initiators and 
polymers. Samples were dissolved at 10 mg/mL concentration in CDCl3, DMSO-d6, D2O 
or MeOD-d4 as solvent. Monomer conversion was calculated by the disappearance of 
vinyl protons (H2C=CH-CO–) (≈ 6.5-5.5 ppm) compared to the monomer’s triazole proton 
(≈ 8.2-7.9 ppm). 
GPC measurements were conducted on an Agilent 1260 infinity system operating 
in DMF with 5mM NH4BF4 and equipped with refractive index detector and variable 
wavelength detector, 2 PLgel 5 μm mixed-C columns (300×7.5mm), a PLgel 5 mm guard 
column (50x7.5mm) and an autosampler. The instrument was calibrated with linear 
narrow poly(methyl methacrylate) standards. All samples were passed through basic 
alumina to remove any copper residues and filtered with a 0.2 μm Nylon 66 before 
analysis. 
Matrix assisted laser desorption/ionisation – time of flight mass spectroscopy 
(MALDI-TOF MS) was performed using a Bruker Daltonics Autoflex MALDI-ToF mass 
spectrometer, equipped with a nitrogen laser at 337 nm with positive ion ToF detection. 
Polymer samples were measured as follows; solutions in acetonitrile of trans-2-[3-(4-tert-
Butylphenyl)-2-methyl-2-propenylidene]malononitrile (DCTB, ≥98%) as matrix (30 
mg·mL−1), potassium trifluoroacetate (KTFA) as cationisation agent (10 mg·mL−1) and 
sample (10 mg·mL−1) were spotted separately on the MALDI plate (0.7 μL each) and 
mixed on the plate. Spectra were recorded in reflectron mode and the mass spectrometer 
was calibrated with a peptide mixture up to 6000 Da. 
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Surface Plasmon Resonance (SPR) - The extent of interaction between the 
glycopolymers and lectins were performed on a BIAcore 3000 system (GE Healthcare). 
The proteins (0.025 mg/ml) were immobilised via a standard amino coupling protocol 
onto a CM5 sensor chip which was activated by flowing a 1:1 mixture of 0.1 M N-
hydroxysuccinimide and 0.1 M N-ethyl-N’-(dimethylaminopropyl)carbodiimide over the 
chip for 6 min at 25 °C at a flow rate of 20 µL/min after the system equilibration with 
HEPES filtered buffer (10 mM HEPES, 150 mM NaCl, 5 mM CaCl2) supplemented with 
0.005% TWEEN® 20 at pH 7.4. Subsequently, channels 1 (blank), 2, 3 and 4 were 
blocked by following a solution of ethanolamine (1 M pH 8.5) for 10 min at 5 µL/min to 
remove remaining reactive groups on the channels. Sample solutions were prepared at 
varying concentrations (4000 nM-250 nM) in the same HEPES buffer to calculate the 
binding kinetics. Sensorgrams for each glycopolymer concentration were recorded with 
a 300 seconds injection of polymer solution (on period) followed by 150 seconds of buffer 
alone (off period). Regeneration of the sensor chip surfaces was performed using 10 mM 
HEPES pH 7.4, 150 mM NaCl, 10 mM EDTA, 0.01% P20 surfactant solution. Kinetic 
data was evaluated using a single set of sites (1:1 Langmuir Binding) model and also 
Biavalent model in the BIAevalulation 3.1 software. 
III.4.3 Experimental procedures 
III.4.3.1 Synthesis of 3-azido-propan-1-ol 
 
Scheme III.4.1 Schematic representation of the synthetic approach to 3-azidopropan-1-ol 
3-bromopropan-1-ol (7.00 g, 50.4 mmol) was dissolved in a solution of acetone 
(250 mL) and water (50 mL) along with sodium azide (1.6 eq., 5.56 g, 85.6 mmol) and 
refluxed overnight at temperature of 70 °C. The organic solvent was removed by rotary 
evaporation. 50 mL water was added to the remaining water phase and was then 
extracted with diethyl ether (3X50 mL). The resulting ether phase was then back 
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extracted with water (50 mL) and dried over magnesium sulphate. The organic solvent 
was removed by rotary evaporation. The product was recovered as a colourless liquid 
and used directly (yield: 64%). 
1H NMR (400 MHz, D2O, 298 K, ppm): δ =3.66 (t, 2 H, 6.3 Hz), 4.41 (t, 2 H, 6.8 Hz), 1.81 
(quin, 2 H, 6.5 Hz). 
13C NMR (100 MHz, D2O, 298 K, ppm): δ = 58.78 (O-CH2), 47.93 (CH2-N3), 30.49 (C-
CH2-C). 
III.4.3.2 Synthesis of 3-azidopropyl acrylate 
 
Scheme III.4.2 Schematic representation of the synthetic approach to 3-azidopropyl acrylate 
A solution of 3-azido-propan-1-ol (6.10 g, 60.3 mmol), TEA (11.8 mL, 84.5 mmol), 
hydroquinone (30 mg) and anhydrous diethyl ether (200 mL) was cooled in an ice water 
bath. Acryloyl chloride (5.88 mL, 72.4 mmol) in 20 mL diethyl ether was added dropwise 
into the solution. The mixture was stirred in the ice bath for 1 h and then at ambient 
temperature overnight. The ammonium salts were removed by filtration and the residue 
was extracted sequentially with aqueous solution of hydrochloric acid (10 v%, 3X50 mL), 
water (2Х50 mL), 5 wt% aqueous NaOH (3Х50 mL) and water (2Х50 mL) and dried over 
magnesium sulphate. The organic solvent was removed by rotary evaporation.  The 
product was recovered as a yellow liquid and used directly (yield: 45%). 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ =6.42 (dd, 1 H, 1.4, 17.3 Hz), 6.12 (dd, 1 
H,10.4, 17.3 Hz), 5.85 (dd, 1 H, 1.4, 10.4 Hz), 4.25 (t, 2 H, 6.2 Hz), 3.41 (t, 2 H, 6.7 Hz), 
1.96 (quin, 2 H, 6.4 Hz). 
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III.4.3.3 Synthesis of 1-(2′-Propargyl) D-Mannose 
 
Scheme III.4.3 Schematic representation of the synthetic approach to 1-(2′-propargyl) D-
Mannose 
1-(2′-Propargyl) D-Mannose was prepared according to the procedure reported 
by Mukhopadhyay et al.38 A suspension solution of D-Mannose (12.0 g, 66.6 mmol), 
propargyl alcohol (19.4 mL, 333 mmol) and H2SO4-silica (333 mg) was stirred at 65 °C 
overnight. After cooling to ambient temperature, the reaction mixture was transferred to 
a silica gel column and eluted with CHCl3-MeOH (8:1) to remove the excess propargyl 
alcohol. 1-(2′-Propargyl) D-Mannose was obtained as a white solid after drying under 
vacuum (8.01 g, yield: 55 %). 1-(2′-propargyl) D-Mannose was found as an anomeric 
mixture in a ratio of 10:1 (α/β).  
1H NMR (400 MHz, CD3OD, 298 K, ppm): δ: 4.96 (d, 1H, 1.6 Hz), 4.27 (d, 2H, 2.5 
Hz), 3.84 (dd, 1H, 2.3, 11.8 Hz), 3.79 (dd, 1H, 1.8, 3.1 Hz), 3.66 (m, 3H), 3.51 (m, 1H), 
2.85 (t, 1 H, 2.4 Hz)  
III.4.3.4 Synthesis of D-Mannose glycomonomer 
 
Scheme III.4.4 Schematic representation of the synthetic approach to the D-Mannose 
glycomonomer 
1-(2′-propargyl) D-mannose (3.64 g, 16.7 mmol) and 3-azidopropyl acrylate (2.85 
g, 18.3 mmol) were dissolved in MeOH/H2O (2:1 vol/vol, 60 mL), aqueous solution of 
CuSO4·5H2O (624 mg, 2.50 mmol) and (+)-sodium L-ascorbate (625 mg, 3.15 mmol) 
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were added into the reaction solution. The reaction mixture was stirred at ambient 
temperature for 24 h and then the methanol was removed in vacuo and the residue 
mixture was freeze dried in order to remove water. The purification of the obtained 
product was done by silica gel column chromatography using DCM-MeOH (8:1) as 
eluent. After removal of the solvent, the product was obtained as a white sticky solid 
(1.62 g, yield: 58.2%).  
1H NMR (D2O, 298 K, 400 MHz): δ =8.07, 8.06 (s, overlapped, 1 H, NCH=C), 6.37 (dd, 
J=1.8, 15.5 Hz), 6.36 (dd, J=1.6, 15.7 Hz) (anomeric 1 H, CH2=C), 6.14 (dd, J=10.4, 6.9 
Hz), 6.13(dd, J=10.4, 7.0 Hz) (anomeric, 1 H, CH2=CHC=O), 5.89 (dd, 1 H, J=1.5, 8.9 
Hz, CH2=C), 4.70-5.05 (m, CH2-OH, H-1 of mannose , overlap with H2O), 4.64 (d, 1 H, 
J=12.3 Hz, CH2-OH), 4.55 (t, 2 H, J=6.9 Hz, CH2-N), 4.19 (t, 2 H, J=6.0 Hz, C=O-O-CH2), 
3.40-3.92 (m, H residues of mannose), 2.30 (m, 2H, CH2-CH2-CH2) ppm.  
III.4.3.5 Synthesis of Initiator I3 (tri-O-(2-bromo-2-methyl propionyl)-glycerol 
ethoxylate)30 
 
Scheme III.4.5 Schematic representation of the synthetic approach to Initiator I3 (tri-O-(2-bromo-
2-methyl propionyl)-glycerol ethoxylate) 
Glycerol ethoxylate (26.40 mL, 30.04 mmol), TEA (22.35 mL, 160.35 mmol) and 
dry THF (250 mL) were added to a round bottom flask equipped with stirring bar and 
cooled down to 0°C in an ice-bath. BIBB (16.7 mL, 135.11 mmol) was dissolved in dry 
THF (50 mL) and the mixture was slowly added to the reaction under Ar over a period of 
1 hour. The resulting suspension was allowed to warm up to ambient temperature and 
furthermore allowed to stir overnight. The salts were removed via filtration and 
subsequently washed with 30 mL of THF. The resulting filtrate was collected and 
concentrated in vacuo, precipitated twice in hexane and subsequently redissolved in 
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DCM and passed over a basic alumina column. The initiator was found as a transparent 
viscous oil. (Yield = 29.0 mL, 78%). 
 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ = 4.32 (t, 6H), 3.76-3.71 (m, 7H), 3.69-3.58 
(broad, 72H), 3.58- 3.48 (m, 4H), 1.96 (s, 18H).  
MALDI-TOF MS m/z:  calculated for C55H103O26Br3+K+: 1455.392 Da; found, 1456.1 
III.4.3.6 Synthesis of Initiator I8 (Octa-O-(2-bromo-2-methylpropionyl)-
tripentaerythritol) 
 
Scheme III.4.6 Schematic representation of the synthetic approach to initiator I8 (Octa-O-(2-
bromo-2-methylpropionyl)-tripentaerythritol) 
Tripentaerythritol (10.0 g, 26.8 mmol) was suspended in dry DCM (200 mL), followed 
by the addition of pyridine (100 mL) and cooled in an ice-water bath to 0 °C. BIBB (53 
mL, 429 mmol) dissolved in dry DCM (50 mL) at 0 °C was added dropwise to the 
tripentaerythritol solution under magnetic stirring. The reaction continued 2 days at room 
temperature. The salts were filtered of and the filtrate was then washed sequentially with 
an aqueous solution of hydrochloric acid (10 v%, 3X100 mL), with a saturated NaHCO3 
aqueous solution (3X100 mL) and water (3X100mL). The solution was passed over silica 
and then concentrated by rotary evaporation. The initiator was found as a beige solid 
(Yield: 19 g, 45 %).  
 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ = 4.29 (s, 12 H), 4.27 (s, 4 H), 3.57 (s, 4 H), 
3.55 (s, 4H), 1.94 (s, 36 H), 1.93 (s, 12 H).  




III.4.3.7 Synthesis of Initiator I15 (Hepta-(2, 3, 6-tri-O-(2-bromo-2-methylpropionyl)-
β-cyclodextrin) 
 
Scheme III.4.7 Schematic representation of the synthetic approach to initiator I15 (Hepta-(2, 3, 
6-tri-O-(2-bromo-2-methylpropionyl)-β-cyclodextrin). 
Initiator I15 was synthesised according to literature through the esterification of 
β-cyclodextrin with α-bromoisobutyryl bromide (BIBB) in 1-methyl-2-pyrrolidone (NMP).29 
β-cyclodextrin was recrystallized twice from water and dried in vacuum overnight at 100 
°C. Anhydrous recrystallized β-cyclodextrin (5.67 g, 5.00 mmol) was dissolved in 40 ml 
anhydrous NMP and cooled in an ice-water bath to 0 °C. BIBB (51.9 mL, 420 mmol) 
dissolved in anhydrous NMP (30 mL) at 0 °C was added dropwise to the β-cyclodextrin 
solution under magnetic stirring. The reaction temperature was kept at 0 °C for 3h and 
was then allowed to rise to ambient temperature. The reaction was allowed to continue 
for 3 days. The brown syrup was concentrated under vacuum and subsequently diluted 
with 100 mL dichloromethane. The solution was then washed sequentially with a 
saturated NaHCO3 aqueous solution (3X70 mL) and water (3X70mL). The 
dichloromethane was removed by rotary evaporation and the resulting syrup was diluted 
with 20 mL of acetone and precipitated in 1L of ice cold water. This purification procedure 
was repeated 5 times. Finally beige solid was obtained after drying under vacuum (12 
g). The average degree of substituted hydroxyl groups at the periphery, determined by 
1H-NMR and MALDI-TOF spectrometry was 15.  
 
1H NMR (400 MHz, CDCl3, 298 K, ppm): δ = 5.27 (m, 7 H), 4.86 (m, 7 H), 4.59 (m, 7 H), 
4.34 (m, 7 H), 4.18 (m, 7 H), 4.06 (m, 7 H), 3.78 (m, 7 H), 1.96 (broad s, 90 H) ppm. 
MALDI-TOF MS m/z: calculated for C102H145Br15O50K+: 3408.86 found, 3408.21 
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III.4.3.8 SET-LRP polymerisations  
 
Scheme III.4.8 Schematic representation of the homopolymerisation of the Mannose 
glycomonomer using initiators I1-I15 
III.4.3.8.1 SET-LRP of M1-30 
A Schlenk tube was charged with initiator I1 (ethyl α-bromoisobutyrate, 3.93 µL, 
0.0267 mmol, 1 eq.), mannose glycomonomer (300 mg, 0.804 mmol, 30 eq.), Me6TREN 
(1.36 µL, 0.19 eq), CuBr2 (0.239 mg, 0.04 eq.) in DMSO (2 mL), sealed with a rubber 
septum and subsequently degassed by gentle bubbling of Ar gas for 15 min. The 
polymerisation was then started by addition of pre-activated Cu(0) wire (5 cm) wrapped 
around a stirring bar under a positive Ar pressure and quickly sealed again and the 
reaction mixture was allowed to polymerise at 25˚C. Sampling was carried out using a 
degassed syringe to check the conversion of mannose glycomonomer. The reaction was 
allowed to polymerise for 420 min until 89.3% conversion. 
III.4.3.8.2 SET-LRP of M3-90 
A Schlenk tube was charged with initiator I3 (tri-O-(2-bromo-2-methyl propionyl)-
glycerol ethoxylate, 13 mg, 9.15 µmol, 1 eq.), mannose glycomonomer (307.6 mg, 0.824 
mmol, 90 eq.), Me6TREN (1.39 µL, 0.57 eq), CuBr2 (0.245 mg, 0.12 eq.) in DMSO (2 
mL), sealed with a rubber septum and subsequently degassed by gentle bubbling of Ar 
gas for 15 min. The polymerisation was then started by addition of pre-activated Cu(0) 
wire (5 cm) wrapped around a stirring bar under a positive Ar pressure and quickly sealed 
again and the reaction mixture was allowed to polymerise at 25˚C. Sampling was carried 
out using a degassed syringe to check the conversion of mannose glycomonomer. The 
reaction was allowed to polymerise for 510 min until 85.6% conversion. 
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III.4.3.8.3 SET-LRP of M7-210 
A Schlenk tube was charged with initiator I7 (per-6-deoxy-6-(thiopropyl-2-bromo-
2-methylpropanoate)-β-cyclodextrin, 10.5 mg, 3.89 µmol, 1 eq.), mannose 
glycomonomer (305.3 mg, 0.817 mmol, 210 eq.), Me6TREN (1.38 µL, 1.33 eq), CuBr2 
(0.244 mg, 0.28 eq.) in DMSO (2 mL), sealed with a rubber septum and subsequently 
degassed by gentle bubbling of Ar gas for 15 min. The polymerisation was then started 
by addition of pre-activated Cu(0) wire (5 cm) wrapped around a stirring bar under a 
positive Ar pressure and quickly sealed again and the reaction mixture was allowed to 
polymerise at 25˚C. Sampling was carried out using a degassed syringe to check the 
conversion of mannose glycomonomer. The reaction was allowed to polymerise for 360 
min until 87.3% conversion. 
III.4.3.8.4 SET-LRP of M8-240 
 A Schlenk tube was charged with initiator I8 (Octa-O-(2-bromo-2-methylpropionyl)-
tripentaerythritol, 5.8 mg, 3.70 µmol, 1 eq.), mannose glycomonomer (332.2 mg, 0.889 
mmol, 240 eq.), Me6TREN (1.50 µL, 1.52 eq), CuBr2 (0.265 mg, 0.32 eq.) in DMSO (2 
mL), sealed with a rubber septum and subsequently degassed by gentle bubbling of Ar 
gas for 15 min. The polymerisation was then started by addition of pre-activated Cu(0) 
wire (5 cm) wrapped around a stirring bar under a positive Ar pressure and quickly sealed 
again and the reaction mixture was allowed to polymerise at 25˚C. Sampling was carried 
out using a degassed syringe to check the conversion of mannose glycomonomer. The 
reaction was allowed to polymerise for 420 min until 89.8% conversion. 
III.4.3.8.5 SET-LRP of M15-450 
A Schlenk tube was charged I15 (Hepta-(2, 3, 6-tri-O-(2-bromo-2-
methylpropionyl)-β-cyclodextrin, 6.2 mg, 1.84 µmol, 1 eq.), mannose glycomonomer 
(309.1 mg, 0.827 mmol, 450 eq.), Me6TREN (1.40 µL, 2.85 eq), CuBr2 (0.246 mg, 0.6 
eq.) in DMSO (2 mL), sealed with a rubber septum and subsequently degassed by gentle 
bubbling of Ar gas for 15 min. The polymerisation was then started by addition of pre-
activated Cu(0) wire (5 cm) wrapped around a stirring bar under a positive Ar pressure 
and quickly sealed again and the reaction mixture was allowed to polymerise at 25˚C. 
Sampling was carried out using a degassed syringe to check the conversion of mannose 
glycomonomer. The reaction was allowed to polymerise for 450 min until 88.6% 
conversion. 
III.4.3.8.6 SET-LRP of M1-150 
A Schlenk tube was charged with initiator I1 (ethyl α-bromoisobutyrate, 0.39 µL, 
0.00267 mmol, 1 eq.), mannose glycomonomer (300 mg, 0.804 mmol, 300 eq.), 
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Me6TREN (1.36 µL, 0.19 eq), CuBr2 (0.239 mg, 0.04 eq.) in DMSO (2 mL), sealed with 
a rubber septum and subsequently degassed by gentle bubbling of Ar gas for 15 min. 
The polymerisation was then started by addition of pre-activated Cu(0) wire (5 cm) 
wrapped around a stirring bar under a positive Ar pressure and quickly sealed again and 
the reaction mixture was allowed to polymerise at 25˚C. Sampling was carried out using 
a degassed syringe to check the conversion of mannose glycomonomer. The 
polymerisation was monitored until the monomer conversion reached 56.8% at 29 h. 
III.4.3.8.7 SET-LRP of M3-150 
A Schlenk tube was charged with initiator I3 (tri-O-(2-bromo-2-methyl propionyl)-
glycerol ethoxylate, 5 mg, 3.52 µmol, 1 eq.), mannose glycomonomer (394.4 mg, 1.06 
mmol, 300 eq.), Me6TREN (0.536 µL, 0.57 eq), CuBr2 (94.4 µg, 0.12 eq.) in DMSO (2 
mL), sealed with a rubber septum and subsequently degassed by gentle bubbling of Ar 
gas for 15 min. The polymerisation was then started by addition of pre-activated Cu(0) 
wire (5 cm) wrapped around a stirring bar under a positive Ar pressure and quickly sealed 
again and the reaction mixture was allowed to polymerise at 25˚C. Sampling was carried 
out using a degassed syringe to check the conversion of mannose glycomonomer. The 
polymerisation was monitored until the monomer conversion reached 54.5% at 300 min. 
III.4.3.8.8 SET-LRP of M7-150 
A Schlenk tube was charged with initiator I7 (per-6-deoxy-6-(thiopropyl-2-bromo-
2-methylpropanoate)-β-cyclodextrin, 10 mg, 3.71 µmol, 1 eq.), mannose glycomonomer 
(415.3 mg, 1.11 mmol, 300 eq.), Me6TREN (1.31 µL, 1.33 eq), CuBr2 (0.231 mg, 0.28 
eq.) in DMSO (2 mL), sealed with a rubber septum and subsequently degassed by gentle 
bubbling of Ar gas for 15 min. The polymerisation was then started by addition of pre-
activated Cu(0) wire (5 cm) wrapped around a stirring bar under a positive Ar pressure 
and quickly sealed again and the reaction mixture was allowed to polymerise at 25˚C. 
Sampling was carried out using a degassed syringe to check the conversion of mannose 
glycomonomer. The polymerisation was monitored until the monomer conversion 
reached 54.3% at 90 min. 
III.4.3.8.9 SET-LRP of M8-150 
A Schlenk tube was charged with initiator I8 (Octa-O-(2-bromo-2-
methylpropionyl)-tripentaerythritol, 5.8 mg, 3.70 µmol, 1 eq.), mannose glycomonomer 
(415.29 mg, 1.11 mmol, 300 eq.), Me6TREN (1.50 µL, 1.52 eq), CuBr2 (0.265 mg, 0.32 
eq.) in DMSO (2 mL), sealed with a rubber septum and subsequently degassed by gentle 
bubbling of Ar gas for 15 min.  The polymerisation was then started by addition of pre-
activated Cu(0) wire (5 cm) wrapped around a stirring bar under a positive Ar pressure 
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and quickly sealed again and the reaction mixture was allowed to polymerise at 25˚C. 
Sampling was carried out using a degassed syringe to check the conversion of mannose 
glycomonomer. The polymerisation was monitored until the monomer conversion 
reached 54.3% at 90 min. 
III.4.3.8.10 SET-LRP of M15-150 
A Schlenk tube was charged I15 (Hepta-(2, 3, 6-tri-O-(2-bromo-2-
methylpropionyl)-β-cyclodextrin, 12 mg, 3.56 µmol, 1 eq.), mannose glycomonomer 
(398.8 mg, 1.07 mmol, 300 eq.), Me6TREN (2.71 µL, 2.85 eq), CuBr2 (0.477 mg, 0.6 eq.) 
in DMSO (2 mL), sealed with a rubber septum and subsequently degassed by gentle 
bubbling of Ar gas for 15 min. The polymerisation was then started by addition of pre-
activated Cu(0) wire (5 cm) wrapped around a stirring bar under a positive Ar pressure 
and quickly sealed again and the reaction mixture was allowed to polymerise at 25˚C. 
Sampling was carried out using a degassed syringe to check the conversion of mannose 
glycomonomer. The polymerisation was monitored until the monomer conversion 
reached 50.2% at 60 min. 
III.4.4 Kinetic data obtained via SPR  
Table III.4.1 Polymer interactions with DC-SIGN 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M1-30 1.23x103 2.26x10-3 5.42x105 1.84x10-6 90 
M3-90 1.16x104 5.34x10-3 2.16x106 4.62x10-7 95 
M7-210 1.45x104 2.72x10-3 5.33x106 1.88x10-7 180 
M8-240 7.65x104 4.16x10-3 1.84x107 5.44x10-8 220 
M15-450 1.39x104 3.29x10-3 4.22x106 2.37x10-7 275 
      
M1-150 1.02x104 1.43x10-3 7.09x106 1.41x10-7 230 
M3-150 2.3x104 3.26x10-3 7.05x106 1.42x10-7 140 
M7-150 1.83x104 3.53x103 5.18x106 1.93x10-7 140 
M8-150 1.84x104 4.16x10-3 4.43x106 2.26x10-7 130 





Table III.4.2 Polymer interactions with DC-SIGNR 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M1-30 471 1.38x10-4 3.41x106 2.93x10-7 315 
M3-90 2.93x103 7.8x10-4 3.75x106 2.67x10-7 310 
M7-210 3.2x103 8.79x10-5 3.64x107 2.75x10-8 785 
M8-240 4.7x104 2.56x10-3 1.83x107 5.45x10-8 690 
M15-450 1.21x104 1.73x10-3 7.02x106 1.43x10-7 805 
      
M1-150 1.22x104 4.59x10-4 2.65x107 3.78x10-8 610 
M3-150 1.14x104 9.05x10-4 1.26x107 7.93x10-8 400 
M7-150 8.94x103 1.23x10-3 7.26x106 1.38x107 370 
M8-150 5.58x103 1.02x10-3 5.44x106 1.84x10-7 360 
M15-150 1.32x103 3.78x10-4 3.5x106 2.86x10-7 590 
 
Table III.4.3 Polymer interactions with MBL 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M1-30 354 4.53x10-4 7.81x105 1.28x10-6 650 
M3-90 7.65x103 7.55x10-4 1.01x107 9.88x10-8 580 
M7-210 1.51x104 5.48x10-4 2.75x107 3.64x10-8 1230 
M8-240 2.34x105 1.66x10-3 1.41x108 7.08x10-9 1025 
M15-450 1.51x105 1.4x10-3 1.08x108 9.3x10-9 1355 
      
M1-150 2.9x104 8.75x10-4 3.31x107 3.02x10-8 1150 
M3-150 7.29x104 1.36x10-3 5.34x107 1.87x10-8 795 
M7-150 3.1x104 1.26x10-3 2.47x107 4.05x10-8 850 
M8-150 3.2x104 1.37x10-3 2.33x107 4.3x10-8 790 





Table III.4.4 Polymer interactions with Langerin 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M1-30 - - - - - 
M3-90 7.96x103 1.63x10-3 4.88x106 2.05x10-7 70 
M7-210 8.23x103 7.96x10-4 1.03x107 9.67x10-8 240 
M8-240 7.31x103 4.19x10-4 1.74x107 5.74 x10-8 210 
M15-450 8.78x103 3.01x10-4 2.92x107 3.42x10-8 320 
      
M1-150 1.02x104 1.95x10-3 5.2x106 1.92x10-7 55 
M3-150 - - - - - 
M7-150 5.8 x103 9.85 x10-4 6.56 x106 1.52 x10-7 94 
M8-150 6.69x103 2.1x10-3 3.19x106 3.14x10-7 90 
M15-150 - - - - - 
 
Table III.4.5 Polymer interactions with SP-D 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M1-30 - - - - - 
M3-90 - - - - - 
M7-210 891 6.07 x10-4 1.47 x106 6.81 x10-7 168 
M8-240 2.25x104 3.47x10-3 6.48 x106 1.54 x10-7 120 
M15-450 3.32 x104 1.71x10-3 1.94 x107 5.16 x10-8 187 
      
M1-150 8.6 x103 8.05 x10-4 1.07 x107 9.35 x10-8 77 
M3-150 6.17 x103 9.19 x10-4 6.72 x106 1.49 x10-7 42 
M7-150 1.69 x104 2.16 x10-3 7.83 x106 1.28 x10-7 50 
M8-150 - - - - - 





Table III.4.6 Polymer interactions with Dectin-2 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M1-30 - - - - - 
M3-90 - - - - - 
M7-210 18.8 2.43x10-3 7.75 x103 1.29x10-4 95 
M8-240 433 2.76x10-3 1.57x105 6.37x10-6 210 
M15-450 73.5 1.45x10-5 5.07x106 1.97x10-7 310 
      
M1-150 - - - - - 
M3-150 - - - - - 
M7-150 - - - - - 
M8-150 - - - - - 
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glycoconjugates for targeted 
saRNA delivery 
Messenger RNA (mRNA) has become a promising platform for both therapeutics and 
vaccines. More specifically, self-amplifying RNA (saRNA) is particularly 
advantageous as it provides a higher protein expression and also dose minimisation. 
In this chapter, we present the synthesis of a novel mannosylated polyethylenimine 
(PEI), enabled by the host-guest interaction between β-cyclodextrin and 
adamantane. For this we firstly modified transfection grade PEI, to obtain 
adamantane bearing PEIs (adaPEI). We have modified β-cyclodextrin to contain 7 
mannose moieties and investigated the host-guest complexation between the two 
systems. We show that the host-guest complexation does not interfere with the 
electrostatic interaction with saRNA, and observed that while increasing the degree 
of mannosylation decreases transfection efficiency in vitro, it increases the number 
of cells expressing GFP by 8-fold in human skin explants. Furthermore, we found 
that increasing the ratio of glycopolymer to saRNA also enhanced the percentage of 
transfected cells ex vivo. We identified that these mannosylated PEIs specifically 
increased protein expression in the epithelial cells resident in human skin in a 
mannose dependent manner.  
 
Biological experiments were performed and written by Dr. A. K. Blakney (I.C.) 
 
Parts of this chapter have been published: 
Oz, Y., Abdouni, Y., Yilmaz, G., Becer, C. R. & Sanyal, A. Magnetic 




IV Supramolecular PEI- 
glycoconjugates for targeted 
saRNA delivery 
IV.1 Introduction 
 Recent advances and investment in RNA technology have enabled messenger 
RNA (mRNA) to become a clinically viable platform for both vaccines and protein 
replacement therapeutics. Self-amplifying mRNA (saRNA) has emerged as a next-
generation approach, and has several advantages compared to both mRNA and plasmid 
DNA (pDNA). Because saRNA vectors are derived from the alphavirus genome,1 they 
are able to self-replicate in the cytoplasm, resulting in amplification of the delivered dose 
of RNA and higher magnitude and duration of protein expression than mRNA.2–4 
Compared to pDNA, saRNA is a minimal genetic vector and does not pose the risk of 
integration or insertional mutagenesis.5 While a number of mRNA vaccines and 
therapeutics are currently being tested in the clinic,6 there have not yet been any non-
viral RNA replicons tested in human clinical trials.7  
 saRNA has previously been formulated with a variety of delivery platforms, 
including lipid nanoparticles (LNPs),8,9 a cationic nanoemulsion, cationic polymers10,11 
and ionisable dendrimers.2 These formulations are not tailored for targeting of certain 
cell populations, but rather increased overall cellular uptake and expression of the 
saRNA. Liang et al. previously observed that while neutrophils, monocytes and dendritic 
cells infiltrate the injection site and take up the RNA, it was mainly monocytes and 
dendritic cells that translated mRNA formulated in LNPs.12 Both siRNA and mRNA have 
previously been targeted to leukocytes using the ASSET platform, in which LNPs are 
coated in monoclonal antibodies to target specific leukocyte subsets.13 Furthermore, 
siRNA has been directly conjugated to a synthetic triantennary N-acetylgalactosamine 
(GalNAc)-based ligand that directly targets hepatocytes in vivo.14 In this chapter, we 
sought a delivery platform that enabled tailoring of glycosylation without the use of 
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expensive monoclonal antibodies or direct conjugation to saRNA, which is much larger 
in size than siRNA and unlikely to be taken up by cells without complexation. 
Host-guest interactions between β-cyclodextrin (CD) and adamantane (Ad) have 
been previously used as a gene delivery platform for intravenous delivery of pDNA, 
wherein polyethylene glycol (PEG) was conjugated to adamantane in order to reduce 
toxicity of a poly(ethyleneimine) (PEI) formulation.15 β-Cyclodextrin and adamantane are 
known to form a specific and stable complex in aqueous environments through the 
interaction between adamantane and the hydrophobic cavity of β-cyclodextrin.16–18 
Glycosylation of β-cyclodextrins has been performed previously, and allows for a facile 
approach for attaching a variety of glycan groups.18,19 Given the ease of chemistry and 
biocompatibility of β-cyclodextrin-adamantane complexes, we chose this host-guest pair 
as a platform for glycosylation of PEI as a targeted delivery vehicle for saRNA.  
 Here, we have developed a mannosylated PEI complex enabled by the host-
guest interaction between β-cyclodextrin and adamantane. We designed and 
synthesised a library of PEI polymers with varying degrees of mannosylation. We then 
characterised the polymers and the polyplexes formed when complexed with saRNA for 
size, charge and transfection efficiency in vitro. After identifying the optimal ratio of PEI 
to saRNA, we then tested these formulations ex vivo in a clinically relevant human skin 
explant model to characterise the transfection efficiency. Finally, we observed how the 
degree of mannosylation and ratio of polymer to saRNA affected cellular expression and 





IV.2 Results and discussion 
IV.2.1 Synthesis of a mannose bearing β-cyclodextrin (CD-Man7) 
 
Figure IV.2.1 Chemical representation of the β-cyclodextrin based mannose glycocluster (CD-
Man7). 
Following the successful (and unsuccessful) synthesis of β-cyclodextrin 
derivatives in Chapter 2, we realised the modification of only the primary rim face of the 
β-cyclodextrin would still allow hydrophobic moieties to enter the cavity of the β-
cyclodextrin. For this reason we decided to repeat the synthesis of per-(6-deoxy-6-
bromine)-β-cyclodextrin and utilise it as a scaffold for a mannose bearing glycocluster 
(CD-Man7). This heptavalent glycocluster has been published elsewhere but we’ve 
updated the synthesis procedure to achieve this glycocluster.20 Starting from per-(6-
deoxy-6-bromine)-β-cyclodextrin we again performed the azidation as in Chapter 2 using 
sodium azide in DMF, achieving per-(6-deoxy-6-azido)-β-cyclodextrin. In Chapter 3, we 
demonstrated the synthesis of propargyl-D-mannose via a Fischer type glycosylation 
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using silica supported sulphuric acid. Eventually both compounds, per-(6-deoxy-6-
bromine)-β-cyclodextrin and propargyl-D-mannose, were clicked together via the copper 
(I)-catalysed azide-alkyne cycloaddition (CuAAC) in DMSO using bipy as a ligand. In the 
original recipe, the DMSO was concentrated in vacuo, and then the compounds were 
purified by precipitation in cold methanol. This proved unsuccessful in our case and thus 
we opted to purify the cyclodextrins using dialysis against water. Propargyl-D-mannose 
which was added in excess was removed this way, eventually obtaining the desired 
product after freeze-drying the remaining water, as a white solid.  
 
Figure IV.2.2 A) 1H-NMR spectrum of CD-Man7 in DMSO-d6 
IV.2.2 Synthesis of a polymeric mannose bearing β-cyclodextrin (CD-(pMan8)7) 
In Chapter 2 we were able to demonstrate the synthesis of a novel β-cyclodextrin 
based SET-LRP initiator. In Chapter 3, we utilised this novel initiator for the synthesis of 
a β-cyclodextrin with 7 polymeric arms bearing mannose moieties successfully. Here 
we’ve utilised the same procedure, anticipating to achieve a β-cyclodextrin with 
polymeric arms bearing 10 mannose units on average. Kinetic experiments in Chapter 3 
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(Figure III.2.5) revealed that when using the same reaction conditions as in section 
III.4.3.8.3, an average arm length of around 10 mannose glycomonomers per arm would 
be achieved after 60 min. The experiment was thus repeated and the polymerisation was 
stopped after 60 min. 1H-NMR then revealed the conversion of the mannose 
glycomonomers as 27.5% (8.3 monomers per arm) by comparing the triazole peak to the 
vinyl protons. Molecular weight of the polymer was then determined via NMR and was 
revealed to be 24499 Da on average. 
IV.2.3 Synthesis of adamantane bearing linear PEI 
 
Scheme IV.2.1 Synthesis route towards adamantane bearing linear PEI (adaPEI) 
A library of different PEI based polymers were successfully modified to contain 
appending adamantane units along the backbone. For this, commercially available PEI 
was first deprotonated using triethylamine in dry chloroform. Achieving good dissolution 
proved to be cumbersome in this case and thus the reaction medium (before adding the 
1-adamantane carbonyl chloride solution) was sonicated for 30 min in order to achieve 
a really fine suspension of (deprotonated) linear PEI. Subsequently the deprotonated 
linear PEI solution was reacted with 1-adamantane carbonyl chloride via a simple 
nucleophilic substitution reaction (Scheme IV.2.1). 1H-NMR samples were taken, clearly 
showing the PEI peak (-CH2-CH2-) around 3 ppm and the adamantane residues between 




Figure IV.2.3 1H-NMR spectrum of the unprotonated adaPEIs in D2O 
The obtained adaPEI polymers were subsequently dissolved in water and 
protonated by addition of a 32% HCl solution and precipitated in acetone. The resulting 
protonated adaPEI polymers were furthermore characterised using 1H-NMR in order to 
determine the average adamantane content per polymer chain together with the change 
in molecular weight (Table IV.2.1). Protonation shifts the PEI peak (-CH2-CH2-) from 
around 3.0 ppm to around 3.5 ppm as can be seen in Figure IV.2.4. Percentages in 
Table IV.2.1 are defined as the percentage of monomer units along the polymer 
backbone. 1H-NMR analysis revealed that there is a huge discrepancy between the 
amount of adamantyl groups added to the reaction and adamantyl actually found along 




Figure IV.2.4 1H-NMR spectrum of the protonated adaPEIs in D2O 
 










PEI1 40 2.18 10.96 41393 
PEI2 20 1.71 8.58 41088 
PEI3 10 0.94 4.76 40603 
PEI4 5 0.54 2.72 40344 
PEI5 2.5 0.37 1.83 40232 





IV.2.4 Synthesis of glycoPEI: Complexation of adaPEI with CD-(pMan8)7 
 
Scheme IV.2.2 Synthetic approach towards mannose glycocluster decorated linear PEI 
(glycoPEI) 
The next big step in achieving linear PEI decorated with mannose glycoclusters 
was achieving the host-guest complexation of both entities with each other. As the host-
guest interaction of CD-Man7 with adamantane hadn’t been studied before we decided 
to do isothermal titration calorimetry (ITC) measurements in order to prove the host-guest 
interaction. ITC works by promptly measuring the heat which is either released or 
absorbed during a molecular binding event measured by a sensitive calorimeter during 
gradual titration of the ligand into the sample cell. For this we first titrated normal β-
cyclodextrin with rimantadine, an adamantane amino derivative), in order to see if we’d 
achieve the same binding affinity as reported in literature (Figure IV.2.5). We found an 
association constant Ka equal to 5.37 x 104 M-1, which is in the same range as those 
values found in literature (see section I.3.1). Confident in the measurements we then 
measured the interaction of rimantadine with CD-Man7, we inspected a reduction in 
binding affinity, as one face of the β-cyclodextrin is blocked from possible interactions. 
ITC revealed an association constant Ka of 1.41 x 104 M-1. This is a four-fold decrease 
as compared to the binding affinity of β-cyclodextrin, but still in the same order of 
magnitude.  
Confident in the complexation between the adaPEIs with CD-Man7, we 
proceeded with the synthesis. For this, aqueous solutions of the different adaPEIs and 
the aqueous solutions of both CD-Man7 and CD-(pMan8)7 were prepared and mixed in 
accordance with Table IV.2.2. PEI7 in this case was achieved by complexation between 
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adaPEI3 and CD-(pMan8)7. The obtained solutions were then freeze-dried to achieve the 
desired mannosylated glycoPEIs. 
Table IV.2.2 Quantities used in glycoPEI synthesis 
glycoPEI adaPEI m (adaPEI) m (CD-Man7) 
PEI1 PEI1 30.4 mg 22.89 mg 
PEI2 PEI2 30.2 mg 17.90 mg 
PEI3 PEI3 30.1 mg 10.00 mg 
PEI4 PEI4 30.1 mg 5.75 mg 
PEI5 PEI5 30.5 mg 3.95 mg 
PEI6 PEI6 30.0 mg 1.51 mg 
PEI7 PEI3 30.1 mg 86.00 mg 
 
 
Figure IV.2.5 A) ITC measurements of β-cyclodextrin titrated with rimantadine and B) ITC 
measurements of CD-Man7 titrated with rimantadine. 
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The host-guest interaction between the adaPEIs and CD-Man7 was studied using 
a combination of 1H-NMR and NOESY NMR. 1H-NMR revealed that the adamantane 
peaks shifted as a result of a change in chemical environment caused by the host-guest 
complexation (Figure IV.2.6). The anticipated host-guest complexation between the 
adamantyl groups and CD-Man7 as NOESY experiments furthermore revealed cross-
peaks between the signals at 4 – 4.4 ppm assigned to the inner protons of the CD-Man7 
cavity and the signals at 1.8 – 2.4 ppm assigned to the adamantane which was not 
present when taken NOESY from the respective pure products (Figure IV.2.7). The 
resulting solutions were subsequently freeze-dried, resulting in a fine powder which is 
easily dissolvable for use in RNA transfection. 
 








Figure IV.2.7 2D NOESY-NMR spectrum of the adaPEI3 and CD-Man7, clearly showing cross 
peaks between the signals at 4.0 – 4.3 ppm assigned to the inner protons of the CD-Man7 cavity 
and the signals at 1.9 – 2.4 ppm assigned to the adamantane. 
IV.2.5 Particle size and charge after complexation with saRNA* 
Particle sizes and charges were characterised after complexation with saRNA 
(Figure IV.2.8). All particles were between 50-200 nm in size, with a slight trend of 
increasing size with increasing degree of mannosylation. All particles were positively 
charged after saRNA complexation, indicating that the host-guest interaction does not 





Figure IV.2.8 Particle size and zeta potential of adaPEI-CD-Man7/saRNA polyplexes as 
determined by DLS. a) Particle diameter and b) zeta potential of complexes prepared at a ratio of 
5:1 polymer to RNA (w/w). Bars represent mean ± standard deviation for n=3. 
IV.2.6 Increasing mannosylation of PEI decreases transfection efficiency in 
vitro* 
 In order to investigate the effects of the ratio of PEI to saRNA and degree of 
mannosylation on transfection efficiency in vitro, we prepared polyplexes with saRNA 
and PEI polymers with and without mannosylation (Figure IV.2.9). We observed similar 
transfection efficiency between the 5:1 and 20:1 ratios of polymer to saRNA (w/w) in vitro 
(Figure IV.2.9.a). We postulate that this is because the glycopolymers are saturated with 
saRNA even at lower ratios of polymer to RNA, which is supported by the zetasizer data 
(Figure IV.2.8) wherein even at a ratio of 5:1, the particles exhibit a positive charge. 
Thus, adding more polymer does not increase the transfection efficiency. 
 We then compared how the degree of mannosylation affected transfection 
efficiency, using either unmodified PEI, PEI with varying amounts of CD-Man7 (PEI1-6) or 
PEI with CD-(pMan8)7 (PEI7) (Figure IV.2.9.b). Because changing the mass ratio of 
polymer to saRNA changes the amount of available positively charges amines, we used 
a fixed ratio of PEI to saRNA of 5:1 (w/w) and then normalised the molar amount of PEI 
in each formulation for PEI1-7. We observed that PEI had the highest transfection 
efficiency, ~106 RLU, whereas all of the mannosylated PEIs were lower, between 1-5x105 
RLU. In addition, increasing the degree of mannosylation decreased the transfection 
efficiency in vitro, as PEI6 had the highest transfection efficiency of the mannosylated 
PEIs, and PEI1 had the lowest. We hypothesise that this is due to sterical hindrance 
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cause by increasing degree of mannosylation which may limit the access that saRNA 
has to the amine groups on PEI. Furthermore, while HEK cells can be induced to express 
the mannose receptor,21 they do not naturally express it, thus these experiments exhibit 
how the structure of the polyplexes affects non-mannose mediated uptake. Overall, we 
observed that the ratio of mannosylated PEI to saRNA did not affect transfection, but 
that increasing the degree of mannosylation interfered with in vitro transfection efficiency 
in a non-mannose dependent manner. 
 
Figure IV.2.9 In vitro transfection efficiency of adaPEI-CD-Man7 complexes with fLuc saRNA in 
HEK293T.17 cells after 24 hours. a) Transfection with complexes prepared at a ratio of total 
polymer complex to RNA of either 5:1 or 20:1 (w/w) or b) normalised to the molar amount of PEI 
in the complex. Bars represent mean ± standard deviation for n=3.RLU = Relative Light Unit. 
IV.2.7 Increasing ratio of mannosylated PEI to RNA increases the percentage of 
resident epithelial cells expressing saRNA* 
 Because in vitro transfection efficiency does not generally correlate well with in 
vivo efficacy,22 we sought to test these glycopolymers in a clinically translational human 
skin explant model (Figure IV.2.10). Human skin explants have previously been shown 
to be a viable model for optimization of nucleic acid formulations,9 and contain many cell 
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types with the mannose receptor including dendritic cells, fibroblasts, and 
macrophages.23–27 We first prepared formulations with either RNA alone, PEI or 
mannosylated PEI (PEI1-6) (Figure IV.2.10a) at a ratio of 5:1 polymer to saRNA (w/w). 
We were surprised to observe that the polyplexes did not enhance the percentage of 
eGFP+ in skin explants, even with unmodified PEI (Figure IV.2.10b). We observed a 
similar effect for PEI with CD-(pMan8)7 - only ~1% of cells expressed GFP and there was 
no observed benefit to naked RNA alone. We then tested whether increasing the ratio of 
PEI1 to saRNA had any effect on the percentage of cells expressing GFP (Figure 
IV.2.10c). We observed that increasing the ratio of PEI1 to saRNA to 10:1 and 20:1 (w/w) 
did indeed increase the number of GFP+ cells to 5% and 8%, with p=0.018 and 0.00038, 
respectively. This enhancement is superior to previously studied LNP formulations.9  
 
Figure IV.2.10 Percentage of eGFP+ cells in human skin explants after treatment with 
saRNA/adaPEICD-Man7 complexes after 72 hours in culture. a) Complexes at a ratio of 5:1 
(complex to RNA, w/w) with PEI1-6, b) Complexes at a ratio of 5:1 (complex to RNA, w/w) 
comparing the effect of polymannosylated CD, c) Varying the ratio of complexes to RNA from 1:1 
to 20:1 (w/w) of PEI1. Bars represent the mean ± standard deviation for n=3. * indicates 
significance of p<0.05. 
 We then characterised which cells were expressing the saRNA using a flow 
cytometry panel capable of identifying epithelial cells (CD45-), fibroblasts (CD90+), NK 
cells (CD56+), leukocytes (CD45+), Langerhans cells (CD1a+), monocytes (CD14+) 
dendritic cells (CD11c+), T cells (CD3+) and B cells (CD19+). As previously observed 
the majority of cells that make up the skin are epithelial cells, fibroblasts and dendritic 
cells, and leukocytes, Langerhans cells, B cells, monocytes and T cells to a lesser extent 
(Figure IV.2.11). While epithelial cells make up ~64% of the total cells, they make up 
only 16% of the cells expressing the saRNA alone. However, when the saRNA was 
complexed with mannosylated PEI1 at a ratio of 20:1 (w/w), it was expressed in ~33% of 
epithelial cells. Furthermore, increasing the ratio of PEI1 to saRNA led to proportional 
increases in the percentage of epithelial cells expressing GFP. GFP was expressed in 
either a similar or lesser percentage of the other cell types. Overall, we observed that 
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increasing the ratio of mannosylated PEI to saRNA increased the number of cells 
expressing saRNA in human skin explants, and we identified that epithelial cells were 
specifically targeted by these polyplexes. 
 
Figure IV.2.11 Phenotypic identity of eGFP+ cells in human skin explants after ID injection of 
GFP saRNA/PEI-Ad-CD-Man7 complexes at varying ratios of PEI1 to saRNA. Cells were 
identified using the following antibodies: epithelial cells (CD45-), fibroblasts (CD90+), NK cells 
(CD56+), leukocytes (CD45+), Langerhans cells (CD1a+), monocytes (CD14+), dendritic cells 
(CD11c+), T cells (CD3+) and B cells (CD19+).  
IV.2.8 Increasing degree of mannosylation enhances uptake into epithelial cells 
in human skin explants* 
 Given our observation that increasing the ratio of mannosylated PEI to saRNA 
enhanced the number of cells expressing saRNA, we then studied whether the degree 
of mannosylation affected cellular uptake and expression ex vivo (Figure IV.2.12). We 
prepared polyplexes at a fixed ratio of 20:1 (w/w) of PEI to saRNA and again evaluated 
which cells were expressing GFP. We observed that at a ratio of 20:1, the PEI 
formulations (both unmodified and mannosylated) increased the percentage of GFP+ 
cells to ~8%. Increasing the degree of mannosylation had a trend of increasing the 
percentage of epithelial cells expressing GFP (Figure IV.2.12), although only the 
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PEI1,2,4,6 groups were found to be statistically significantly higher.  While the mannose 
receptor is primarily known to be expressed by macrophages, dendritic cells, fibroblasts 
and keratinocytes, it has previously been shown to be expressed by vaginal epithelial 
cells.28 It is possible that human skin epithelial cells also express the mannose receptor, 
leading to increased polyplex uptake and saRNA expression in these cells. However, in 
these studies we quantified the percentage of cells expressing the saRNA, not the 
percentage of cellular uptake, so it is possible that there is increased uptake into cells 
that are known to express the mannose receptor. In the context of RNA vaccines, it has 
yet to be defined as to which cells are desired to express the protein; we hypothesize 
that overall increased protein expression will result in increased immunogenicity. Overall, 
we show that increasing the degree of mannosylation increases protein expression, 




Figure IV.2.12 Phenotypic identity of eGFP+ cells in human skin explants after ID injection of 
saRNA/adaPEI-CD-Man7 complexes prepared at a ratio of 20:1 (w/w) with PEI1-7 after 72 hours 
in culture. a) % of GFP+ epithelial cells in human skin explants. Bars represent the mean ± 
standard deviation for n=3. * indicates significance of p<0.05. b) Phenotypes of cells expressing 
GFP. Cells were identified using the following antibodies: epithelial cells (CD45-), fibroblasts 
(CD90+), NK cells (CD56+), leukocytes (CD45+), Langerhans cells (CD1a+), monocytes 





In this chapter, we have shown the successful synthesis and characterisation of 
a library of mannosylated linear PEI polymers enabled by the host-guest interaction 
between β-cyclodextrin and adamantane. For this we firstly modified transfection grade 
PEI, to obtain adamantane bearing PEIs (adaPEI) by reacting the linear PEI polymer 
with adamantane carbonyl chloride. We have modified β-cyclodextrin to contain 7 
mannose moieties and investigated the host-guest complexation between the two 
systems. The resulting complexes were subsequently used for targeted saRNA delivery. 
We show that while increasing the degree of mannosylation stifles in vitro transfection 
efficiency, it enhances the percentage of cells expressing the saRNA in human skin 
explants. Furthermore, we found that increasing the ratio of polymer to saRNA also 
enhanced the protein expression ex vivo, which was specifically due to an increase in 
epithelial cell expression. We observed that increasing the degree of mannosylation also 
increased expression specifically in epithelial cells. We anticipate that this platform, 
which enables glycosylation of PEI through host-guest chemistry, is a highly clinically 
translational delivery vehicle and is dually useful for targeting specific cell types for 





IV.4 Experimental section 
IV.4.1 Materials 
PEI MAX (Transfection grade linear polyethylenimine hydrochloride, MW 40,000) 
was purchased from Polysciences, Inc. Dry triethylamine (TEA) (≥99.5%) equipped with 
septum, 1-adamantane carbonyl chloride and CuBr2 were purchased from Sigma Aldrich 
and used as received. Tris(2-(dimethylamino)ethyl)amine (Me6TREN) was synthesised 
according to literature procedures and stored at 4°C prior to use. Cyclodextrin initiator, 
mannose glycomonomer and heptamannose β-cyclodextrin (CD-Man7) were 
synthesised as previously reported and stored at -20 °C prior to use.20,29 All other 
reagents and solvents were purchased from Sigma Aldrich at the highest purity available 
and used without further purification unless stated otherwise. 
IV.4.2 Instruments and analysis 
 Proton (1H) Nuclear Magnetic Resonance (1H-NMR) spectra were recorded on 
a 400 MHz Bruker Avance III spectrometer using DMSO-d6, CDCl3, MeOD-d4 or D2O as 
the solvent at 300K. 2D Nuclear Overhauser Effect SpectroscopY (NOESY) NMR 
experiments were performed on a 600 MHz Bruker Avance NEO spectrometer in D2O at 
a temperature of 303 K using the states-TPPI method with a 5ms Z-gradient spoil pulse 
in the mixing time and zero-quantum suppression using the method of M.J. Thrippleton 
& J.Keeler.30 Mixing time was set to 0.3 s, spectra were recorded using 20 scans per t1 
increment and the spectral width was set to 8 x 8 ppm. 
Isothermal Titration Calorimetry (ITC) experiments were performed at 25 °C 
using a MicroCal PEAQ-ITC microcalorimeter (Malvern-Panalytical, U.K.). Solutions 
were prepared in water. In a typical experiment, 19 injections of 2.0 μL of titrant were 
titrated into the sample cell over 2 s with a stirring speed of 750 rpm and 120 s separation 
to ensure thermal equilibration. Data were baseline adjusted by subtracting background 
data obtained from equivalent injections of titrant into solution. The titration curves were 




GPC measurements were conducted on an Agilent 1260 infinity system operating 
in DMF with 5mM NH4BF4 and equipped with refractive index detector and variable 
wavelength detector, 2 PLgel 5 μm mixed-C columns (300×7.5mm), a PLgel 5 mm guard 
column (50x7.5mm) and an autosampler. The instrument was calibrated with linear 
narrow poly(methyl methacrylate) standards. All samples were passed through basic 
alumina to remove any copper residues and filtered with a 0.2 μm Nylon 66 before 
analysis. 
 
Dynamic Light Scattering (DLS). The hydrodynamic diameters (Dh, the volume 
weight diameter of the distribution) evolution were determined characterised by a 
Malvern Zetasizer Nano ZS instrument equipped with a He−Ne laser at 633 nm. DLS 
measurements were performed by dissolving polymer samples at 1 mg/ml in deionised 
water and all the samples were passed through a 0.22 µm nylon filter before 
measurement. For complex samples, polymers were dissolved separately in deionised 
in water and mixed together at different molar ratio. Then the samples were stirred 
overnight at room temperature and filtered using a 0.22 nylon filter before analysis. All 






IV.4.3 Experimental procedures 
IV.4.3.1 Synthesis of a heptamannose-β-cyclodextrin (CD-Man7) 
 
Scheme IV.4.1 Schematic representation of the synthetic approach to CD-(Man)7. 
β-CD-(N3)7 (1.96 g , 1.5 mmol), 1-(2‘-propargyl)-D-Mannose (2.61 g ,12 mmol) were 
dissolved in DMSO (20  mL) in a Schlenk tube. Bipyridine (0,37 g , 0.0024 mmol) and 
CuBr (0.17 g ,0.0012 mmol) were added. The resulting mixture was evacuated and filled 
with argon and 3 freeze-pump-thaw cycles were performed to eliminate oxygen from the 
reaction mixture. The mixture was then allowed to stir at 50 °C for 24 h. After the reaction, 
water was added to the reaction medium and the resulting mixture was dialysed against 
water. After dialysis, the resulting clear solution was freeze dried. 
1H NMR (DMSO-d6, 298 K, 400 MHz): δ = 7.95, 7.92 (s, overlapped, 7 H, NCH=C), 5.80-
6.10 (m, 14 H, OH-2, OH-3 of CD), 5.10 (s, 7 H, H-1), 3.00-5.00 (m, CD & mannose 
residues, overlap with H2O) ppm. 
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IV.4.3.2 Synthesis of a polymeric mannose bearing β-cyclodextrin (CD-
(pMan8)7) 
 
Scheme IV.4.2 Schematic representation of the homopolymerisation of the mannose 
glycomonomer achieving a polymeric mannose bearing β-cyclodextrin (CD-(pMan8)7 
A Schlenk tube was charged with CD7-initiator (10.0 mg, 2696.88 g/mol, 3.71 
µmol), mannose glycomonomer (291 mg, 373.36 g/mol, 779 µmol, 30 eq. per initiating 
site), Me6TREN (1.32 µL, 4.93 µmol, 0.19 eq. per initiating site), CuBr2 (232 µg, 1.04 
µmol, 1.04 eq. per initiating site) in DMSO (2 mL), sealed with a rubber septum and 
subsequently degassed by gentle bubbling of Ar gas for 15 min. The polymerisation was 
then started by addition of pre-activated Cu(0) wire (5 cm) wrapped around a stirring bar 
under a positive Ar pressure and quickly sealed again and the reaction mixture was 
allowed to polymerise for 1 h at 25˚C. Sampling was carried out using a degassed syringe 
to check the conversion of mannose glycomonomer. NMR samples was dissolved in 
DMSO-d6 and conversion was determined as 27.5% (8.3 monomers per arm) by 
comparing the triazole peak to the vinyl protons. After polymerisation the glycopolymer 
CD-p(Man8)7 was dialysed against water to remove excess glycomonomer and further 
impurities. Molecular weight of the polymer was then determined via 1H NMR and was 
revealed to be 24.5 kDa on average. 
IV.4.3.3 General procedure for adaPEI synthesis. 
Linear polyethylenimine hydrochloride 40 kDa (PEI, 100 mg, 2.5 x 10-6 mol) was 
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suspended in 40 mL dry CHCl3 in a 100 mL RBF under Ar, equipped with stirring bar and 
sonicated for 30 min. Subsequently the suspension was stirred and 1 mL of dry TEA was 
added. Afterwards, the suspension was sonicated for 30 min until a fine suspension was 
achieved. A solution of adamantane carbonyl chloride (50 mg, 2.515 x 10-4 mol, 0.2 eq. 
per repeating unit) in 10 mL dry CHCl3 was prepared and subsequently added to the 
suspension. The mixture was allowed to stir overnight at ambient temperature. After the 
reaction the suspension was filtered over the MilliPore and washed with 2 x 30 mL CHCl3 
and an NMR sample was taken in D2O. Subsequently the filtered residue was dissolved 
in 10 mL H2O to which 1 mL of a 32% HCl solution in water was added. The solution was 
subsequently precipitated in acetone, filtered over the MilliPore and dried under vacuum. 
An NMR sample was taken in D2O and average amount of adamantanes per chain were 
calculated by comparing the CH2- peak to the amount of adamantane protons.  
Quantities for synthesis of other adaPEIs can be found in Table IV.4.1. 
Table IV.4.1 Quantities used in adaPEI synthesis 
adaPEI PEI 
Eq. of adamantane 




PEI1 100 mg 0.4 99.93 mg 
PEI2 100 mg 0.2 49.96 mg 
PEI3 100 mg 0.1 24.98 mg 
PEI4 100 mg 0.05 12.49 mg 
PEI5 100 mg 0.025 6.25 mg 
PEI6 100 mg 0.0125 3.13 mg 
IV.4.3.4 Synthesis of glycoPEI: Complexation of adaPEI with CD-Man7  
A solution of adaPEI2 (30.2 mg, 41088 g/mol, 0.734 µmol) and CD-Man7 (17.9 
mg, 2836.53 g/mol, 6.26 µmol, 8.58 eq. per polymer chain) was prepared in 10 mL H2O 
amounting to a 1 / 1 ratio of cyclodextrin derivative per adamantane and sonicated until 
the solution became clear. Subsequently the solution was transferred to a 20 mL glass 
vial and freeze-dried. An NMR sample was made by dissolving 10 mg in D2O for Nuclear 
Overhauser Effect Spectroscopy (NOESY). Quantities for synthesis of other adaPEIs 
can be found in the Supporting Information Table IV.2.2. 
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IV.4.3.5 Synthesis of glycoPEI: Complexation of adaPEI with CD-(pMan8)7  
A solution of adaPEI3 (30.1 mg, 40603 g/mol, 0.741 µmol) and CD-(pMan8)7 (86 
mg, 24499 g/mol, 3.51 µmol, 4.75 eq. per polymer chain) was prepared in 10 mL H2O 
amounting to a 1 / 1 ratio of gycopolymer CD-(pMan8)7 per adamantane and sonicated 
until the solution became clear. Subsequently the solution was transferred to a 20 mL 
glass vial and freeze-dried.  
 
Figure IV.4.1 1H-NMR spectrum of the glycoPEI7 (adaPEI3 complexed with CD-(pMan8)7. 
IV.4.3.6 saRNA synthesis and purification*  
 Self-amplifying RNA encoding the non-structural proteins (NSPs) from the 
Venezuelan Equine Encephalitis Virus (VEEV) and either firefly luciferase (fLuc) or 
enhanced green fluorescent protein (eGFP) was prepared using in vitro transcription. 
pDNA was transformed into Eschericia coli and cultured in 50 mL of LB broth with 1 
mg/mL carbenicillin (Sigma Aldrich, UK) and isolated using a Plasmid Plus Maxiprep kit 
(QIAGEN, UK). pDNA concentration and purified were quantified on a NanoDrop One 
(ThermoFisher, UK) and then linearised using MluI for 2 h at 37 °C and heat inactivated 
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at 80 °C for 20 min. Co-transcriptionally capped saRNA, used for in vitro experiments, 
was synthesised using 1 μg of linearised DNA template in a mMessage mMachine 
reaction (Promega, UK) according to the manufacturer’s protocol, and purified using a 
MEGAclear column (Invitrogen, UK) according to the manufacturer’s protocol. For ex 
vivo experiments, uncapped in vitro RNA transcripts were synthesised using 1 μg of 
linearised DNA template in a MEGAScript reaction (Promega, UK) according to the 
manufacturer’s protocol. Transcripts were then purified by overnight LiCl precipitation at 
-20 °C, pelleted by centrifugation at 14,000 RPM for 20 min, washed with 70% EtOH, 
centrifuged at 14,000 RPM for 5 min, and then resuspended in UltraPure H2O. Purified 
transcripts were then capped using the ScriptCap™ and m7G Capping System 
(CellScript, Madison, WI, USA) and ScriptCap™ 2’-O-Methyltransferase Kit (CellScript, 
Madison, WI, USA) simultaneously according to the manufacturer’s protocol. Capped 
transcripts were then purified again by LiCl precipitation and stored at -80 °C in a buffer 
of 10 mM HEPES with 100 mg/mL trehalose until use. 
IV.4.3.7 Particle complexation and characterisation* 
 Stock solutions of glycopolymers were prepared at a concentration of 5 mg/mL 
in ultrapure H2O and purified using a 0.22 μm syringe filter (Millipore, Sigma, UK). saRNA 
complexes were prepared by mixing the RNA and polymer in 20 mM HEPES buffer (pH 
7.4) with 5% glucose, with a ratio of polymer to RNA of 5:1 (w/w) unless otherwise 
specified. The solution was immediately vortexed for 30 seconds and then allowed to 
rest for 10 minutes prior to use. 
 Polyplexes were prepared in a volume of 800 μL of 20 mM HEPES with 5% 
glucose for particle size and charge analysis, and characterised on a Zetasizer NanoZS 
(Malvern Instruments, UK) with Zetasizer 7.1 software (Malvern Instruments, UK) in a 
clear disposable 1 mL cuvette. The polyplexes were analysed using the following 
settings: a material refractive index of 1.529, absorbance of 0.010, dispersant viscosity 
of 0.8820 cP, refractive index of 1.330 and dielectric constant of 79. Each sample was 




IV.4.3.8 In vitro transfection and luciferase assay* 
HEK 293T.17 cells (ATCC, USA) were plated at a density of 50,000 cells/well 48 
hours prior to transfection. The polyplexes were added to each well in a total volume of 
100 μL with a total dose of 100 ng of RNA in 20 mM HEPES with 5% glucose with n=3. 
The cells were then incubated with the polyplexes for 4 hours, and then the media was 
replaced with 100 μL of complete Dulbecco’s Modified Eagle’s Medium (cDMEM) (with 
10% fetal bovine serum (FBS), 5 mg/mL L-glutamine, 5 mg/mL penicillin streptomycin 
(ThermoFisher, UK)). After 24 hours, 50 uL of media was removed and 50 uL of ONE-
Glo™ luciferase substrace (Promega, UK) was added, and the total 100 μL was 
transferred to a white 96-well plate and analyzed on a FLUOstar Omega plate reader 
(BMG LABTECH, UK) with a gain of 4000. The average of the media only wells were 
subtracted from each sample measurement. 
IV.4.3.9 Human skin explant culture and digestion* 
Surgically resected specimens of human skin tissue were collected at Charing 
Cross Hospital, Imperial College London, UK. All tissues were collected after receiving 
signed, informed consent from all patients under protocols approved by the Local 
Research Ethics Committee. The tissue was obtained from patients undergoing elective 
abdominoplasty, breast reduction or mastectomy surgeries. Tissue was refrigerated until 
arrival in the laboratory. The subcutaneous layer of fat was completely removed, and the 
remaining skin layers were trimmed into ~1 cm2 sections. Explants were cultured in 10 
mL of cDMEM in a petri dish at 37 °C and 5% CO2, and the media was refreshed daily.  
Explants were injected with 2 μg of saRNA in a volume of 50 μL intradermally 
(ID) using a Micro-Fine Demi 0.3 mL syringe (Becton Dickinson, UK). After 3 days, skin 
was digested as previously described.9 Briefly, explants were minced well with scissors 
and incubated in 2 mL DMEM supplemented with 1 mg/mL collagenase P (Sigma, UK) 
and 5 mg/mL dispase II (Sigma, UK) for 4 hours at 37°C on a rotational shaker. Digests 
were then filtered through a 70 μm cell strainer and centrifuged for 5 min at 1750 RPM. 
Cells were resuspended in 100 μL of FACS buffer (PBS + 2.5% FBS) and stained with 
100 μL of Aqua Live/Dead Stain (ThermoFisher, UK) diluted 1:400 in FACS buffer for 20 
min on ice. Cells were then washed with 1 mL of FACS buffer, centrifuged at 1750 RPM 
for 5 min and stained with a panel of antibodies to identify cellular phenotypes for 30 
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minutes. Cells were then washed with 1 mL of FACS buffer, centrifuged at 1750 RPM 
for 5 minutes and resuspended in 250 μL of PBS. Cells were fixed with 250 μL of 3% 
paraformaldehyde for a total concentration of 1.5% and refrigerated until flow cytometry 
analysis.   
IV.4.3.10 Flow cytometry analysis* 
 Single cell suspensions were analyzed on a LSRFortessa™ (BD Biosciences, 
UK) using FACSDiva software (BD Biosciences, UK) with 100,000 acquired events. 
Gating was performed as previously described.9 GFP+ cells and phenotypes were 
quantified using FlowJo Version 10 (FlowJo LLC, Oregon, USA).  
IV.4.3.11 Statistical analysis* 
 Graphs and statistical analysis of in vitro and ex vivo data were prepared in 
GraphPad Prism, version 8.0. Statistical analysis was performed using a two-tailed t test 
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In this chapter, we describe the physicochemical characterisation of amphiphilic 
glycopolymers synthesised via Single-Electron Transfer – Living Radical 
Polymerisation (SET-LRP). Depending on the chemical composition of the polymer, 
these glycopolymers are able to fold into multi-chain or single-chain polymeric 
nanoparticles (SCPNs). The folding of these polymers is first of all based on the 
amphiphilicity of the glycopolymers and furthermore on the supramolecular formation 
of helical supramolecular stacks of benzene-1,3,5-tricarboxamides (BTAs) stabilised 
by threefold hydrogen bonding and π- π stacking along the polymer chain. The 
obtained polymeric nanoparticles were subsequently evaluated for their lectin-
binding affinity towards a series of mannose- and galactose-binding lectins via 




SPR measurements were performed by Dr. G. Yilmaz and Miss A. Monaco, SAXS 
measurements were performed by Dr. G.M. ter Huurne 
 
Parts of this chapter have been performed in close collaboration with Dr. G.M. ter 
Huurne and Dr. A.R.A. Palmans at the T.U. Eindhoven, Netherlands 
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Recent advances in polymer science, ranging from sequence-controlled 
polymers to single-chain folding polymeric nanoparticles have made it possible to mimic 
Nature’s machinery closer than ever by introducing new levels of structural control and 
even function into our polymer chains.1,2 Myriad macromolecules common in Nature such 
as proteins, nucleic acids and glycans are built upon basic principles of a limited number 
of ‘monomers’ (amino acids, nucleic acids and carbohydrates) orderly attached to one 
another, which translates further to a controlled folding and finally delivers specific 
function.3 
 Due to the significant difficulty in synthesis of complex glycans, owing to their 
inherently branched structure, polymer chemists have sought ways of synthesizing 
possible biomimetics for these highly functional structures.4 Myriad synthetic 
glycostructures have been synthesised and evaluated in biological platforms, both in vitro 
and ex vivo.5 The significance of these highly branched carbohydrates is evidenced by 
their major role in cellular processes such as signal transduction, intercellular recognition 
but also for other processes such as the protection against and recognition of 
pathogens.6,7 Lectins or carbohydrate binding proteins form interesting targets thanks to 
the processes they affect. Lectin binding affinity (to synthetic glycostructures) can notably 
be enhanced by what is known as the “glycocluster effect”. The glycocluster effect can 
be defined as the increase in binding affinity originating from multivalent lectin-
carbohydrate interactions.8,9 This glycocluster effect has extensively been exploited by 
polymer chemists in the hopes of discovering new molecular designs with improved 
binding avidity.10–12  
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After a surge in sequence-controlled glycopolymers over the last decade it has 
become clear that also in glycopolymer science, the next stage in the design of improved 
architectures would be the introduction of single-chain folding polymer technology.13–15 
A plethora of novel polymeric structures based on the reversible and/or non-reversible 
folding ability of polymeric nanoparticles have paved the way for glycoscience to step up 
its game into this new exciting field.16,17 Altintas et al., state that two main approaches 
can be followed, namely ‘selective point folding’ and ‘repeat unit folding’. Repeat unit 
folding is the synthetically most accessible of the two, however it results in a less-defined 
and chaotic collapse. For the design of single-chain polymeric glyconanoparticles it is 
important however that the intramolecular linkages are compatible with the medium in 
which these structures are dissolved and thus have to be stable in water. Stenzel et al., 
have taken the lead into these glyco-SCPNs by employing covalent techniques such as 
the use of ‘click’-inspired thiol-Michael additions and light-induced profluorescent nitrile-
imine-mediated tetrazole-ene cycloadditions.18–20  
Another means of inducing the collapse of a polymer chain into a single-chain 
polymeric nanoparticle, is the use of solvophobic effects. By synthesizing amphiphilic 
random copolymers of poly(ethylene glycol) (PEG) and alkyl pendant groups, Terashima 
et al., were able to induce reversible single-chain folding in water.21,22 Other 
supramolecular interactions that are heavily exploited include the use of hydrogen 
bonding groups.23–25 Benzene-1,3,5-tricarboxamides (BTAs) have proven to be a 
versatile platform for the control of single polymer chain conformations, as BTAs have 
the inherent ability to self-assemble into supramolecular polymers via π-π stacking and 
threefold hydrogen bonding.26–28 
 As mentioned vide supra, lectins are able to bind glycans with great specificity. 
Here, newly developed glycopolymeric nanoparticles are evaluated towards C-type 
lectins and two galactose binding lectins called Galectin-3 and RCA. C-type lectin 
receptors (CLRs) form a large family composed of both secreted and transmembrane 
proteins containing calcium dependent carbohydrate recognition domains known as C-
type lectin-like domains (CTLD).29 The dendritic cell-specific intracellular adhesion 
molecules (ICAM)-3 grabbing non-integrin (DC-SIGN or CD209), the liver/lymph node-
specific ICAM-3 grabbing non-integrin (L-SIGN, DC-SIGNR or CD209L), the C-type 
lectin-like receptor -1 (CLEC-1) and the dendritic cell-associated C-type lectin-2 (Dectin-
2) are important members of a subdivision classified as pattern recognition receptors.30–
32 The mannose-binding lectin (MBL) and also surfactant protein-D (SP-D) are both C-
type lectins which are members of the collectin family and are involved in the detection 
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and clearance of dying and dead cells.33 These processes are crucial for the 
maintenance of tissue and organ homeostasis. Other lectins in this study that are able 
to detect cell-death include the dendritic and epithelial cell receptor (DEC205) and the 
dendritic cell natural killer (NK) lectin group receptor 1 (DNGR1) which are membrane-
bound CLRs. 34–36 The last C-type lectin in this study is the Langerhans cell-specific C-
type lectin (Langerin or CD207). Langerin plays an important protective role in the 
recognition of HIV glycoproteins and more in general, prompts the uptake and 
degradation of viral particles. 37,38 The other two lectins, Galectin-3 and RCA120 are both 
galactose binding lectins. Galectin-3 is part of the Galectin family which affects numerous 
biological processes such as immune reaction, development and metastasis.39 Ricinus 
communis agglutinin or RCA120 on the other hand, is a lectin present in castor beans, 
known in popular culture for its highly toxic properties.40 
 In this work we present the synthesis and physicochemical characterisation of 
novel chain folding glycopolymers based on both amphiphilicity of the glycopolymer 
chain and through the use of BTAs along the polymer chain via the ‘repeat unit folding’ 
method. Finally the mannose and galactose containing nanoparticles were tested for 
their binding ability towards the lectins mentioned above, in order to investigate the 





V.2 Results  
V.2.1 Synthesis of a galactose glycomonomer 
Similar as in Chapter 3, the first step in making glycopolymers is the synthesis of 
a suitable glycomonomer. In this chapter, we synthesised a galactose glycomonomer 
using similar conditions as in Chapter 3. The galactose glycomonomer that we 
synthesised here is also an acrylate which polymerises similarly as the previously made 
mannose glycomonomer. To achieve this, D-galactose was treated with propargyl 
alcohol in the presence of silica supported sulphuric acid. Because of the different 
position of the hydroxyl group at the C2, the propargylation (which can visually be seen 
by dissolution of the sugar into the reaction medium) took longer up to 2 days instead of 
overnight. Subsequently 3-azidopropyl acrylate was prepared by reacting sodium azide 
with 3-bromopropanol and the resulting 3-azidopropanol was then reacted with acryloyl 
chloride as previously reported in Chapter 3. Finally galactose acrylate was achieved by 
‘clicking’ the propargyl-D-galactose to 3-azidopropyl acrylate using the well-known 




Figure V.2.1 A) 1H-NMR spectrum of D-galactose acrylate in MeOD  
V.2.2 Synthesis of a BTA monomer 
 
Scheme V.2.1 Synthesis of BTA acrylate: a) H2, Pd/C (cat.), EtOAc; b) phthalimide, DIAD, PPh3, 
Et2O; c) H2NNH2•H2O, THF, 90 ˚C; d) potassium phthalimide, DMF, 70 ˚C; e) H2NNH2•H2O, THF, 
90 ˚C; f) Et3N, CHCl3, 0 ˚C; g) acryloyl chloride, Et3N, CH2Cl2, 0 ˚C. 
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In this Chapter, we worked in close collaboration with the group of prof. E.W. 
Meijer at the Eindhoven University of Technology, especially with prof. Dr. Anja R.A. 
Palmans and Dr. Gijs M. ter Huurne who are experts in the field of supramolecular 
polymerisations and single-chain folding polymeric nanoparticles. They were so kind to 
provide us with a compound described further as BTA-OH (a chiral BTA-bearing alcohol) 
synthesised as reported.41 After receipt of the BTA-OH we subsequently converted it 
using acryloyl chloride in dichloromethane and purified via column chromatography, 
achieving the desired BTA acrylate. 
 
Figure V.2.2 A) 1H-NMR spectrum of BTA acrylate in CDCl3 
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V.2.3 Synthesis and characterisation of the copolymers 
 
Figure V.2.3 Chemical structures of the amphiphilic glycopolymers A) Set 1 containing mannose 
acrylate, ethyl hexyl acrylate and BTA acrylate B) Set 2 containing galactose acrylate and ethyl 
hexyl acrylate 
Previous studies using BTAs to induce supramolecular folding of a copolymer 
chain, used polyethylene glycol chains in order to make the particles water soluble. In 
this work water solubility is not achieved using PEG grafts but the highly water soluble 
nature of carbohydrates grafted along the polymer backbone. Three distinct sets of 
glycopolymers were prepared using conventional SET-LRP. Set 1A consists of 
glycopolymers containing an acrylic mannose monomer and 2-ethylhexyl acrylate (EHA), 
Set 1B on the other hand contains and additional acrylic monomer displaying a benzene-
1,3,5-tricarboxamide (BTA) (Fig V.2.3A). Finally Set 2 consists of polymers containing 
an acrylic galactose monomer and EHA (Figure V.2.3B). Both glycomonomers 
(mannose acrylate and galactose acrylate) were synthesised as previously published 
and as reported in Chapter 3 and section V.2.1.42 The third acrylic monomer containing 
a chiral BTA was achieved by reacting BTA-OH (which was synthesised as previously 
reported) with acryloyl chloride resulting in a chiral BTA-acrylate as discussed in section 
V.2.2.28 
The synthesis of the glycopolymers was then accomplished via SET-LRP in 
DMSO. The goal was to achieve glycopolymers with a length of roughly 100 monomer 
units. For this a Schlenk tube was charged with ethyl α-bromoisobutyrate as the initiator, 
Me6TREN, CuBr2, the relevant glycomonomer, EHA, DMSO and in the case of Set 1b 
the BTA-acrylate, all with a combined monomer to initiator ratio of 200:1. The resulting 
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mixture was then degassed by bubbling Ar gas through the solution. The polymerisation 
was then started by addition of a pre-activated Cu(0) wire (5 cm) wrapped around the 
stirring bar under a positive Ar pressure and quickly sealed again and the reaction 
mixture was allowed to polymerise at 25˚C. The conversion of all polymers was 
monitored using 1H-NMR by comparing the signals of the vinyl protons (H2C=CH-CO–
)(≈ 6.5-5.5 ppm) to the glycomonomer’s triazole proton (≈ 8.2-7.9 ppm) and the 
polymerisation was stopped at roughly 50% conversion by removing the Cu(0) wire. The 
resulting glycopolymers were then dialysed against water to remove the remaining 
glycomonomers and subsequently gradually dialysed against a mixture of water/THF 
(2:1) to (1:2) to remove the remaining EHA and BTA-acrylate. 
The resulting glycopolymers were furthermore analysed via 1H-NMR and GPC to 
determine the chemical composition and polymer properties (Table V.2.1). 1H-NMR 
spectra revealed that the hydrophobic content of the polymers (EHA and BTA) was 
higher than anticipated. Gel permeation chromatography was performed using DMF as 
eluent and PMMA standards and revealed slightly elevated dispersities (Đ) ranging 
between 1.23 and 1.65, attributed to the long reaction times (+24h) as the hydrophobic 





Table V.2.1 Summary of monomer conversions (ρ), degree of polymerisation (DP), glycopolymer 
composition (CHO = carbohydrate, EHA = ethylhexyl acrylate, BTA = BTA acrylate), number 
average molar masses as determined by NMR (Mn,NMR) and by GPC (Mn,GPC) and dispersities (Đ) 











CHO EHA BTA CHO EHA BTA 
Set 1 Mannose glycopolymers 
M90-10 73 146 90 10 - 83.8 16.2 - 50200 35600 1.29 
M85-15 68 136 85 15 - 74.9 25.1 - 44500 34000 1.29 
M80-20 74 148 80 20 - 68 32 - 46500 38200 1.29 
M75-25 58 116 75 25 - 67.7 32.3 - 36400 25000 1.27 
M70-30 54 108 70 30 - 67 33 - 34400 20900 1.58 
M100-0-0 51 102 100 - - 100 - - 38300 20600 1.48 
 M97-0-2.5 75 150 97.5 - 2.5 97.7 - 2.3 55650 28500 1.23 
M95-0-5 58 116 95 - 5 95.7 - 4.3 42600 29700 1.28 
M90-0-10 40 80 90 - 10 84.6 - 15.4 27700 17500 1.56 
M80-17-2.5 49 98 80 17.5 2.5 71 26.8 2.2 45270 23700 1.22 
M72-23-5 53 106 72.5 22.5 5 71.6 22.2 6.1 46400 23350 1.66 
M75-15-10 40 80 75 15 10 71.8 14.3 13.8 31700 17850 1.62 
Set 2 Galactose glycopolymers 
G100-0 200 50 100 0 - 100 - - 37500 24100 1.40 
G95-5 200 66 95 5 - 89.1 10.9 - 46760 32500 1.53 
G90-10 200 59 90 10 - 86 14 - 41100 33400 1.39 
G85-15 200 51 85 15 - 81.5 18.5 - 34700 28000 1.35 
G80-20 200 54 80 20 - 76 24 - 35600 26600 1.29 
Conversion (ρ) obtained from 1H-NMR; b) Mn,NMR = (Based on conversion and composition as calculated by 
1H-NMR); c) Determined by DMF GPC (relative to PMMA stn.). 
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V.2.4 Sample preparation procedure 
 
Figure V.2.4 DLS volumes size distribution of mannose glycopolymers (cpolymer = 1 mg mL−1 in 
water and HEPES buffered saline, T = 20 ˚C), A) polymer M70-30 containing mannose and EHA 
and B) polymer M72-23-5 containing mannose, EHA and BTA 
 Preliminary DLS results performed on the samples revealed that the sample 
preparation procedure showed to be crucial for the dissolution and desired chain folding 
and aggregation behaviour of the amphiphilic glycopolymers (Figure V.2.1). In this work, 
dissolution of the amphiphilic glycopolymers was performed both in HEPES buffered 
saline and in deionized water. HEPES buffered saline was used here as it is more 
representative for the physiological environment and for later SPR measurements. 
Dissolution was facilitated by three cycles of the following: 45 min of sonication at 60 ˚C 
and subsequent heating for 45 min at 95 ˚C. Subsequently, the samples were allowed to 
slowly cool down overnight in the oven and afterwards the samples were filtered using a 
100 nm PVDF filter. As can be seen from de DLS graphs, non-BTA containing polymers 
are easily dissolved with a low hydrodynamic radius (< 10 nm) both in HEPES buffered 
saline and in water. On the other hand BTA containing polymers proved to dissolve better 
in HEPES buffer saline and HEPES buffer saline showed to disrupt intermolecular 




V.2.5 Conformation of the glycopolymers 
 The effect of glycopolymer composition on the conformation in solution of the 
particles was studied using small-angle X-ray scattering (SAXS) experiments. At lower 
q values the acquired scattering profiles were levelling off as is typical for small polymeric 
nanoparticles in solution.  
 
Figure V.2.5 Comparison of the SAXS curves for the synthesised glycopolymers (cpolymer = 1 mg 
mL−1 in HEPES buffered saline, T = 20 ˚C) with (A) Set 1a consisting of mannose glycopolymers 
and EHA, (B) Set 1b comprised of mannose glycopolymers containing BTA and (C) Set 2 
consisting of galactose glycopolymers and EHA. 
Table V.2.2 Overview of the effect of EHA (ethylhexyl acrylate) content on the Aggregation 
Number (Nagg) and the Radius of Gyration (RG) for Set 1A 





 mol% - nm 
M100-0-0 0 1.1 4.1 
M90-10 16 1.0 3.8 
M85-15 25 1.1 3.4 
M70-30 33 1.0 2.6 
 
 In glycopolymer Set 1A, the point at which the curves start to decay shifts to 
higher q values as a function of hydrophobic content which shows that the particles 
become smaller (Figure V.2.2A and Table V.2.2). Furthermore it can be seen that the 
slope of decay becomes steeper when increasing the EHA content indicating more 
compact particles. Apart from these observations, the scattering profiles for all polymers 
in Set 1A remained featureless. Based on these observations, we can conclude that the 





Figure V.2.6 Comparison of the SAXS curves for BTA containing glycopolymers (cpolymer = 1 mg 
mL−1 in HEPES buffered saline, T = 20 ˚C) with (A) polymers with 5% BTA, (B) polymers with 
2.5% BTA 
Table V.2.3 Overview of the effect of the BTA content on the Aggregation Number (Nagg)  and the 
Radius of Gyration (RG) for Set 1B 





 mol% - nm 
M100-0-0 0 1.0 4.1 
M97-0-2.5 2 1.8 6.1 
M95-0-5 4 2.9 5.5 
M90-0-10 15 6.9 9.0 
 
When BTA’s are added to the polymer composition such as in Set 1B, additional 
features appear. Looking at the polymers only containing mannose and BTA we can first 
of all observe that with increasing BTA content the value at q → 0, becomes higher, 
which indicates a higher mass of the formed particles (Figure V.2.2B and Table V.2.3). 
Secondly, increasing the BTA content shifts the point at which the curves starts to decay 
to lower q values, this indicates an increase in particle size. For polymer M90-0-10, an 
additional decay can be observed which indicates the presence of an additional small 
internal structure. As with the increase in EHA, adding more BTA and thus hydrophobic 
content to the polymer composition results in more compact particles. We can conclude 
that the incorporation of more BTAs, induces clustering of the glycopolymers into small 
multi-chain polymeric nanoparticles. 
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Table V.2.4 Comparison of the effect of the BTA and EHA content on the Aggregation Number 











 mol% mol% - nm 
M95-0-5 4 0 2.9 5.5 
M72-23-5 6 22 3.2 7.2 
M97-0-2.5 2 0 1.8 6.1 
M80-17-2.5 2 27 1.6 3.7 
 
Adding EHA to the BTA polymers gives similar results as Set 1A, meaning the 
point at which the curves start to decay shifts to higher q values and the slope of decay 
becomes steeper (Figure V.2.3 and Table V.2.4). It can also be noted that the intensity 
at low q values is similar when adding EHA to the BTA glycopolymers, which indicates 
the aggregation number remains unaffected. As with Set 1A we can conclude that adding 
more EHA results in smaller and more compact nanoparticles. 
Table V.2.5 Overview of the effect of EHA content on the Aggregation Number (Nagg) and the 
radius of gyration (RG) for Set 2 





 mol% - nm 
G100-0 0 1.0 4.0 
G95-5 11 1.0 4.4 
G90-10 14 1.0 4.1 





In resemblance with glycopolymer Set 1A, Set 2 (which contains galactose 
containing polymers) reveals that the incorporation of more EHA results in slightly 
smaller and more compact single-chain nanoparticles (Figure V.2.2C and Table V.2.5).  
168 
 
V.2.6 Folding of the BTA containing glycopolymers 
 
Figure V.2.7 (A) Comparison of the molar CD spectra obtained for Set 1b (cBTA = 50 μM in HEPES 
buffered saline, T = 20 ˚C) as a function of the incorporation of BTA and EHA and (B) Influence 
of temperature on the CD intensity (cBTA = 50 μM in HEPES buffered saline, λ = 225 nm, l = 5mm) 
Chiral BTA grafts are able to fold a polymer backbone into a compact polymeric 
nanoparticle. Threefold hydrogen bonds facilitate and stabilise the formation of helical 
assemblies with a preferred handedness, induced by the chiral sidechains. In order to 
monitor the presence of these structured assemblies, circular dichroism (CD) 
spectroscopy can be used as a valuable tool. The intensity of the CD signal is directly 
proportional to the fraction of BTA effectively present in the helical stacks. For all the 
glycopolymers containing BTA, negative CD effects were detected in HEPES buffered 
saline with identical shapes, with a maximum at 225 nm (Figure V.2.4A). This 
observation indicates that the same conformation is adopted by the BTA’s amides within 
left-handed self-assembled helices. The other glycopolymers without BTA, do not exhibit 
CD activity in the range of 200 – 400 nm. Set 1B can be split in 2 glycopolymer samples, 
a sample without EHA and a sample with EHA. Glycopolymers containing 2.5% and 5% 
BTA residues, feature similar CD effects in both subsets (Δε = – 22 M-1 cm-1 for  M90-0-
10 and M95-0-5 and Δε = – 45 M-1 cm-1  for M72-23-5 and M80-17-2.5), whereas 10% 
BTA exhibits a much lower intensity and thus a reduction in BTA self-assembly. Addition 
of EHA to the glycopolymer composition dramatically enhances the folding ability of the 
BTA moieties resulting in a two-fold increase in CD effect compared to non-EHA 
containing glycopolymers. Figure V.2.6B shows the temperature dependence of the CD 
effect in the range between 5 ˚C and 95 ˚C. It can be noted that with increasing 
temperature, the CD effect experiences a gradual decrease which is in agreement with 
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previous research. Remarkably, even at high temperatures (> 90 ˚C) a strong CD effect 
can still be observed in buffer. 
V.2.7 Lectin binding studies 
 Set 1 and Set 2 were subjected to SPR measurements in order to evaluate their 
ability to bind a series of 9 different lectins found on dendritic and Langerhans cells, 
known from literature to bind specific carbohydrates. No considerable binding interaction 
could be detected for the mannose containing polymers with the lectins CLEC-1 and 
DNGR-1. These lectins respectively have roles in dendritic cells as an inhibitory receptor 
and as a facilitator in the cross-presentation of antigens associated with dead cells.  
 
Figure V.2.8 A) SPR sensorgram of Set 1a with MBL (cpolymer = 4000 nM). B and C) Graphical 
representation of association constants (Ka) for glycopolymer Set 1a with various lectins, as 
determined by SPR. 
 Set 1a consisting of mannose glyco-SCPNs, shows a clear decreasing trend in 
binding affinity between the glycopolymers and the lectins DC-SIGN, Langerin, Dectin-2 
and DEC-205 with increasing EHA content (Figure V.2.5B). MBL (or the mannose 
binding lectin) on the other hand, experiences a maximal binding affinity at 20% EHA 
content, which can be explained by an optimal distance between sugar residues and 
thus increase in binding affinity (Figure V.2.5C). However, SP-D (a lectin found to be 
involved in the recognition of viral particles) doesn’t present a clear trend in terms of EHA 
content of the glycopolymer. It should be noted however that binding affinity of the 
glycopolymers with SP-D and MBL is very high, with Ka’s ranging between 107 1/M to 





Figure V.2.9 A) SPR sensorgram of Set 1b with Dectin-2 (cpolymer = 4000 nM). B and C) Graphical 
representation of association constants (Ka) for glycopolymer Set 1b with various lectins, as 
determined by SPR. 
Moving further to the BTA containing glycopolymers of Set 1b, conclusions 
become a bit more difficult (Figure V.2.6). However, when comparing association 
constants Ka between polymers with or without EHA but with similar BTA content we can 
conclude that addition of more EHA results in a slightly reduced binding affinity.  This 
observation was most pronounced in lectin binding affinity results for the lectin Dectin-2 
as can be seen in Figure V.2.6A. This observation is in agreement with the findings in 
glycopolymer Set 1a. We can furthermore see that upon addition of more BTA to the 
glycopolymer composition, an increase in binding affinity is attained. This increase in 
binding affinity can be seen in both the series with and without EHA within this set. Figure 
V.2.7 shows binding affinity of Set 2 consisting of galactose glyco-SCPNs. Set 2 shows 
a minimum binding affinity at 10 % EHA content for lectin RCA120 with a binding constant 
Ka around 2.37 x 105 1/M. The exact opposite appears for the lectin Galectin-3. For 
Galectin-3, 10 % experiences maximal binding at around 4.5 x 106 1/M. 
 
Figure V.2.10 A) SPR sensorgram of Set 2 with RCA120 (cpolymer = 4000 nM) B) SPR sensorgram 
of Set 2 with Galectin-3 (cpolymer = 4000 nM) B) Graphical representation of association constants 





SAXS measurements were performed on the amphiphilic glycopolymers. All 
amphiphilic glycopolymers (without BTA) proved to have masses (determined with SAXS 
in solution) in close agreement with the mass values based on the composition as 
determined by NMR. For this reason we can conclude that all the non-BTA containing 
glycopolymers (mannose and galactose) fold into single-chain nanoparticles, 
independent of the exact composition of the glycopolymer. This is furthermore evidenced 
by DLS measurements which gave similar results. BTA containing glycopolymers on the 
other hand show higher masses with an aggregation number (Nagg) averaging between 
1 to 7 polymer chains per aggregate.  
 These findings are furthermore evidenced by the CD spectroscopy experiments. 
CD spectroscopy measurements were performed to see the influence of using 
carbohydrates as solubilizing agent instead of PEG graft along the polymer chain. 
Disruption of the intermolecular forces between glycopolymers chains (BTA self-
assembly) proved to be very difficult as can be seen in Figure V.2.4B. When the solution 
is heated up to 95 ˚C, still about one third of the BTA moieties are present in helical 
stacks. Interestingly the intensity of the CD signal increases significantly when sugars 
are used instead of PEG chains (PEG: |Δε| = - 23 M−1 cm−1 to carbohydrates = - 45 M−1 
cm−1) for polymers both containing 5% BTA and additional hydrophobic monomers.43 
Non-BTA glycopolymers however show a much lower CD intensity, especially for 
polymers with a BTA content over 10 %. Where for PEG graft based polymers, the 
magnitude of the CD signal increases with increasing BTA content, we found that folding 
becomes worse for glycopolymers with increasing BTA content resulting in a lower 
amount of BTA incorporated into stacks.  Similar as with the increase in EHA content, 
we can conclude from SAXS and CD measurements that higher BTA content results in 
a less compact and more elongated particle due to a worse folding of the BTA particles. 
Moving back to the relationship between particle composition and lectin binding 
affinity, it’s become clear that particle size and morphology have great impact on 
glycopolymer interactions. From SPR measurements we could conclude that in increase 
in EHA content results in a slightly reduced binding affinity between the 
glyconanoparticles and the lectins. This can be explained by the more compact and 
globular conformation the glycopolymer chains adopt upon addition of EHA which limits 
the freedom to adopt an optimal conformation to reach different binding pockets. 
Secondly, as can be seen from the SPR binding results, increasing BTA content actually 
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shows an increase in binding affinity. Also these findings can be explained from a 
physicochemical point of view. As increasing EHA content contracts the nanoparticles 
size, increasing the BTA content results in bigger particles composed of multiple polymer 
chains and thus a morphologically less controlled and less compact nanoparticle. This 
demonstrates the highly dynamic nature of protein glycopolymer interactions, where a 







In a pursuit of controlling the dynamic chain folding of polymeric 
glyconanoparticles, mannose and galactose amphiphilic glycopolymers were 
synthesised and characterised containing both hydrophobic pendants (ethyl hexyl) and 
supramolecular motifs (BTA). Physicochemical properties were investigated using 1H-
NMR, GPC, DLS, CD spectroscopy and SAXS. The results have shown that addition of 
more EHA to the glycopolymer composition results in more compact single-chain 
polymeric nanoparticles and that the amphiphilic glycopolymers adopt a more compact 
spherical conformation, having a radius of gyration ranging between 2.6 and 4.4 nm. 
Addition of more BTA on the other hand, makes the glyconanoparticles more compact, 
however, it induces clustering of the copolymers into small multi-chain polymeric 
nanoparticles with radii of gyration between 3.7 and 9 nm composed of 1 to 7 
glycopolymer chains. Lectin binding studies were performed towards a series of lectins 
found on dendritic and Langerhans cells and towards two galactose binding lectins, 
RCA120 and Galectin-3. All mannose containing glyconanoparticles have great binding 
affinity towards the lectins DC-SIGN, DC-SIGNR, Langerin, Dectin-2 and DEC-205. 
Especially SP-D and MBL showed extremely high binding constants Ka of up to 1010-1012 
1/M. We found that addition of EHA (and thus more compact nanoparticles) results in a 
reduction in binding affinity and addition of low amounts of BTAs furthermore results in 




V.5 Experimental section 
V.5.1 Materials 
Tris(2-(Dimethylamino)ethyl)amine (Me6TREN) was previously synthesised 
within the group. D-Mannose glycomonomer was synthesised as previously 
reported.42,44All other reagents and solvents were obtained at the highest purity available 
from Sigma Aldrich Chemical Company unless stated otherwise. HEPES buffered saline 
was prepared by dissolving HEPES (2.38 g), NaCl (8.77 g), CaCl2 (0.74 g) in 1 L water. 
Once everything was dissolved, the pH was adjusted until a pH of 7.4. 
V.5.2 Instruments and analysis 
Proton (1H-NMR) nuclear magnetic resonance spectroscopy (Bruker DPX-
400/600) was used to determine the chemical structure of the synthesised initiators and 
polymers. Samples were dissolved at 10 mg/mL concentration in CDCl3, DMSO-d6, D2O 
or MeOD-d4 as solvent. Monomer conversion was calculated by the disappearance of 
vinyl protons (H2C=CH-CO–) (≈ 6.5-5.5 ppm) compared to the mannose glycomonomer’s 
triazole proton (≈ 8.2-7.9 ppm). Polymer compositions were calculated based on the 
comparison of the triazole proton (≈ 8.2-7.9 ppm), with the BTAs aromatic and amide 
protons (≈ 8.3-8.9 ppm) and the methyl protons of the BTA and ethyl hexyl acrylate after 
subtraction of the backbone peaks (≈ 0.5-1.1 ppm). 
GPC measurements were conducted on an Agilent 1260 infinity system operating 
in DMF with 5mM NH4BF4 and equipped with refractive index detector and variable 
wavelength detector, 2 PLgel 5 μm mixed-C columns (300×7.5mm), a PLgel 5 mm guard 
column (50x7.5mm) and an autosampler. The instrument was calibrated with linear 
narrow poly(methyl methacrylate) standards. All samples were passed through basic 
alumina to remove any copper residues and filtered with a 0.2 μm Nylon 66 before 
analysis.  
Dynamic light scattering (DLS) measurements were performed using a Malvern 
µV Zetasizer equipped with an 830 nm laser and a scattering angle of 90° at a 
temperature of 20 °C. Samples were prepared at 1 mg/mL and filtered with a 0.2 µm 
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PVDF-filter (Whatman) to prevent the presence of dust. A fluorescence cell with a 1 cm 
path length was used for the measurements.  
Small-angle X-ray scattering (SAXS) was performed on a SAXSLAB Ganesha 
system using a GeniX-Cu ultra-low divergence source producing X-ray photons with a 
wavelength of 1.54 Å and a flux of 1 x 108 ph/s. Scattering patterns were collected using 
a Pilatus 300K silicon pixel detector. Sample-to-detector distances of 0.13, 0.73 m, and 
1.53 m were used giving an observed q range of 1.3 ⋅ 10–3 nm–1 ≤ q ≤ 2.4 nm–1. The 
solutions (typically 1 mg/mL) were measured in 2 mm quartz capillaries, typically 
measurement times were: 1 h at a sample-to-detector distance of 0.13 m, 5 h at 0.73 m, 
and 9 h at 1.53 m. The SAXSgui software package was used to radially average the 
resulting 2D images to obtain the intensity I (q) vs. q profiles. Standard data reduction 
procedures, i.e. subtraction of the solvent’s contribution, were performed using the same 
software. The curves were fitted using the SasView 4.1.2 software packages. A polymer 
excluded volume model was used to fit the scattering curves. 
Circular dichroism spectroscopy measurements were performed on a Jasco J-
815 circular dichroism (CD) spectropolarimeter equipped with a PFD-425S/15 Peltier-
type temperature controller. A quartz cuvette with an optical path length of 1 mm was 
used. The molar circular dichroism Δε was calculated using Δε= CD effect / (32980 x cBTA 
x l), in which c is the concentration of the BTAs attached to the polymer backbone and l 
is the optical pathway. 
Surface Plasmon Resonance (SPR) - The extent of interaction between the 
glycopolymers and lectins were performed on a BIAcore 3000 system (GE Healthcare). 
The proteins (0.025 mg/ml) were immobilized via a standard amino coupling protocol 
onto a CM5 sensor chip which was activated by flowing a 1:1 mixture of 0.1 M N-
hydroxysuccinimide and 0.1 M N-ethyl-N’-(dimethylaminopropyl)carbodiimide over the 
chip for 6 min at 25 °C at a flow rate of 20 µL/min after the system equilibration with 
HEPES filtered buffer (10 mM HEPES, 150 mM NaCl, 5 mM CaCl2) supplemented with 
0.005% TWEEN® 20 at pH 7.4. Subsequently, channels 1 (blank), 2, 3 and 4 were 
blocked by following a solution of ethanolamine (1 M pH 8.5) for 10 min at 5 µL/min to 
remove remaining reactive groups on the channels. Sample solutions were prepared at 
varying concentrations (4000 nM-250 nM) in the same HEPES buffer to calculate the 
binding kinetics. Sensorgrams for each glycopolymer concentration were recorded with 
a 300 seconds injection of polymer solution (on period) followed by 150 seconds of buffer 
alone (off period). Regeneration of the sensor chip surfaces was performed using 10 mM 
HEPES pH 7.4, 150 mM NaCl, 10 mM EDTA, 0.01% P20 surfactant solution. Kinetic 
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data was evaluated using a single set of sites (1:1 Langmuir Binding) model and also 
Biavalent model in the BIAevalulation 3.1 software. 
V.5.3 Experimental procedures 
V.5.3.1 Synthesis of 1-(2′-Propargyl) D-Galactose 
 
Scheme V.5.1 Schematic representation of the synthetic approach to the D-galactose 
glycomonomer 
1-(2′-Propargyl) D-Galactose was prepared according to the procedure reported 
by Mukhopadhyay et al.45 A suspension solution of D-Galactose (12 g, 66.6 mmol), 
propargyl alcohol (19.4 mL, 333 mmol) and H2SO4-silica (500 mg) was stirred at 65 °C 
for two days. After cooling to ambient temperature, the reaction mixture was transferred 
to a silica gel column and eluted with CHCl3-MeOH (8:1) to remove the excess propargyl 
alcohol. 1-(2′-Propargyl) D-galactose was obtained as white hygroscopic solid after 
drying under vacuum (6.5 g, yield: 45 %). 1-(2′-propargyl)-D-galactose was found as an 
anomeric mixture in a ratio of 4:1 (β/α). 
1H NMR (400 MHz, CD3OD, 300 K, ppm): δ: 5.03 (d, 1H, 3.9 Hz), 4.42 (m, 1H), 4.30 (d, 




V.5.4 Synthesis of D-Galactose glycomonomer  
 
Scheme V.5.2 Schematic representation of the synthetic approach to the D-galactose 
glycomonomer 
To a solution of 3-azidopropyl acrylate (3.16 g, 20.3 mmol) and 1-(2′-propargyl) 
D-galactose (4.04 g, 18.5 mmol) and a spatula tip of hydroquinone in MeOH/H2O (2:1 
vol/vol, 180 mL), an aqueous solution of CuSO4·5H2O (624 mg, 2.5 mmol) and (+)-
sodium L-ascorbate (625 mg, 3.15 mmol) were sequentially added. The mixture was 
stirred at ambient temperature for 24 h. The methanol was removed via rotary evaporator 
and residue mixture was freeze dried in order to remove water. The obtained green solid 
was purified by silica gel column chromatography using dichloromethane-MeOH (10:1) 
as eluent. The relevant fractions were collected and after removal of solvent pure D-
galactose glycomonomer was isolated as white solid (4.78 g, yield: 69.1%). The obtained 
unprotected D-galactose glycomonomer is an anomeric mixture. 
1H NMR (400 MHz, CD3OD, 300 K, ppm): δ =8.05 (s, 1 H), 6.37 (dd, 1H, 1.4, 17.3 Hz), 
6.14 (dd, 1H, 10.4, 17.3 Hz), 5.89 (dd, 1H, 1.4, 10.4 Hz), 4.94 (d, 1H, 3.6 Hz), 4.90-4.60 
(m, 2H, overlap with H2O), 4.54 (t, 2 H, 6.8 Hz), 4.19 (t, 2 H, 6.1 Hz), 4.00-3.40 (m, 6 H, 
galactose residues), 2.3 (quin, 2 H, 6.3 Hz) 
V.5.5 Synthesis of (S,S)-BTA acrylate 
 
Scheme V.5.3 Schematic representation of the synthetic approach to the BTA-acrylate monomer 
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(S,S)-BTA-C11-OH (2.86 g, 4.35 mmol) and triethylamine (0.750 mL, 5.38 mmol) 
were dissolved in 25 mL of dry DCM and the solution was placed under an argon 
atmosphere. The mixture was cooled using an ice bath before a solution of acryloyl 
chloride (0.55 mL, 5.63 mmol) in 20 mL dry DCM was added in a dropwise fashion. The 
reaction was stirred overnight and washed with 1 M HCl (2x), saturated NaHCO3 (2x) 
and brine subsequently. After drying the organic layer over MgSO4, the product was 
purified via column chromatography (silica, elution: 15% EtOAc in CHCl3). After removal 
of the solvent in vacuo, the product was obtained as a white wax (yield: 80%). 
1H-NMR (400 MHz, CDCl3): δ 8.31 (s, 3H), 6.46 (t, 1H), 6.42 (t, 2H) 6.40 (dd, 1H, 1.5, 
17.3 Hz), 6.13 (dd, 1H, 10.4, 17.3 Hz), 5.82 (dd, 1H, 1.5, 10.4 Hz), 5.54 (m, 1H), 4.13 (t, 
J = 6.7 Hz, 2H), 3.54 – 3.37 (m, 6H), 1.94 (m, 3H), 1.73 – 1.06 (m, 40H), 0.93 (d, J = 6.5 
Hz, 6H), 0.86 (d, J = 6.6 Hz, 12H). 
V.5.6 General procedure for the SET-LRP polymerisation of Set 1 
 
Scheme V.5.4 Schematic representation of the polymerisation procedure for Set 1 
A Schlenk tube was charged with initiator ethyl α-bromoisobutyrate, 1.17 µL, 
0.00803 mmol, 1 eq.), mannose glycomonomer (480 mg, 1.28 mmol, 160 eq.), ethyl 
hexyl acrylate (47.12 µL, 0.28 mmol, 35 eq), BTA acrylate (28.61 mg, 0.402 mmol, 5 eq),  
Me6TREN (0.408 µL, 0.19 eq), CuBr2 (0.35 mg, 0.04 eq.) in DMSO (2 mL), sealed with 
a rubber septum and subsequently degassed by gentle bubbling of Ar gas for 15 min. 
The polymerisation was then started by addition of pre-activated Cu(0) wire (5 cm) 
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wrapped around a stirring bar under a positive Ar pressure and quickly sealed again and 
the reaction mixture was allowed to polymerise at 25˚C. Sampling was carried out using 
a degassed syringe to check the conversion of mannose glycomonomer. The 
polymerisation was allowed to continue to polymerise until at least 50% conversion was 
reached. 
 
Figure V.5.1 A) 1H-NMR in DMSO-d6 of Set 1A showing the purity of the synthesised star 
glycopolymers, with clear visibility of the triazole peak at 8.0 ppm and disappearance of the vinyl 
protons between 6.5 and 5.5 ppm, B) 1H-NMR in DMSO-d6 of Set 1B showing the purity of the 
synthesised star glycopolymers, with clear visibility of the triazole peak at 8.0 ppm and 
disappearance of the vinyl protons between 6.5 and 5.5 ppm 
 
 




V.5.7 General procedure for the SET-LRP polymerisation of Set 2 
  
Scheme V.5.5 Schematic representation of the polymerisation procedure for Set 2 
A Schlenk tube was charged with initiator ethyl α-bromoisobutyrate, 1.17 µL, 
0.00803 mmol, 1 eq.), galactose glycomonomer (480 mg, 1.28 mmol, 160 eq.), ethyl 
hexyl acrylate (53.85 µL, 0.231 mmol, 40 eq), Me6TREN (0.408 µL, 0.19 eq), CuBr2 (0.35 
mg, 0.04 eq.) in DMSO (2 mL), sealed with a rubber septum and subsequently degassed 
by gentle bubbling of Ar gas for 15 min. The polymerisation was then started by addition 
of pre-activated Cu(0) wire (5 cm) wrapped around a stirring bar under a positive Ar 
pressure and quickly sealed again and the reaction mixture was allowed to polymerise 
at 25˚C. Sampling was carried out using a degassed syringe to check the conversion of 
the monomers by comparing the acrylate peaks to the triazole proton. The polymerisation 




Figure V.5.3 A) 1H-NMR in DMSO-d6 of Set 2 showing the purity of the synthesised star 
glycopolymers, with clear visibility of the triazole peak at 8.0 ppm and disappearance of the vinyl 
protons between 6.5 and 5.5 ppm, B) GPC chromatograms of Set 2. 
V.5.8 DLS measurements 
 
Figure V.5.4 Volume distribution of the hydrodynamic radius (RH) of Set 1A (filtered with a 200 




Figure V.5.5 Volume distribution of the hydrodynamic radius (RH) of Set 1B (filtered with a 200 
nm PVDF filter) 
 




V.5.9 SAXS measurements 
 
Figure V.5.7 Small-angle X-ray scattering curves of Set 1A (filtered with a 200 nm PVDF filter) 
 




Figure V.5.9 Small-angle X-ray scattering curves of Set 2 (filtered with a 200 nm PVDF filter) 
V.5.10  Kinetic data obtained via SPR  
Table V.5.1 Polymer interactions with DC-SIGN 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M100-0-0 2.69x10-4 3.95x10-3 6.8x106 1.47x10-7 120 
M90-0-10 6.03x103 1.05x10-3 5.76x106 1.74x10-7 325 
M95-0-5 6.41x103 1.19x10-3 5.83x106 1.85x10-7 420 
M97-0-2.5 9.12x103 1.61x10-3 5.66x106 1.77x10-7 350 
M75-15-10 7.56x103 1.34x10-3 5.62x106 1.78x10-7 300 
M80-17-2.5 1.29x104 2.53x10-3 5.08x106 1.97x10-7 200 
M72-23-5 8.97x103 2.14x10-3 4.18x106 2.39x10-7 280 
M70-30 6.77x103 2.28x10-3 2.97x106 3.37x10-7 185 
M75-25 2.18x104 4.73x10-3 4.21x106 2.17x10-7 120 
M80-20 1.81x104 2.69x10-3 6.73x106 1.49x10-7 165 
M85-15 1.64x104 2.66x10-3 6.17x106 1.62x10-7 150 




Table V.5.2 Polymer interactions with DC-SIGNR 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M100-0-0 8.8x103 8.55x10-4 1.03x107 9.71x10-8 250 
M90-0-10 4.82x103 2.48x10-5 1.95x108 5.14x10-9 1300 
M95-0-5 3.88x103 4.74x10-5 8.18x107 1.22x10-8 1400 
M97-0-2.5 6.33x103 3.03x10-4 2.09x107 4.78x10-8 1000 
M75-15-10 4.26x103 1.45x10-4 2.94x107 3.4x10-4 1000 
M80-17-2.5 2.83x103 2.34x10-4 1.21x107 8.3x10-8 800 
M72-23-5 3.27x103 8.81x10-5 3.71x107 2.67x10-8 840 
M70-30 2.83x103 1.15x10-4 2.46x107 4.07x107 270 
M75-25 1.53x103 1.65x10-4 9.48x106 1.05x10-7 350 
M80-20 2.77x103 7.45x10-5 3.71x107 2.69x10-8 710 
M85-15 2.08x103 5.56x10-5 3.75x107 2.67x10-8 650 
M90-10 3.71x103 2.31x10-4 1.6x107 6.24x10-8 540 
 
Table V.5.3 Polymer interactions with MBL 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M100-0-0 1.57x104 6.35x10-4 2.47x107 4.05x10-8 650 
M90-0-10 8.24x103 1.89x10-4 4.37x107 2.29x10-8 2800 
M95-0-5 9.81x103 1.93x10-4 5.09x107 1.96x10-8 2200 
M97-0-2.5 1.22x104 2.64x10-4 4.63x107 2.16x10-8 1800 
M75-15-10 8.2x103 1.67x10-4 4.91x107 2.04x10-8 3000 
M80-17-2.5 9.22x103 5.2x10-4 1.77x107 5.64x10-8 1700 
M72-23-5 1.49x104 4.81x10-4 3.09x107 3.23x10-8 2100 
M70-30 7.14x103 2.19x10-4 3.25x107 3.08x10-8 1300 
M75-25 4.01x103 1.59x10-6 2.52x109 3.98x10-10 1100 
M80-20 6.13x103 3.65x10-7 1.68x1010 5.96x10-11 1510 
M85-15 4.25x103 8.46x10-7 5.02x109 1.99x10-10 1210 





Table V.5.4 Polymer interactions with Langerin 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M90-0-10 6.41x103 2.69x10-4 2.38x107 4.2x10-8 450 
M70-30 8.43x103 1.96x10-3 4.31x106 2.32x10-7 240 
M95-0-5 9.31x103 9.14x10-4 3.14x106 3.19x10-7 360 
M75-25 8.57x103 2.16x10-3 3.97x106 2.52x10-7 210 
M80-20 9.79x103 1.75x10-3 5.61x106 1.78x10-7 260 
M90-10 1.17x104 1.21x10-3 9.69x106 1.03x10-7 230 
M85-15 7.35x103 1.71x10-3 4.29x106 2.33x10-7 265 
M100-0-0 8.29x103 7.64x10-4 1.09x107 9.21x10-8 190 
M97-0-2.5 6.54x103 5.15x10-4 1.27x107 7.87x10-8 330 
M75-15-10 5.07x103 1.93x10-7 2.63x1010 3.8x10-11 390 
M80-17-2.5 5.14x103 7.58x10-4 6.78x106 1.47x10-7 250 
M72-23-5 5.67x103 1.64x10-3 3.45x107 2.9x10-8 265 
 
Table V.5.5 Polymer interactions with Dectin-2 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M90-0-10 3.81x103 7.95x10-4 4.79x106 2.09x10-7 450 
M70-30 3.09x103 3.01x10-3 1.03x106 3.74x10-7 110 
M95-0-5 6.08x103 2.05x10-3 2.97x106 3.37x10-7 380 
M75-25 7.51x103 6.63x10-3 1.13x106 8.82x10-7 65 
M80-20 5.31x103 3.93x10-3 1.35x106 7.4x10-7 200 
M90-10 6.7x103 2.87x10-3 2.33x106 4.28x10-7 280 
M85-15 3.98x103 3.41x10-3 1.17x106 8.57x10-7 220 
M100-0-0 5.43x103 2.45x10-3 2.22x106 4.51x10-7 120 
M97-0-2.5 4.55x103 1.71x10-3 2.66x106 3.75x10-7 380 
M75-15-10 7.54 1.24x10-3 6.1x103 1.64x10-4 260 
M80-17-2.5 956 1.4x10-3 6.85x105 1.46x10-6 275 





Table V.5.6 Polymer interactions with DEC-205 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M90-0-10 1.24x104 3.99x10-3 3.12x106 3.21x10-7 190 
M70-30 2.39x104 7.62x10-3 3.14x106 3.19x10-7 160 
M95-0-5 1.56x104 4.27x10-3 3.65x106 2.74x10-7 165 
M75-25 1.75x104 7.33x10-3 2.38x106 4.2x10-7 155 
M80-20 1.69x104 6.95x10-3 2.43x106 4.11x10-7 180 
M90-10 8.81x103 2.16x10-3 4.08x106 2.45x10-7 170 
M85-15 2.09x104 6.84x10-3 3.05x106 3.28x10-7 170 
M100-0-0 4.37x103 7.62x10-4 5.74x106 1.47x10-7 140 
M97-0-2.5 1.16x103 3.39x10-3 3.41x105 2.93x10-6 170 
M75-15-10 3.71x105 0.235 1.58x106 6.33x10-7 180 
M80-17-2.5 16.7 1.06x10-3 1.58x104 6.35x10-7 140 
M72-23-5 332 4.68x10-3 7.1x104 1.41x10-5 120 
 
Table V.5.7 Polymer interactions with SP-D 
Polymer ka [M-1s-1] kd [s-1] KA[M-1] KD [M] Rmax [RU] 
M75-25 706 5.05x10-5 1.4x107 7.15x10-8 450 
M85-15 785 6.86x10-7 1.14x109 8.74x10-10 710 
M80-17-2.5 1.39x103 1.66x10-8 8.36x1010 1.2x10-11 1330 
M70-30 1.12x103 2.14x10-6 5.26x108 1.9x10-9 435 
M80-20 1.56x103 7.78x10-10 2x1012 5x10-13 820 
M90-10 1.4x103 7.14x10-8 1.96x1010 5.1x10-11 480 
M72-23-5 1.93x103 9.2x10-7 2.1x109 4.77x10-10 1480 
M100-0-0 2.91x103 1.81x10-6 1.61x109 6.21x10-10 80 
M90-0-10 2.07x103 1.22x10-8 1.71x1011 5.86x10-12 1435 
M95-0-5 6.9x103 4.14x10-3 1.66x106 6.02x10-7 170 
M97-0-2.5 1.47x104 4.09x10-7 3.59x1010 2.79x10-11 555 
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In this short chapter, we reflect on what has been achieved in this PhD thesis, what 





VI Overview and Future Prospects 
In this PhD thesis, we have successfully demonstrated the synthesis, 
characterisation and use of new polymeric structures with novel architectures and proven 
their relevancy in biological applications. For me the beauty of this thesis lies in the fact 
that as a polymer chemist I was able to successfully combine the three core Natural 
Sciences of today, meaning the beautiful discipline of Chemistry, studying substances, 
their composition, properties, structures and how they react with other substances, but 
also Physics, studying matter, energy, forces and the interactions between them, and 
then lastly Biology, the study of life and living organisms, most probably the study with 
which most people can relate and understand its importance through Medicine and 
Pharmacology. 
 In a first project, we were able to demonstrate (by trial and error) the successful 
synthesis of a novel β-Cyclodextrin and its use in the sequence-controlled polymerisation 
of a series of acrylates. The original goal was to use these systems for the polymerisation 
of saccharide bearing acrylates, however the combination of both star initiators, which 
demand more dilute reaction conditions, and sequence-controlled polymerisations, 
which demand very high conversion rates, proved to be cumbersome when applying to 
glycomonomers, as they have a slower propagation rate as compared to other acrylates. 
As discussed in Section I.5, Solid-Phase synthesis (as employed by the group of 
Hartmann) proved to be much more attractive to achieve sequence-defined oligomers, 
as the desired compounds can be optimised to display optimal distances between 
carbohydrates.  
In the second project, we explored the influence of molecular architecture of 
glycopolymers on lectin binding, meaning how star polymer design and thus amount of 
glycopolymer arms has an effect on binding affinity. We demonstrated that for polymers 
with an equal amount of carbohydrates per molecule, an increase in amount of arms 
lowers the binding affinity, thus we concluded (as established before) that this is due a 
reduction in glycopolymer arm length. We furthermore demonstrated that when arm 
length is kept the same, an increase in amount of arms results in an increase in binding 
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affinity, and thus for future designs, it is beneficial to include more arms per 
glycopolymer. 
 In a third project, we investigated the synthesis and use of glycosylated 
polyethylenimine (glycoPEI) for self-amplifying RNA (saRNA) transfection both in vitro 
and ex vivo. Nature’s toolbox, for the synthesis of various biomolecules, exploits all types 
of chemical and physical interactions to achieve function in life. One of the tools that is 
not heavily exploited yet synthetically by humans, is the use of supramolecular 
interactions to achieve functional and biologically relevant materials (apart from drug 
delivery via polymersomes). Here we glycosylated PEI by covalently attaching 
adamantane moieties and subsequently exploiting these adamantane through modified 
β–cyclodextrin host-guest interactions. We showed that although in vitro transfection 
efficiency stifles, glycosylation of the PEIs does enhance the percentage of cells 
expressing saRNA ex vivo in human skin explants. Increasing mannosylation, did 
increase saRNA in epithelial cells specifically, demonstrating our intended targeted 
delivery. 
Lastly, the pièce de résistance, the project combining all three core Natural 
Sciences, was the synthesis and physicochemical characterisation of single-chain 
folding glyconanoparticles and applying them in lectin binding studies. We were able to 
demonstrate that increasing the hydrophobic content along the polymer chain results in 
more compact nanoparticles, which unfortunately meant paying a penalty in lectin-
binding affinity. We were also able to show here that using the directional supramolecular 
interactions of benzene-1,2,3-tricarboxamides (BTA) can be beneficial in lectin-binding 
affinity, as they induce clustering of glycopolymer chains into small multi-chain 
nanoparticles, illustrating the fine balance between intermolecular and intramolecular 
interactions. 
It should be clear, that when designing new glycopolymeric systems in the future 
(be it for drug delivery or as adjuvants or vaccines), molecular architecture plays an 
important role and not only ‘the type of sugar which is used’. We are still a long way from 
achieving absolute control over structure and function as Nature has, but Science has 
achieved tremendous steps forward over the past decade. Undoubtedly, when all 
characteristics for ideal binding affinity (in specific cases) are understood, the novel tools 
of sequence-control and single-chain folding nanotechnology should be able to offer us 
specifically tailored macromolecules in the same way as we are able to make specifically 
tailored small molecules in pharmacology. 
